Per Ljungman

Om mig
Publikationer
Populärvetenskap och samverkan

Om mig

Per Ljungman är emeritus professor i hematology and medlem av KIs etikråd. Han har tidiigare varit verksamhetschef vid Hematologiskt centrum (2004-2013) och allogen stamcellstransplantation (2014 - 2017) vid Karolinska Univeristetssjukhuset. Han är hedersmedlem av
European Society for Blood and Marrow Transplantation och Svensk förening för Hematologi. Han är för närvarande vetenskaplig ordförande för
Transplant Associated Virus Forum vid University of California Berkeley och rådgivare för Adult Immunization Board som organiseras av University of Antwerp och University Degli Studi Firenze.

Forskningsbeskrivning

Virusinfektioner och vaccinationer hos patienter efter allogen stamcellstransplantation

Artiklar

Article: INFECTION. 2024;52(5):1941-1952
Outcome of Human Parainfluenza Virus infection in allogeneic stem cell transplantation recipients: possible impact of ribavirin therapy
Perez A; Montoro J; Chorao P; Gomez D; Guerreiro M; Gimenez E; Villalba M; Sanz J; Hernani R; Hernandez-Boluda JC; Lorenzo I; Navarro D; Solano C; Ljungman P; Pinana JL
Journal article: CURRENT RESEARCH IN TRANSLATIONAL MEDICINE. 2024;72(3):103461
Pitfalls in definitions on respiratory viruses and particularities of Adenovirus infection in hematopoietic cell transplantation patients: Recommendations from the EBMT practice harmonization and guidelines committee
Pinana JL; Cesaro S; Mikulska M; Verweij PE; Bergeron A; Neofytos D; Styczynski J; Sanchez-Ortega I; Greco R; Onida F; Yakoub-Agha I; Averbuch D; de la Camara R; Ljungman P
Article: BONE MARROW TRANSPLANTATION. 2024;59(6):832-837
Harmonizing definitions for hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell transplantation: a report on behalf of the EBMT, ASTCT, CIBMTR, and APBMT
Sureda A; Carpenter PA; Bacigalupo A; Bhatt VR; de la Fuente J; Ho A; Kean L; Lee JW; Sanchez-Ortega I; Savani BN; Schetelig J; Stadtmauer EA; Takahashi Y; Atsuta Y; Koreth J; Kroeger N; Ljungman P; Okamoto S; Popat U; Soiffer R; Stefanski HE; Kharfan-Dabaja MA
Article: JOURNAL OF CLINICAL ONCOLOGY. 2024;42(14):1699-1721
Vaccination of Adults With Cancer: ASCO Guideline
Kamboj M; Bohlke K; Baptiste DM; Dunleavy K; Fueger A; Jones L; Kelkar AH; Law LY; Lefebvre KB; Ljungman P; Miller ED; Meyer LA; Moore HN; Soares HP; Taplitz RA; Woldetsadik ES; Kohn EC
Article: JOURNAL OF CLINICAL ONCOLOGY. 2024;42(12):1378-1390
Patient-Specific Measurable Residual Disease Markers Predict Outcome in Patients With Myelodysplastic Syndrome and Related Diseases After Hematopoietic Stem-Cell Transplantation
Tobiasson M; Pandzic T; Illman J; Nilsson L; Westrom S; Ejerblad E; Olesen G; Bjorklund A; Olsnes Kittang A; Werlenius O; Lorentz F; Rasmussen B; Cammenga J; Weber D; Lindholm C; Wiggh J; Dimitriou M; Moen AE; Lundstrom LY; von Bahr L; Baltzer-Sollander K; Jadersten M; Kytola S; Walldin G; Ljungman P; Groenbaek K; Mielke S; Jacobsen SEW; Ebeling F; Cavelier L; Smidstrup Friis L; Dybedal I; Hellstrom-Lindberg E
Article: BLOOD. 2024;143(11):953-966
Identification and surveillance of rare relapse-initiating stem cells during complete remission after transplantation
Dimitriou M; Mortera-Blanco T; Tobiasson M; Mazzi S; Lehander M; Hoegstrand K; Karimi M; Walldin G; Jansson M; Vonlanthen S; Ljungman P; Langemeijer S; Yoshizato T; Hellstroem-Lindberg E; Woll PS; Jacobsen SEW
Article: CELL HOST AND MICROBE. 2024;32(2):156-161.e3
Memory T cells effectively recognize the SARS-CoV-2 hypermutated BA.2.86 variant
Muller TR; Gao Y; Wu J; Ribeiro O; Chen P; Bergman P; Blennow O; Hansson L; Mielke S; Nowak P; Vesterbacka J; Akber M; Soderdahl G; Smith CIE; Lore K; Chen MS; Ljungman P; Ingelman-Sundberg HM; Ljunggren H-G; Osterborg A; Sette A; Grifoni A; Aleman S; Buggert M
Article: JOURNAL OF INFECTIOUS DISEASES. 2024;229(1):83-94
Upper and/or Lower Respiratory Tract Infection Caused by Human Metapneumovirus After Allogeneic Hematopoietic Stem Cell Transplantation
Luis Pinana J; Tridello G; Xhaard A; Wendel L; Montoro J; Vazquez L; Heras I; Ljungman P; Mikulska M; Salmenniemi U; Perez A; Kroeger N; Cornelissen J; Sala E; Martino R; Geurten C; Byrne J; Maertens J; Kerre T; Martin M; Jesus Pascual M; Yeshurun M; Finke J; Groll AH; Shaw PJ; Blijlevens N; Arcese W; Ganser A; Suarez-Lledo M; Alzahrani M; Choi G; Forcade E; Paviglianiti A; Solano C; Wachowiak J; Zuckerman T; Bader P; Clausen J; Mayer J; Schroyens W; Metafuni E; Knelange N; Averbuch D; de la Camara R
Article: JOURNAL OF NEUROLOGY, NEUROSURGERY AND PSYCHIATRY. 2024;95(2):125-133
Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study
Silfverberg T; Zjukovskaja C; Ljungman P; Nahimi A; Ahlstrand E; Dreimane A; Einarsdottir S; Fagius J; Iacobaeus E; Hagglund H; Lange N; Lenhoff S; Lycke J; Mellergard J; Piehl F; Svenningsson A; Tolf A; Cherif H; Carlson K; Burman J
Article: BONE MARROW TRANSPLANTATION. 2024;59(1):52-58
Outcomes for patients with EBV-positive PTLD post-allogeneic HCT after failure of rituximab-containing therapy
Socie G; Barba P; Barlev A; Sanz J; Garcia-Cadenas I; Chevallier P; Fagioli F; Guzman-Becerra N; Kumar D; Ljungman P; Pigneux A; Sadetsky N; San Segundo LY; Shadman M; Storek J; Thirumalai D; Xing B; Mohty M
Article: BONE MARROW TRANSPLANTATION. 2024;59(1):59-65
Prevalence, management, and new treatment modalities of EBV-DNA-emia and EBV-PTLD after allo-HCT: survey of Infectious Diseases Working Party EBMT
Styczynski J; Tridello G; Wendel L; Knelange N; Cesaro S; Gil L; Ljungman P; Mikulska M; Averbuch D; de la Camara R
Article: BMJ OPEN. 2023;13(12):e078023
ProFertil study protocol for the investigation of gonadotropin-releasing hormone agonists (GnRHa) during chemotherapy aiming at fertility protection of young women and teenagers with cancer in Sweden-a phase III randomised double-blinded placebo-controlled study
Rodriguez-Wallberg KA; Nilsson HP; Bergh J; Malmros J; Ljungman P; Foukakis T; Stragliotto CL; Friman EI; Linderholm B; Valachis A; Andersson A; Harrysson S; Vennstrom L; Frisk P; Moerse H; Eloranta S
Article: BONE MARROW TRANSPLANTATION. 2023;58(12):1348-1356
Fresh or frozen grafts for allogeneic stem cell transplantation: conceptual considerations and a survey on the practice during the COVID-19 pandemic from the EBMT Infectious Diseases Working Party (IDWP) and Cellular Therapy & Immunobiology Working Party (CTIWP)
Worel N; Ljungman P; Verheggen ICM; Hoogenboom JD; Knelange NS; Eikema D-J; Sanchez-Ortega I; Riillo C; Centorrino I; Averbuch D; Chabannon C; de la Camara R; Kuball J; Ruggeri A
Article: CLINICAL INFECTIOUS DISEASES. 2023;77(8):1102-1110
A Phase 3, Randomized, Double-Blind, Comparator-Controlled Study to Evaluate Safety, Tolerability, and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, in Allogeneic Hematopoietic Cell Transplant Recipients (PNEU-STEM)
Wilck M; Cornely OA; Cordonnier C; Diego Velez J; Ljungman P; Maertens J; Selleslag D; Mullane KM; Nabhan S; Chen Q; Dagan R; Richmond P; Daus C; Geddie K; Tamms G; Sterling T; Patel SM; Shekar T; Musey L; Buchwald UK
Article: OPEN FORUM INFECTIOUS DISEASES. 2023;10(8):ofad386
Impact of Baseline and Week 2 and Week 4 Posttransplant CMV Cell-Mediated Immunity on Risk of CMV Infections and Mortality in Recipients of Allogeneic Hematopoietic Cell Transplant
Ariza-Heredia EJ; Winston DJ; Rowley SD; Mullane K; Chandrasekar P; Hari P; Avery RK; Peggs KS; Kumar D; Nath R; Ljungman P; Mossad SB; El Haddad L; Shah DP; Jiang Y; Khawaja F; Dadwal S; Blanchard T; Chemaly RF
Article: BONE MARROW TRANSPLANTATION. 2023;58(8):881-892
Decrease of lethal infectious complications in the context of causes of death (COD) after hematopoietic cell transplantation: COD-2 and COD-1 study of the Infectious Diseases Working Party EBMT
Styczynski J; Tridello G; Koster L; Knelange N; Wendel L; van Biezen A; van der Werf S; Mikulska M; Gil L; Cordonnier C; Ljungman P; Averbuch D; Cesaro S; Baldomero H; Chabannon C; Corbacioglu S; Dolstra H; Glass B; Greco R; Kroeger N; de Latour RP; Mohty M; Neven B; Peric Z; Snowden JA; Sureda A; Yakoub-Agha I; de la Camara R
Article: EBIOMEDICINE. 2023;94:104700
Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a one-year follow-up of the prospective clinical trial COVAXID
Chen P; Bergman P; Blennow O; Hansson L; Mielke S; Nowak P; Soderdahl G; oesterborg A; Smith CIE; Vesterbacka J; Wullimann D; Cuapio A; Akber M; Bogdanovic G; Muschiol S; aberg M; Lore K; Chen MS; Buggert M; Ljungman P; Aleman S; Ljunggren H-G
Article: SCIENCE TRANSLATIONAL MEDICINE. 2023;15(704):eadg9452
Additive effects of booster mRNA vaccination and SARS-CoV-2 Omicron infection on T cell immunity across immunocompromised states
Muller TRR; Sekine T; Trubach D; Niessl J; Chen P; Bergman P; Blennow O; Hansson L; Mielke S; Nowak P; Vesterbacka J; Akber M; Olofsson A; Hernandez SPA; Gao Y; Cai C; Soderdahl G; Smith CIE; Osterborg A; Lore K; Sallberg Chen M; Ljungman P; Ljunggren H-G; Karlsson ACC; Saini SK; Aleman S; Buggert M
Article: JOURNAL OF AUTOIMMUNITY. 2023;136:103024
Outcome of SARS-CoV2 infection in hematopoietic stem cell transplant recipients for autoimmune diseases
Greco R; Snowden JA; Knelange NS; Tridello G; Cacciatore C; Xhaard A; Ciceri F; Collin M; Ferra C; De Becker A; Badoglio M; Averbuch D; Alexander T; Ljungman P; De la Camara R
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2023;29(4):275.e1-275.e5
Long-Term Immunity Against Tetanus and Diphtheria after Vaccination of Allogeneic Stem Cell Transplantation Recipients
Einarsdottir S; Sverrisdottir I; Vaht K; Bergstrom T; Brune M; Andersson P-O; Wenneras C; Ljungman P
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2023;110(3):313-321
Bone marrow expression of CD68/CD163 macrophages, IL-17 and FOXP3 cells in aplastic anemia and their relation to prognosis
Vaht K; Brenner J; Ednersson SB; Ljungman P; Brune M; Andersson P-O
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2023;29(3):151-163
Harmonizing Definitions for Diagnostic Criteria and Prognostic Assessment of Transplantation-Associated Thrombotic Microangiopathy: A Report on Behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation and Cellular Therapy, Asia-Pacific Blood and Marrow Transplantation Group, and Center for International Blood and Marrow Transplant Research
Schoettler ML; Carreras E; Cho B; Dandoy CE; Ho VT; Jodele S; Moissev I; Sanchez-Ortega I; Srivastava A; Atsuta Y; Carpenter P; Koreth J; Kroger N; Ljungman P; Page K; Popat U; Shaw BE; Sureda A; Soiffer R; Vasu S
Article: BONE MARROW TRANSPLANTATION. 2023;58(2):203-208
New trends in the management of cytomegalovirus infection after allogeneic hematopoietic cell transplantation: a survey of the Infectiois Diseases Working Pary of EBMT
Cesaro S; Ljungman P; Tridello G; Mikulska M; Wendel L; Styczynski J; Averbuch D; de la Camara R
Article: FRONTIERS IN IMMUNOLOGY. 2023;14:1125824
Improved outcomes over time and higher mortality in CMV seropositive allogeneic stem cell transplantation patients with COVID-19; An infectious disease working party study from the European Society for Blood and Marrow Transplantation registry
Ljungman P; Tridello G; Pinana JL; Ciceri F; Sengeloev H; Kulagin A; Mielke S; Yegin ZA; Collin M; Einardottir S; Lepretre SD; Maertens J; Campos A; Metafuni E; Pichler H; Folber F; Solano C; Nicholson E; Yuksel MK; Carlson K; Aguado B; Besley C; Byrne J; Heras I; Dignan F; Kroger N; Robin C; Khan A; Lenhoff S; Grassi A; Dobsinska V; Miranda N; Jimenez M-J; Yonal-Hindilerden I; Wilson K; Averbuch D; Cesaro S; Xhaard A; Knelange N; Styczynski J; Mikulska M; de la Camara R
Article: CLINICAL INFECTIOUS DISEASES. 2022;75(7):1210-1216
Consensus Definitions of BK Polyomavirus Nephropathy in Renal Transplant Recipients for Clinical Trials
Imlay H; Baum P; Brennan DC; Hanson KE; Hodges MR; Hodowanec AC; Komatsu TE; Ljungman P; Miller V; Natori Y; Nickeleit V; O'Rear J; Pikis A; Randhawa PS; Sawinski D; Singh HK; Westman G; Limaye AP
Article: IMMUNITY. 2022;55(9):1732-1746.e5
Immunodeficiency syndromes differentially impact the functional profile of SARS-CoV-2-specific T cells elicited by mRNA vaccination
Gao Y; Cai C; Wullimann D; Niessl J; Rivera-Ballesteros O; Chen P; Lange J; Cuapio A; Blennow O; Hansson L; Mielke S; Nowak P; Vesterbacka J; Akber M; Perez-Potti A; Sekine T; Muller TR; Boulouis C; Kammann T; Parrot T; Muvva JR; Sobkowiak M; Healy K; Bogdanovic G; Muschiol S; Soderdahl G; Osterborg A; Hellgren F; Grifoni A; Weiskopf D; Sette A; Lore K; Chen MS; Ljungman P; Sandberg JK; Smith CIE; Bergman P; Ljunggren H-G; Aleman S; Buggert M
Article: VIRUSES. 2022;14(7):1350
The Importance of Secretor-Status in Norovirus Infection Following Allogeneic Hematopoietic Stem Cell Transplantation
Swartling L; Sparrelid E; Ljungman P; Boriskina K; Valentini D; Svensson L; Nordgren J
Article: JOURNAL OF CLINICAL MEDICINE. 2022;11(12):3541
Complications of Autologous Stem Cell Transplantation in Multiple Myeloma: Results from the CALM Study
Waszczuk-Gajda A; Penack O; Sbianchi G; Koster L; Blaise D; Remenyi P; Russell N; Ljungman P; Trneny M; Mayer J; Iacobelli S; Kobbe G; Scheid C; Apperley J; Touzeau C; Lenhoff S; Jantunen E; Anagnostopoulos A; Paris L; Browne P; Thieblemont C; Schaap N; Sierra J; Yakoub-Agha I; Garderet L; Styczynski J; Schoemans H; Moiseev I; Duarte RF; Peric Z; Montoto S; van Biezen A; Mikulska M; Aljurf M; Ruutu T; Kroeger N; Morris C; Koenecke C; Schoenland S; Basak GW
Article: BLOOD ADVANCES. 2022;6(9):2723-2730
Deficiency of SARS-CoV-2 T-cell responses after vaccination in long-term allo-HSCT survivors translates into abated humoral immunity
Einarsdottir S; Martner A; Waldenstrom J; Nicklasson M; Ringlander J; Arabpour M; Tornell A; Wiktorin HG; Nilsson S; Bittar R; Nilsson M; Lisak M; Veje M; Friman V; Al-Dury S; Bergstrom T; Ljungman P; Brune M; Hellstrand K; Lagging M
Article: BONE MARROW TRANSPLANTATION. 2022;57(5):817-823
Allogeneic hematopoietic stem cell transplantation for adult HLH: a retrospective study by the chronic malignancies and inborn errors working parties of EBMT
Machowicz R; Suarez F; Wiktor-Jedrzejczak W; Eikema D-J; de Wreede LC; Blok H-J; Isaksson C; Einsele H; Poire X; van Dorp S; Nikolousis E; Johansson J-E; Kobbe G; Zecca M; Arnold R; Gerbitz A; Finke J; Diez-Martin JL; Bonifazi F; McQuaker G; Lenhoff S; Rohrlich P-S; Theobald M; Ljungman P; Collin M; Albert MH; Ehninger G; Carlson K; Halaburda K; Lehmberg K; Schoenland S; Yakoub-Agha I; Gennery AR; Lankester AC; Kroeger N
Article: BONE MARROW TRANSPLANTATION. 2022;57(5):795-802
Cancer incidence in healthy Swedish peripheral blood stem cell donors
Pahnke S; Nygell UA; Johansson J-E; Kisch A; Ljungman P; Sandstedt A; Hagglund H; Larfors G
Article: AMERICAN JOURNAL OF HEMATOLOGY. 2022;97(4):421-430
Adverse outcomes in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: Follow-up of patients diagnosed 2002-2017 in a complete coverage and nationwide agnostic register study
Dahlen T; Edgren G; Ljungman P; Flygt H; Richter J; Olsson-Stromberg U; Wadenvik H; Dreimane A; Myhr-Eriksson K; Zhao J; Sjalander A; Hoglund M; Stenke L
Article: BONE MARROW TRANSPLANTATION. 2022;57(4):598-606
Failure to reach hematopoietic allogenic stem cell transplantation in patients with myelodysplastic syndromes planned for transplantation: a population-based study
Lindholm C; Olofsson E; Creignou M; Nilsson L; Garelius HG; Cammenga J; Ljungman P; Ejerblad E; Tobiasson M
Article: CELL REPORTS MEDICINE. 2022;3(2):100508
Autologous NK cells as consolidation therapy following stem cell transplantation in multiple myeloma
Nahi H; Chrobok M; Meinke S; Gran C; Marquardt N; Afram G; Sutlu T; Gilljam M; Stellan B; Wagner AK; Blomberg P; Holmqvist P-H; Walther-Jallow L; Mellstrom K; Liwing J; Gustafsson C; Mansson R; Klimkowska M; Gahrton G; Lund J; Ljungman P; Ljunggren H-G; Alici E
Article: MED. 2022;3(2):137-153.e3
Salivary IgG to SARS-CoV-2 indicates seroconversion and correlates to serum neutralization in mRNA-vaccinated immunocompromised individuals
Healy K; Pin E; Chen P; Soderdahl G; Nowak P; Mielke S; Hansson L; Bergman P; Smith CIE; Ljungman P; Valentini D; Blennow O; Osterborg A; Gabarrini G; Al-Manei K; Alkharaan H; Sobkowiak MJ; Yousef J; Mravinacova S; Cuapio A; Xu X; Akber M; Lore K; Hellstrom C; Muschiol S; Bogdanovic G; Buggert M; Ljunggren H-G; Hober S; Nilsson P; Aleman S; Chen MS
Article: MOLECULAR MEDICINE. 2022;28(1):20
NK cell frequencies, function and correlates to vaccine outcome in BNT162b2 mRNA anti-SARS-CoV-2 vaccinated healthy and immunocompromised individuals
Cuapio A; Boulouis C; Filipovic I; Wullimann D; Kammann T; Parrot T; Chen P; Akber M; Gao Y; Hammer Q; Strunz B; Potti AP; Ballesteros OR; Lange J; Muvva JR; Bergman P; Blennow O; Hansson L; Mielke S; Nowak P; Soderdahl G; Osterborg A; Smith CIE; Bogdanovic G; Muschiol S; Hellgren F; Lore K; Sobkowiak MJ; Gabarrini G; Healy K; Chen MS; Alici E; Bjorkstrom NK; Buggert M; Ljungman P; Sandberg JK; Aleman S; Ljunggren H-G
Article: BONE MARROW TRANSPLANTATION. 2022;57(2):215-223
Long-term results and GvHD after prophylactic and preemptive donor lymphocyte infusion after allogeneic stem cell transplantation for acute leukemia
Schmid C; Labopin M; Schaap N; Veelken H; Brecht A; Stadler M; Finke J; Baron F; Collin M; Bug G; Ljungman P; Blaise D; Tischer J; Bloor A; Kulagin A; Giebel S; Gorin N-C; Esteve J; Ciceri F; Savani B; Nagler A; Mohty M
Article: FRONTIERS IN IMMUNOLOGY. 2022;13:1027593
Different recovery patterns of CMV-specific and WT1-specific T cells in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: Impact of CMV infection and leukemia relapse
Luo X-H; Poiret T; Liu Z; Meng Q; Nagchowdhury A; Ljungman P
Article: JOURNAL OF INFECTION. 2022;84(1):71-79
Efficacy, safety and feasibility of treatment of chronic HCV infection with directly acting agents in hematopoietic stem cell transplant recipients - Study of infectious diseases working party of EBMT
Mikulska M; Knelange N; Nicolini LA; Tridello G; Santarone S; Di Bartolomeo P; de la Camara R; Cuellar C; Velardi A; Perruccio K; Ljungman P; Zaucha J; Piekarska A; Basak G; Karakulska-Prystupiuk E; Angelucci E; Ciceri F; Lupo-Stanghellini MT; Fouillard L; Garcia-Cadenas I; Menconi M; Blau IW; Nassi L; Cesaro S; Styczynski J
Article: FRONTIERS IN IMMUNOLOGY. 2022;13:1079995
Persistence of salivary antibody responses after COVID-19 vaccination is associated with oral microbiome variation in both healthy and people living with HIV
Ghorbani M; Al-Manei K; Naud S; Healy K; Gabarrini G; Sobkowiak MJ; Chen P; Ray S; Akber M; Muschiol S; Bogdanovic G; Bergman P; Ljungman P; Buggert M; Ljunggren H-G; Pin E; Nowak P; Aleman S; Saellberg Chen M
Article: HEMATOLOGY. AMERICAN SOCIETY OF HEMATOLOGY. EDUCATION PROGRAM. 2021;2021(1):587-591
Infectious complications and vaccines
Ljungman P
Article: JOURNAL OF CANCER SURVIVORSHIP. 2021;15(6):933-941
Important factors associated with sick leave after allogeneic haematopoietic stem cell transplantation-a 1-year prospective study
Eriksson L; Wennman-Larsen A; Bergkvist K; Ljungman P; Winterling J
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2021;27(12):991.e1-991.e9
Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelomonocytic Leukemia: Clinical and Molecular Genetic Prognostic Factors in a Nordic Population
Wedge E; Hansen JW; Dybedal I; Creignou M; Ejerblad E; Lorenz F; Werlenius O; Ungerstedt J; Holm MS; Nilsson L; Kittang AO; Antunovic P; Rohon P; Andersen MK; Papaemmanuil E; Bernard E; Jadersten M; Hellstrom-Lindberg E; Gronbaek K; Ljungman P; Friis LS
Article: EBIOMEDICINE. 2021;74:103705
Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial
Bergman P; Blennow O; Hansson L; Mielke S; Nowak P; Chen P; Soderdahl G; Osterborg A; Smith CIE; Wullimann D; Vesterbacka J; Lindgren G; Blixt L; Friman G; Wahren-Borgstrom E; Nordlander A; Gomez AC; Akber M; Valentini D; Norlin A-C; Thalme A; Bogdanovic G; Muschiol S; Nilsson P; Hober S; Lore K; Chen MS; Buggert M; Ljunggren H-G; Ljungman P; Aleman S
Article: BONE MARROW TRANSPLANTATION. 2021;56(10):2367-2381
Second allogeneic transplants for multiple myeloma: a report from the EBMT Chronic Malignancies Working Party
Hayden PJ; Eikema D-J; de Wreede LC; Koster L; Kroger N; Einsele H; Minnema M; Dominietto A; Potter M; Passweg J; Bermudez A; Nguyen-quoc S; Platzbecker U; Tischer J; Ciceri F; Veelken JH; Ljungman P; Schaap N; Forcade E; Carella AM; Gandemer V; Arcese W; Bloor A; Olivieri A; Vincent L; Beksac M; Schonland S; Yakoub-Agha I
Article: LEUKEMIA. 2021;35(10):2885-2894
COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey
Ljungman P; de la Camara R; Mikulska M; Tridello G; Aguado B; Al Zahrani M; Apperley J; Berceanu A; Bofarull RM; Calbacho M; Ciceri F; Lopez-Corral L; Crippa C; Fox ML; Grassi A; Jimenez M-J; Demir SK; Kwon M; Llamas CV; Lorenzo JLL; Mielke S; Orchard K; Porras RP; Vallisa D; Xhaard A; Knelange NS; Cedillo A; Kroger N; Pinana JL; Styczynski J
Article: BONE MARROW TRANSPLANTATION. 2021;56(10):2518-2532
Special issues related to the diagnosis and management of acquired aplastic anemia in countries with restricted resources, a report on behalf of the Eastern Mediterranean blood and marrow transplantation (EMBMT) group and severe aplastic anemia working party of the European Society for blood and marrow transplantation (SAAWP of EBMT)
Iftikhar R; Ahmad P; de Latour R; Dufour C; Risitano A; Chaudhri N; Bazarbachi A; De la Fuente J; Hoechsmann B; Ahmed SO; Gergis U; Elhaddad A; Halkes C; Albeirouti B; Alotaibi S; Kulasekararaj A; Alzahrani H; Ben Othman T; Cesaro S; Alahmari A; Rihani R; Alshemmari S; Hamidieh AA; Bekadja M-A; Passweg J; Al-Khabori M; Rasheed W; Bacigalupo A; Chaudhry Q-U; Ljungman P; Marsh J; El Fakih R; Aljurf M
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2021;194(1):145-157
Incidence and impact of community respiratory viral infections in post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis and haploidentical stem cell transplantation
Mulroney CM; Bilal Abid M; Bashey A; Chemaly RF; Ciurea SO; Chen M; Dandoy CE; Diaz Perez MA; Friend BD; Fuchs E; Ganguly S; Goldsmith SR; Kanakry CG; Kim S; Komanduri KV; Krem MM; Lazarus HM; Ljungman P; Maziarz R; Nishihori T; Patel SS; Perales M-A; Romee R; Singh AK; Reid Wingard J; Yared J; Riches M; Taplitz R
Article: BONE MARROW TRANSPLANTATION. 2021;56(7):1493-1508
Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendations
Greco R; Alexander T; Burman J; Del Papa N; de Vries-Bouwstra J; Farge D; Henes J; Kazmi M; Kirgizov K; Muraro PA; Ricart E; Rovira M; Saccardi R; Sharrack B; Snarski E; Withers B; Jessop H; Boglione C; Kramer E; Badoglio M; Labopin M; Orchard K; Corbacioglu S; Ljungman P; Mikulska M; De la Camara R; Snowden JA
Article: BONE MARROW TRANSPLANTATION. 2021;56(7):1563-1572
Impact of early candidemia on the long-term outcome of allogeneic hematopoietic stem cell transplant in non-leukemic patients: an outcome analysis on behalf of IDWP-EBMT
Cesaro S; Tridello G; Knelange NS; Blijlevens N; Martin M; Snowden JA; Malladi R; Ljungman P; Deconinck E; Gedde-Dahl T; Byrne J; Xhaard A; Chevallier P; Maertens J; Zuckerman T; Lioure B; Petersen E; Cornelissen JJ; Arcese W; Blaise D; Milpied N; Cahn JY; Aljurf M; de Wreede L; Mauro M; de la Camara R; Averbuch D; Mikulska M; Styczynski J
Article: BLOOD. 2021;137(23):3291-3305
Posttransplant cyclophosphamide is associated with increased cytomegalovirus infection: a CIBMTR analysis
Goldsmith SR; Abid MB; Auletta JJ; Bashey A; Beitinjaneh A; Castillo P; Chemaly RF; Chen M; Ciurea S; Dandoy CE; Diaz MA; Fuchs E; Ganguly S; Kanakry CG; Kanakry JA; Kim S; Komanduri KV; Krem MM; Lazarus HM; Liu H; Ljungman P; Masiarz R; Mulroney C; Nathan S; Nishihori T; Page KM; Perales M-A; Taplitz R; Romee R; Riches M
Article: BONE MARROW TRANSPLANTATION. 2021;56(5):1171-1179
Use of letermovir in off-label indications: Infectious Diseases Working Party of European Society of Blood and Marrow Transplantation retrospective study
Styczynski J; Tridello G; Xhaard A; Medinger M; Mielke S; Taskinen M; Blijlevens N; Rodriguez MAB; Solano C; Nikolousis E; Biffi A; Groll AH; Junghanss C; Tsirigotis P; Lioure B; Sramek J; Holler E; Galaverna F; Fagioli F; Knelange N; Wendel L; Gil L; de la Camara R; Mikulska M; Ljungman P
Article: BMJ OPEN. 2021;11(3):e044483
A randomised, open-label trial to assess the optimal treatment strategy in early diffuse cutaneous systemic sclerosis: the UPSIDE study protocol
Spierings J; van Rhenen A; Welsing PMW; Marijnissen ACA; De Langhe E; Del Papa N; Dierickx D; Gheorghe KR; Henes J; Hesselstrand R; Kerre T; Ljungman P; van de Loosdrecht AA; Marijt EWAF; Mayer M; Schmalzing M; Schroers R; Smith V; Voll RE; Vonk MC; Voskuyl AE; de Vries-Bouwstra JK; Walker UA; Wuttge DM; van Laar JM
Article: ECLINICALMEDICINE. 2021;33:100787
A randomised, placebo-controlled phase 3 study to evaluate the efficacy and safety of ASP0113, a DNA-based CMV vaccine, in seropositive allogeneic haematopoietic cell transplant recipients
Ljungman P; Bermudez A; Logan AC; Kharfan-Dabaja MA; Chevallier P; Martino R; Wulf G; Selleslag D; Kakihana K; Langston A; Lee D-G; Solano C; Okamoto S; Smith LR; Boeckh M; Wingard JR; Cywin B; Fredericks C; Lademacher C; Wang X; Young J; Maertens J
Article: ANNALS OF HEMATOLOGY. 2021;100(3):779-787
Abatacept as salvage therapy in chronic graft-versus-host disease-a retrospective analysis
Wertheimer T; Dohse M; Afram G; Weber D; Heidenreich M; Holler B; Kattner A-S; Neubauer A; Mielke S; Ljungman P; Holler E; Herr W; Edinger M; Martinez AP; Fante M; Wolff D
Article: VACCINE. 2021;39(7):1035-1038
Vaccination against tick-borne encephalitis (TBE) after autologous and allogeneic stem cell transplantation
Einarsdottir S; Nicklasson M; Veje M; Bergstrom T; Studahl M; Lisak M; Olsson M; Johansson B; Andreasson B; Piauger B; Roth A; Friman V; Ljungman P; Brune M
Article: BLOOD ADVANCES. 2021;5(1):262-273
Allogeneic hematopoietic stem cell transplantation in leukocyte adhesion deficiency type I and III
Bakhtiar S; Salzmann-Manrique E; Blok H-J; Eikema D-J; Hazelaar S; Ayas M; Toren A; Goldstein G; Moshous D; Locatelli F; Merli P; Michel G; Ozturk G; Schulz A; Heilmann C; Ifversen M; Wynn RF; Aleinikova O; Bertrand Y; Tbakhi A; Veys P; Karakukcu M; Kupesiz A; Ghavamzadeh A; Handgretinger R; Unal E; Perez-Martinez A; Gokce M; Porta F; Aksu T; Karasu G; Badell I; Ljungman P; Skorobogatova E; Yesilipek A; Zuckerman T; Bredius RRG; Stepensky P; Shadur B; Slatter M; Gennery AR; Albert MH; Bader P; Lankester A
Article: BONE MARROW TRANSPLANTATION. 2021;56(1):210-217
Upfront stem cell transplantation for newly diagnosed multiple myeloma with del(17p) and t(4;14): a study from the CMWP-EBMT
Gagelmann N; Eikema D-J; de Wreede LC; Rambaldi A; Iacobelli S; Koster L; Caillot D; Blaise D; Rememyi P; Bulabois C-E; Passweg J; Leleu X; Zver S; Kobbe G; Ljungman P; Chevallier P; Ringhoffer M; Martin M; Salmenniemi U; Poire X; Lenhoff S; Pioltelli P; Mordini N; Delforge M; Garderet L; Schoenland S; Yakoub-Agha I; Kroeger N
Article: CLINICAL INFECTIOUS DISEASES. 2020;71(11):2777-2786
A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant Recipients
Chemaly RF; Dadwal SS; Bergeron A; Ljungman P; Kim Y-J; Cheng G-S; Pipavath SN; Limaye AP; Blanchard E; Winston DJ; Stiff PJ; Zuckerman T; Lachance S; Rahav G; Small CB; Mullane KM; Patron RL; Lee D-G; Hirsch HH; Waghmare A; McKevitt M; Jordan R; Guo Y; German P; Porter DP; Gossage DL; Watkins TR; Marty FM; Chien JW; Boeckh M
Article: CLINICAL INFECTIOUS DISEASES. 2020;71(11):2787-2795
A Phase 2b, Randomized, Double-blind, Placebo-Controlled Multicenter Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of Presatovir in Hematopoietic Cell Transplant Recipients with Respiratory Syncytial Virus Infection of the Lower Respiratory Tract
Marty FM; Chemaly RF; Mullane KM; Lee D-G; Hirsch HH; Small CB; Bergeron A; Shoham S; Ljungman P; Waghmare A; Blanchard E; Kim Y-J; McKevitt M; Porter DP; Jordan R; Guo Y; German P; Boeckh M; Watkins TR; Chien JW; Dadwal SS
Article: CLINICAL INFECTIOUS DISEASES. 2020;71(9):2365-2374
Cytomegalovirus (CMV) Cell-Mediated Immunity and CMV Infection After Allogeneic Hematopoietic Cell Transplantation: The REACT Study
Chemaly RF; El Haddad L; Winston DJ; Rowley SD; Mulane KM; Chandrasekar P; Avery RK; Hari P; Peggs KS; Kumar D; Nath R; Ljungman P; Mossad SB; Dadwal SS; Blanchard T; Shah DP; Jiang Y; Ariza-Heredia E
Article: JOURNAL OF INFECTION. 2020;81(6):882-894
Intercontinental study on pre-engraftment and post-engraftment Gram-negative rods bacteremia in hematopoietic stem cell transplantation patients: Risk factors and association with mortality
Averbuch D; Tridello G; Hoek J; Mikulska M; Pabst T; Yanez San Segundo L; Akan H; Ozcelik T; Donnini I; Klyasova G; de Sousa AB; Zuckerman T; Tecchio C; de la Camara R; Aki SZ; Ljungman P; Gulbas Z; Nicolas-Virelizier E; Calore E; Perruccio K; Ram R; Annaloro C; Martino R; Avni B; Shaw PJ; Jungova A; Codeluppi K; O'Brien T; Waszczuk-Gajda A; Batlle M; Pouli A; Lueck C; Gil L; Iacobelli S; Styczynski J; Engelhard D; Cesaro S
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2020;26(12):2181-2189
Real-World Issues and Potential Solutions in Hematopoietic Cell Transplantation during the COVID-19 Pandemic: Perspectives from the Worldwide Network for Blood and Marrow Transplantation and Center for International Blood and Marrow Transplant Research Health Services and International Studies Committee
Algwaiz G; Aljurf M; Koh M; Horowitz MM; Ljungman P; Weisdorf D; Saber W; Kodera Y; Szer J; Jawdat D; Wood WA; Brazauskas R; Lehmann L; Pasquini MC; Seber A; Lu PH; Atsuta Y; Riches M; Perales M-A; Worel N; Okamoto S; Srivastava A; Chemaly RF; Cordonnier C; Dandoy CE; Wingard JR; Kharfan-Dabaja MA; Hamadani M; Majhail NS; Waghmare AA; Chao N; Kroger N; Shaw B; Mohty M; Niederwieser D; Greinix H; Hashmi SK
Article: BONE MARROW TRANSPLANTATION. 2020;55(11):2071-2076
The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy
Ljungman P; Mikulska M; de la Camara R; Basak GW; Chabannon C; Corbacioglu S; Duarte R; Dolstra H; Lankester AC; Mohty M; Montoto S; Murray J; de Latour RP; Snowden JA; Yakoub-Agha I; Verhouven B; Kroeger N; Styczynski J
Article: STEM CELLS TRANSLATIONAL MEDICINE. 2020;9(10):1190-1202
Treatment of chronicGvHDwith mesenchymal stromal cells induces durable responses: A phaseIIstudy
Boberg E; von Bahr L; Afram G; Lindstrom C; Ljungman P; Heldring N; Petzelbauer P; Legert KG; Kadri N; Le Blanc K
Article: BLOOD. 2020;136(10):1201-1211
Hematopoietic cell transplantation in chronic granulomatous disease: a study of 712 children and adults
Chiesa R; Wang J; Blok H-J; Hazelaar S; Neven B; Moshous D; Schulz A; Hoenig M; Hauck F; Al Seraihy A; Gozdzik J; Ljungman P; Lindemans CA; Fernandes JF; Kalwak K; Strahm B; Schanz U; Sedlacek P; Sykora K-W; Aksoylar S; Locatelli F; Stepensky P; Wynn R; Lurn SH; Zecca M; Porta F; Taskinen M; Gibson B; Matthes S; Karakukcu M; Hauri-Hohl M; Veys P; Gennery AR; Lucchini G; Felber M; Albert MH; Balashov D; Lankester A; Gungor T; Slatter MA
Article: BONE MARROW TRANSPLANTATION. 2020;55(9):1796-1809
Long-term outcome after allogeneic hematopoietic stem cell transplantation for Shwachman-Diamond syndrome: a retrospective analysis and a review of the literature by the Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation (SAAWP-EBMT)
Cesaro S; Pillon M; Sauer M; Smiers F; Faraci M; de Heredia CD; Wynn R; Greil J; Locatelli F; Veys P; Uyttebroeck A; Ljungman P; Chevalier P; Ansari M; Badell I; Guengoer T; Salim R; Tischer J; Tecchio C; Russell N; Chybicka A; Styzynski J; Krivan G; Smith O; Stein J; Afanasyev B; Pochon C; Menconi MC; Bosman P; Mauro M; Tridello G; de Latour RP; Dufour C
Article: PEDIATRIC BLOOD AND CANCER. 2020;67(9):e28507
A prospective study on the long-term outcome of prepubertal and pubertal boys undergoing testicular biopsy for fertility preservation prior to hematologic stem cell transplantation
Borgstrom B; Fridstrom M; Gustafsson B; Ljungman P; Rodriguez-Wallberg KA
Article: ONCOIMMUNOLOGY. 2020;9(1):1792058
Complete and long-lasting clinical responses in immune checkpoint inhibitor-resistant, metastasized melanoma treated with adoptive T cell transfer combined with DC vaccination
Lovgren T; Wolodarski M; Wickstrom S; Edback U; Wallin M; Martell E; Markland K; Blomberg P; Nystrom M; Lundqvist A; Jacobsson H; Ullenhag G; Ljungman P; Hansson J; Masucci G; Tell R; Poschke I; Adamson L; Mattsson J; Kiessling R
Article: BONE MARROW TRANSPLANTATION. 2020;55(7):1255-1263
Hepatitis E virus is an infrequent but potentially serious infection in allogeneic hematopoietic stem cell transplant recipients
Swartling L; Norden R; Samuelsson E; Boriskina K; Valentini D; Westin J; Norder H; Sparrelid E; Ljungman P
Article: AMERICAN JOURNAL OF TRANSPLANTATION. 2020;20(6):1703-1711
Outcomes of patients with detectable CMV DNA at randomization in the phase III trial of letermovir for the prevention of CMV infection in allogeneic hematopoietic cell transplantation
Marty FM; Ljungman PT; Chemaly RF; Wan H; Teal VL; Butterton JR; Yeh WW; Leavitt RY; Badshah CS
Article: CLINICAL INFECTIOUS DISEASES. 2020;70(8):1525-1533
A Mortality Analysis of Letermovir Prophylaxis for Cytomegalovirus (CMV) in CMV-seropositive Recipients of Allogeneic Hematopoietic Cell Transplantation
Ljungman P; Schmitt M; Marty FM; Maertens J; Chemaly RF; Kartsonis NA; Butterton JR; Wan H; Teal VL; Sarratt K; Murata Y; Leavitt RY; Badshah C
Article: JOURNAL OF NEUROLOGY. 2020;267(2):430-439
Central nervous system disorders after hematopoietic stem cell transplantation: a prospective study of the Infectious Diseases Working Party of EBMT
Schmidt-Hieber M; Engelhard D; Ullmann A; Ljungman P; Maertens J; Martino R; Rovira M; Shaw PJ; Robin C; Faraci M; Byrne J; Schaefer-Eckart K; Einsele H; Faber E; Rigacci L; Saccardi R; Balaguer-Rosello A; Isaksson C; Christopeit M; Tridello G; Wang J; Knelange N; Mikulska M; Cesaro S; Styczynski J
Article: VACCINE. 2020;38(5):1084-1088
Humoral immunity to tetanus, diphtheria and polio in adults after treatment for hematological malignancies
Einarsdottir S; Ljungman P; Kaijser B; Nicklasson M; Horal P; Norder H; Bergstrom T; Brune M
Article: BONE MARROW TRANSPLANTATION. 2020;55(1):126-136
Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors
Styczynski J; Tridello G; Koster L; Iacobelli S; van Biezen A; van der Werf S; Mikulska M; Gil L; Cordonnier C; Ljungman P; Averbuch D; Cesaro S; de la Camara R; Baldomero H; Bader P; Basak G; Bonini C; Duarte R; Dufour C; Kuball J; Lankester A; Montoto S; Nagler A; Snowden JA; Kroeger N; Mohty M; Gratwohl A
Article: FRONTIERS IN IMMUNOLOGY. 2020;11:584520
Haplotype Motif-Based Models for KIR-Genotype Informed Selection of Hematopoietic Cell Donors Fail to Predict Outcome of Patients With Myelodysplastic Syndromes or Secondary Acute Myeloid Leukemia
Schetelig J; Baldauf H; Koster L; Kuxhausen M; Heidenreich F; de Wreede LC; Spellman S; van Gelder M; Bruno B; Onida F; Lange V; Massalski C; Potter V; Ljungman P; Schaap N; Hayden P; Lee SJ; Kroeger N; Hsu K; Schmidt AH; Yakoub-Agha I; Robin M
Article: BONE MARROW TRANSPLANTATION. 2019;54(12):2060-2071
Prognostic impact of EBV serostatus in patients with lymphomas or chronic malignancies undergoing allogeneic HCT
Styczynski J; Tridello G; Gil L; Ljungman P; Mikulska M; Ward KN; Cordonnier C; de la Camara R; Averbuch D; Knelange N; Socie G; Chevallier P; Blaise D; Yakoub-Agha I; Forcade E; Cornelissen J; Maertens J; Petersen E; Nguyen-Quoc S; Veelken H; Schaap N; Passweg J; Michallet M; Fegueux N; Deconinck E; Russell N; Basak G; Bader P; Montoto S; Kroeger N; Cesaro S
Article: CLINICAL TRANSPLANTATION. 2019;33(12):e13742
Bone and hormonal status 10 years post-allogeneic bone marrow transplantation
Gubrianska D; Machaczka M; Hassan M; Hagglund H; Ljungman P; Palmer M
Article: HEMASPHERE. 2019;3(6):e321
Nordic Guidelines for Germline Predisposition to Myeloid Neoplasms in Adults: Recommendations for Genetic Diagnosis, Clinical Management and Follow-up
Baliakas P; Tesi B; Wartiovaara-Kautto U; Stray-Pedersen A; Friis LS; Dybedal I; Hovland R; Jahnukainen K; Raaschou-Jensen K; Ljungman P; Rustad CF; Lautrup CK; Kilpivaara O; Kittang AO; Gronbaek K; Cammenga J; Hellstrom-Lindberg E; Andersen MK
Article: HAEMATOLOGICA. 2019;104(11):2155-2163
Guidelines from the 2017 European Conference on Infections in Leukaemia for management of HHV-6 infection in patients with hematologic malignancies and after hematopoietic stem cell transplantation
Ward KN; Hill JA; Hubacek P; de la Camara R; Crocchiolo R; Einsele H; Navarro D; Robin C; Cordonnier C; Ljungman P
Article: BONE MARROW TRANSPLANTATION. 2019;54(11):1764-1774
Allogeneic stem cell transplantation for chronic myeloid leukemia in the TKI era: population-based data from the Swedish CML registry
Lubking A; Dreimane A; Sandin F; Isaksson C; Markevarn B; Brune M; Ljungman P; Lenhoff S; Stenke L; Hoglund M; Richter J; Olsson-Stromberg U
Article: CLINICAL INFECTIOUS DISEASES. 2019;69(10):1771-1779
Bloodstream Infection Due to Vancomycin-resistant Enterococcus Is Associated With Increased Mortality After Hematopoietic Cell Transplantation for Acute Leukemia and Myelodysplastic Syndrome: A Multicenter, Retrospective Cohort Study
Papanicolaou GA; Ustun C; Young J-AH; Chen M; Kim S; Ahn KW; Komanduri K; Lindemans C; Auletta JJ; Riches ML; Abdel-Azim H; Ahmed IA; Aljurf M; Antin J; Ballen KK; Beitinjaneh A; Brown VI; Cerny J; Champlin R; Chao N; Chhabra S; Dahi PB; Daly A; Dandoy C; Dvorak CC; Forman S; Freytes C; Ganguly S; Hashmi SK; Kharfan-Dabaja MA; Lazarus H; Ljungman P; Malone AK; Murthy G; Nishihori T; Page K; Pingali RSR; Reddy V; Saad A; Savani BN; Seftel M; Szer J; Vij R; Weisdorf D; William BM; Williams K; Wirk B; Yared J; Yu LC
Article: TRANSPLANT INFECTIOUS DISEASE. 2019;21(5):e13145
Survival outcomes of allogeneic hematopoietic cell transplants with EBV-positive or EBV-negative post-transplant lymphoproliferative disorder, A CIBMTR study
Naik S; Riches M; Hari P; Kim S; Chen M; Bachier C; Shaughnessy P; Hill J; Ljungman P; Battiwalla M; Chhabra S; Daly A; Storek J; Ustun C; Diaz MA; Cerny J; Beitinjaneh A; Yared J; Brown V; Page K; Dahi PB; Ganguly S; Seo S; Chao N; Freytes CO; Saad A; Savani BN; Ahn KW; Boeckh M; Heslop HE; Lazarus HM; Auletta JJ; Kamble RT
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2019;25(10):2008-2016
Allogeneic Stem Cell Transplantation for Blast Crisis Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors: A Retrospective Study by the EBMT Chronic Malignancies Working Party
Radujkovic A; Dietrich S; Blok H-J; Nagler A; Ayuk F; Finke J; Tischer J; Mayer J; Koc Y; Sora F; Passweg J; Byrne JL; Jindra P; Veelken JH; Socie G; Maertens J; Schaap N; Stadler M; Itala-Remes M; Tholouli E; Arat M; Rocha V; Ljungman P; Yakoub-Agha I; Kroeger N; Chalandon Y
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2019;25(10):1970-1974
High Graft-versus-Host Disease-Free, Relapse/Rejection-Free Survival and Similar Outcome of Related and Unrelated Allogeneic Stem Cell Transplantation for Aplastic Anemia: A Nationwide Swedish Cohort Study
Vaht K; Goransson M; Carlson K; Isaksson C; Lenhoff S; Sandstedt A; Uggla B; Winiarski J; Ljungman P; Andersson P-O; Brune M
Article: HAEMATOLOGICA. 2019;104(9):1782-1788
Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
Robin M; de Wreede LC; Wolschke C; Schetelig J; Eikema D-J; Van Lint MT; Knelange NS; Beelen D; Brecht A; Niederwieser D; Vitek A; Bethge W; Arnold R; Finke J; Volin L; Yakoub-Agha I; Nagler A; Poire X; Einsele H; Chevallier P; Holler E; Ljungman P; Robinson S; Radujkovic A; McLornan D; Chalandon Y; Kroeger N
Article: BONE MARROW TRANSPLANTATION. 2019;54(9):1391-1398
EBMT prospective observational study on allogeneic hematopoietic stem cell transplantation in T-prolymphocytic leukemia (T-PLL)
Wiktor-Jedrzejczak W; Drozd-Sokolowska J; Eikema DJ; Hoek J; Potter M; Wulf G; Sellner L; Ljungman P; Chevallier P; Volin L; Koc Y; Martin S; Bunjes D; Rovira M; Itala-Remes M; Foa R; Deconinck E; Gedde-Dahl T; Cornelissen J; Collin M; Brecht A; Patel A; de Groot M; Remenyi P; Nagler A; Finke J; Turlure P; Iacobelli S; van Biezen A; Schetelig J; Kroeger N; Dreger P
Article: LEUKEMIA AND LYMPHOMA. 2019;60(10):2404-2414
A prospective non-interventional study on the impact of transfusion burden and related iron toxicity on outcome in myelodysplastic syndromes undergoing allogeneic hematopoietic cell transplantation
Cremers EMP; de Witte T; de Wreede L; Eikema D-J; Koster L; van Biezen A; Finke J; Socie G; Beelen D; Maertens J; Nagler A; Kobbe G; Ziagkos D; Itala-Remes M; Gedde-Dahl T; Sierra J; Niederwieser D; Ljungman P; Beguin Y; Ozkurt ZN; Anagnostopoulos A; Jindra P; Robin M; Kroeger N
Article: BONE MARROW TRANSPLANTATION. 2019;54(8):1275-1280
A survey on incidence and management of adenovirus infection after allogeneic HSCT
Cesaro S; Berger M; Tridello G; Mikulska M; Ward KN; Ljungman P; Van der Werf S; Averbuch D; Styczynski J
Article: BONE MARROW TRANSPLANTATION. 2019;54(8):1254-1265
Bacterial blood stream infections (BSIs), particularly post-engraftment BSIs, are associated with increased mortality after allogeneic hematopoietic cell transplantation
Ustun C; Young J-AH; Papanicolaou GA; Kim S; Ahn KW; Chen M; Abdel-Azim H; Aljurf M; Beitinjaneh A; Brown V; Cerny J; Chhabra S; Kharfan-Dabaja MA; Dahi PB; Daly A; Dandoy CE; Dvorak CC; Freytes CO; Hashmi S; Lazarus H; Ljungman P; Nishihori T; Page K; Pingali SRK; Saad A; Savani BN; Weisdorf D; Williams K; Wirk B; Auletta JJ; Lindemans CA; Komanduri K; Riches M
Article: ANNALS OF HEMATOLOGY. 2019;98(8):1867-1875
Allogeneic donor split skin grafts for treatment of refractory ulcers in cutaneous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation-a retrospective analysis on seven patients
Lamby P; Wolff D; Mielke S; Grigoleit GU; Ljungman P; Hilgendorf I; Holler E; Holler B; Weber D; Herr W; Schiltz D; Klein S; Graf S; Bjornhagen-Safwenberg V; Dolderer J; Prantl L
Article: ANNALS OF HEMATOLOGY. 2019;98(7):1755-1763
The prognostic impact of the cytomegalovirus serostatus in patients with chronic hematological malignancies after allogeneic hematopoietic stem cell transplantation: a report from the Infectious Diseases Working Party of EBMT
Schmidt-Hieber M; Tridello G; Ljungman P; Mikulska M; Knelange N; Blaise D; Socie G; Volin L; Blijlevens N; Fegueux N; Yakoub-Agha I; Forcade E; Maertens J; Chevallier P; Passweg J; Cornelissen J; Russell N; Craddock C; Bourhis JH; Marchand T; Remenyi P; Cahn JY; Michallet M; Montoto S; Kroeger N; Glass B; Styczynski J
Article: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2019;143(6):2238-2253
Hematopoietic stem cell transplantation for CD40 ligand deficiency: Results from an EBMT/ESID-IEWP-SCETIDE-PIDTC study
Ferrua F; Galimberti S; Courteille V; Slatter MA; Booth C; Moshous D; Neven B; Blanche S; Cavazzana M; Laberko A; Shcherbina A; Balashov D; Soncini E; Porta F; Al-Mousa H; Al-Saud B; Al-Dhekri H; Arnaout R; Formankova R; Bertrand Y; Lange A; Smart J; Wolska-Kusnierz B; Aquino VM; Dvorak CC; Fasth A; Fouyssac F; Heilmann C; Hoenig M; Schuetz C; Kelecic J; Bredius RGM; Lankester AC; Lindemans CA; Suarez F; Sullivan KE; Albert MH; Kalwak K; Barlogis V; Bhatia M; Bordon V; Czogala W; Alonso L; Dogu F; Gozdzik J; Ikinciogullari A; Krivan G; Ljungman P; Meyts I; Mustillo P; Smith AR; Speckmann C; Sundin M; Keogh SJ; Shaw PJ; Boelens JJ; Schulz AS; Sedlacek P; Veys P; Mahlaoui N; Janda A; Davies EG; Fischer A; Cowan MJ; Gennery AR
Article: ANNALS OF HEMATOLOGY. 2019;98(6):1341-1350
Use of eltrombopag in aplastic anemia in Europe
Ecsedi M; Lengline E; Knol-Bout C; Bosman P; Eikema D-J; Afanasyev B; Maschan A; Dreger P; Halkes CJM; Drexler B; Cortelezzi A; Drenou B; Patriarca A; Bruno B; Onofrillo D; Lanino E; Pulanic D; Serventi-Seiwerth R; Garnier A; Ljungman P; Bonifazi F; Giammarco S; Tournilhac O; Pioltelli P; Rovo A; Risitano AM; de Latour RP; Dufour C; Passweg J
Article: HAEMATOLOGICA. 2019;104(5):929-936
Optimized EBMT transplant-specific risk score in myelodysplastic syndromes after allogeneic stem-cell transplantation
Gagelmann N; Eikema D-J; Stelljes M; Beelen D; de Wreede L; Mufti G; Knelange NS; Niederwieser D; Friis LS; Ehninger G; Nagler A; Yakoub-Agha I; Meijer E; Ljungman P; Maertens J; Kanz L; Lopez-Corral L; Brecht A; Craddock C; Finke J; Cornelissen JJ; Bernasconi P; Chevallier P; Sierra J; Robin M; Kroeger N
Article: CLINICAL INFECTIOUS DISEASES. 2019;68(8):1420-1426
Definitions of Resistant and Refractory Cytomegalovirus Infection and Disease in Transplant Recipients for Use in Clinical Trials
Chemaly RF; Chou S; Einsele H; Griffiths P; Avery R; Razonable RR; Mullane KM; Kotton C; Lundgren J; Komatsu TE; Lischka P; Josephson F; Douglas CM; Umeh O; Miller V; Ljungman P
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2019;25(3):522-528
Family Mismatched Allogeneic Stem Cell Transplantation for Myelofibrosis: Report from the Chronic Malignancies Working Party of European Society for Blood and Marrow Transplantation
Raj K; Eikema D-J; McLornanl DP; Olavarria E; Bloke H-J; Bregante S; Ciceri F; Passweg J; Ljungman P; Schaap N; Carlson K; Zuckerman T; de Wreede LC; Volin L; Koc Y; Luis Diez-Martin J; Brossart P; Wolf D; Blaise D; Di Bartolomeo P; Vitek A; Robin M; Yakoub-Agha I; Chalandon Y; Kroger N
Article: LEUKEMIA. 2019;33(3):686-695
Late treatment-related mortality versus competing causes of death after allogeneic transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia
Schetelig J; de Wreede LC; van Gelder M; Koster L; Finke J; Niederwieser D; Beelen D; Mufti GJ; Platzbecker U; Ganser A; Heidenreich S; Maertens J; Socie G; Brecht A; Stelljes M; Kobbe G; Volin L; Nagler A; Vitek A; Luft T; Ljungman P; Yakoub-Agha I; Robin M; Kroeger N
Article: LEUKEMIA. 2019;33(2):508-517
European experience and risk factor analysis of donor cell-derived leukaemias/MDS following haematopoietic cell transplantation
Engel N; Rovo A; Badoglio M; Labopin M; Basak GW; Beguin Y; Guyotat D; Ljungman P; Nagler A; Schattenberg A; Schroeder T; Schroyens W; Tischer J; Socie G; Kolb H-J; Tichelli A; Salooja N; Duarte RF
Article: BONE MARROW TRANSPLANTATION. 2019;54(1):44-52
Ibrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma: a study by the EBMT Chronic Malignancies and Lymphoma Working Parties
Dreger P; Michallet M; Bosman P; Dietrich S; Sobh M; Boumendil A; Nagler A; Scheid C; Cornelissen J; Niederwieser D; Mueller L; Vandenberghe E; Scortechini I; Schoemans H; Andersen NS; Finke J; Russo D; Ljungman P; Passweg J; van Gelder M; Durakovic N; Labussiere-Wallet H; Berg T; Wulf G; Bethge W; Bunjes D; Stilgenbauer S; Canepari ME; Schaap M; Fox CP; Kroeger N; Montoto S; Schetelig J
Article: EXPERIMENTAL HEMATOLOGY & ONCOLOGY. 2019;8:7
The Karolinska experience of autologous stem-cell transplantation for lymphoma: a population-based study of all 433 patients 1994-2016
Carlsten M; Jadersten M; Hellstrom A; Littmann K; Melen CM; Junlen HR; Sonnevi K; Ljungman P; Bjorkstrand B; Wahlin BE
Article: FRONTIERS IN IMMUNOLOGY. 2019;10:189
Individualization of Hematopoietic Stem Cell Transplantation Using Alpha/Beta T-Cell Depletion
Radestad E; Sundin M; Torlen J; Thunberg S; Onfelt B; Ljungman P; Watz E; Mattsson J; Uhlin M
Article: EUROPEAN JOURNAL OF CANCER. 2019;106:212-219
Impact of anti-thymocyte globulin on results of allogeneic peripheral blood stem cell transplantation for patients with Philadelphia-positive acute lymphoblastic leukaemia: An analysis by the Acute Leukemia Working Party of the EBMT
Giebel S; Labopin M; Czerw T; Socie G; Blaise D; Ghavamzadeh A; Passweg J; Ljungman P; Poire X; Chevallier P; Remenyi P; Rambaldi A; Anafasyev B; Fegueux N; Rovira M; Itala-Remes M; Bornhaeuser M; Mohty M; Nagler A
Article: PLOS ONE. 2019;14(2):e0211927
Infectious complications and NK cell depletion following daratumumab treatment of Multiple Myeloma
Nahi H; Chrobok M; Gran C; Lund J; Gruber A; Gahrton G; Ljungman P; Wagner AK; Alici E
Article: BONE MARROW TRANSPLANTATION. 2018;53(12):1548-1552
Recommendations from the European Society for Blood and Marrow Transplantation (EBMT) for a curriculum in hematopoietic cell transplantation
Mohty M; Duarte RF; Kuball J; Bader P; Basak GW; Bonini C; Carreras E; Chabannon C; Dufour C; Gennery A; Lankester A; Lanza F; Ljungman P; Montoto S; Nagler A; Snowden JA; Styczynski J; Sureda A; Kroeger N
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2018;24(9):1783-1787
Varicella Zoster Virus Reactivation in Adult Survivors of Hematopoietic Cell Transplantation: How Do We Best Protect Our Patients?
Lee CJ; Savani BN; Ljungman P
Article: AMERICAN JOURNAL OF HEMATOLOGY. 2018;93(9):1142-1152
Measurable residual disease, conditioning regimen intensity, and age predict outcome of allogeneic hematopoietic cell transplantation for acute myeloid leukemia in first remission: A registry analysis of 2292 patients by the Acute Leukemia Working Party European Society of Blood and Marrow Transplantation
Gilleece MH; Labopin M; Yakoub-Agha I; Volin L; Socie G; Ljungman P; Huynh A; Deconinck E; Wu D; Bourhis JH; Cahn JY; Polge E; Mohty M; Savani BN; Nagler A
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2018;182(3):418-422
Outcome of patients with Myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMT
McLornan DP; Szydlo R; Robin M; van Biezen A; Koster L; Blok HJP; Van Lint MT; Finke J; Vitek A; Carlson K; Griskevicius L; Holler E; Itala-Remes M; Schaap M; Socie G; Bay J-O; Beguin Y; Bruno B; Cornelissen JJ; Gedde-Dahl T; Ljungman P; Rubio MT; Yakoub-Agha I; Klyuchnikov E; Olavarria E; Chalandon Y; Kroeger N
Article: CLINICAL INFECTIOUS DISEASES. 2018;67(4):564-572
Incidence, Risk Factors, and Long-term Outcome of Acute Leukemia Patients With Early Candidemia After Allogeneic Stem Cell Transplantation: A Study by the Acute Leukemia and Infectious Diseases Working Parties of European Society for Blood and Marrow Transplantation
Cesaro S; Tridello G; Blijlevens N; Ljungman P; Craddock C; Michallet M; Martin A; Snowden JA; Mohty M; Maertens J; Passweg J; Petersen E; Nihtinen A; Isaksson C; Milpied N; Rohlich P-S; Deconinck E; Crawley C; Ledoux M-P; Hoek J; Nagler A; Styczynski J
Article: JOURNAL OF CLINICAL APHERESIS. 2018;33(3):226-235
Short-term side effects and attitudes towards second donation: A comparison of related and unrelated haematopoietic stem cell donors
Pahnke S; Larfors G; Axdorph-Nygell U; Fischer-Nielsen A; Haastrup E; Heldal D; Itala-Remes M; Johansson J-E; Kauppila M; Lenhoff S; Ljungman P; Niittyvuopio R; Sandstedt A; Hagglund H
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2018;100(6):613-620
Low response rate to ATG-based immunosuppressive therapy in very severe aplastic anaemia A Swedish nationwide cohort study
Vaht K; Goransson M; Carlson K; Isaksson C; Lenhoff S; Sandstedt A; Uggla B; Winiarski J; Ljungman P; Brune M; Andersson P-O
Article: SCIENTIFIC REPORTS. 2018;8(1):8293
The effect of N-acetyl-l-cysteine (NAC) on liver toxicity and clinical outcome after hematopoietic stem cell transplantation
El-Serafi I; Remberger M; El-Serafi A; Benkessou F; Zheng W; Martell E; Ljungman P; Mattsson J; Hassan M
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2018;24(5):930-936
Incidence of Second Primary Malignancies after Autologous Transplantation for Multiple Myeloma in the Era of Novel Agents
Sahebi F; Iacobelli S; Sbianchi G; Koster L; Blaise D; Remenyi P; Russell NH; Ljungman P; Kobbe G; Apperley J; Trneny M; Krejci M; Wiktor-Jedrzejczak W; Sanchez JF; Schaap N; Isaksson C; Lenhoff S; Browne P; Scheid C; Wilson KMO; Yakoub-Agha I; Muniz SG; Schoenland S; Morris C; Garderet L; Kroeger N
Article: MEDICAL ONCOLOGY. 2018;35(6):79
Reduced intensity conditioning increases risk of severe cGVHD: identification of risk factors for cGVHD in a multicenter setting
Afram G; Perez-Simon JA; Remberger M; Caballero-Velazquez T; Martino R; Luis Pinana J; Ringden O; Esquirol A; Lopez-Corral L; Garcia I; Lopez-Godino O; Sierra J; Caballero D; Ljungman P; Vazquez L; Hagglund H
Article: CLINICAL CANCER RESEARCH. 2018;24(8):1834-1844
Complete Remission with Reduction of High-Risk Clones following Haploidentical NK-Cell Therapy against MDS and AML
Bjorklund AT; Carlsten M; Sohlberg E; Liu LL; Clancy T; Karimi M; Cooley S; Miller JS; Klimkowska M; Schaffer M; Watz E; Wikstrom K; Blomberg P; Wahlin BE; Palma M; Hansson L; Ljungman P; Hellstrom-Lindberg E; Ljunggren H-G; Malmberg K-J
Article: TRANSPLANT INFECTIOUS DISEASE. 2018;20(2):e12847
Norovirus causing severe gastrointestinal disease following allogeneic hematopoietic stem cell transplantation: A retrospective analysis
Swartling L; Ljungman P; Remberger M; Sundin M; Tiveljung A; Mattsson J; Sparrelid E
Article: BONE MARROW TRANSPLANTATION. 2018;53(4):422-430
Comparable survival using a CMV-matched or a mismatched donor for CMV plus patients undergoing T-replete haplo-HSCT with PT-Cy for acute leukemia: a study of behalf of the infectious diseases and acute leukemia working parties of the EBMT
Cesaro S; Crocchiolo R; Tridello G; Knelange N; Van Lint MT; Koc Y; Ciceri F; Gulbas Z; Tischer J; Afanasyev B; Bruno B; Castagna L; Blaise D; Mohty M; Irrera G; Diez-Martin JL; Pierelli L; Pioltelli P; Arat M; Delia M; Fagioli F; Ehninger G; Aljurf M; Carella AM; Ozdogu H; Mikulska M; Ljungman P; Nagler A; Styczynski J
Article: EUROPEAN JOURNAL OF CANCER CARE. 2018;27(2):e12808
Occupational status among adult survivors following allogeneic stem cell transplantation in childhood
Winterling J; Johansson E; Wettergren L; Ljungman P; Alexanderson K
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2018;24(3):507-513
Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome Patients with a 5q Deletion
Garderet L; Ziagkos D; Van Biezen A; Lacobelli S; Finke J; Maertens J; Volin L; Ljungman P; Chevallier P; Passweg J; Schaap N; Beelen D; Nagler A; Blaise D; Poire X; Yakoub-Agha I; Lenhoff S; Craddock C; Schots R; Rambaldi A; Sanz J; Jindra P; Mufti GJ; Robin M; Kroeger N
Article: AMERICAN JOURNAL OF HEMATOLOGY. 2018;93(1):31-39
Relatively favorable outcome after allogeneic stem cell transplantation for BCR-ABL1-positive AML: A survey from the acute leukemia working party of the European Society for blood and marrow transplantation (EBMT)
Lazarevic VL; Labopin M; Wu D; Yakoub-Agha I; Huynh A; Ljungman P; Schaap N; Cornelissen JJ; Maillard N; Pioltelli P; Gedde-Dahl T; Lenhoff S; Houhou M; Esteve J; Mohty M; Nagler A
Article: NEW ENGLAND JOURNAL OF MEDICINE. 2017;377(25):2433-2444
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
Marty FM; Ljungman P; Chemaly RF; Maertens J; Dadwal SS; Duarte RF; Haider S; Ullmann AJ; Katayama Y; Brown J; Mullane KM; Boeckh M; Blumberg EA; Einsele H; Snydman DR; Kanda Y; DiNubile MJ; Teal VL; Wan H; Murata Y; Kartsonis NA; Leavitt RY; Badshah C
Article: SUPPORTIVE CARE IN CANCER. 2017;25(12):3675-3682
Feasibility of a self-help web-based intervention targeting young cancer patients with sexual problems and fertility distress
Wiklander M; Strandquist J; Obol CM; Eriksson LE; Winterling J; Rodriguez-Wallberg KA; Fugl-Meyer KS; Ahlgren J; Ljungman P; Lampic C; Wettergren L
Article: CLINICAL INFECTIOUS DISEASES. 2017;65(11):1819-1828
Antimicrobial Resistance in Gram-Negative Rods Causing Bacteremia in Hematopoietic Stem Cell Transplant Recipients: Intercontinental Prospective Study of the Infectious Diseases Working Party of the European Bone Marrow Transplantation Group
Averbuch D; Tridello G; Hoek J; Mikulska M; Akan H; Yanez San Segundo L; Pabst T; Ozcelik T; Klyasova G; Donnini I; Wu D; Gulbas Z; Zuckerman T; de Sousa AB; Beguin Y; Xhaard A; Bachy E; Ljungman P; de la Camara R; Rascon J; Ruiz Camps I; Vitek A; Patriarca F; Cudillo L; Vrhovac R; Shaw PJ; Wolfs T; O'Brien T; Avni B; Silling G; Al Sabty F; Graphakos S; Sankelo M; Sengeloev H; Pillai S; Matthes S; Melanthiou F; Iacobelli S; Styczynski J; Engelhard D; Cesaro S
Article: BONE MARROW TRANSPLANTATION. 2017;52(11):1519-1525
Validation of the revised IPSS at transplant in patients with myelodysplastic syndrome/transformed acute myelogenous leukemia receiving allogeneic stem cell transplantation: a retrospective analysis of the EBMT chronic malignancies working party
Scheid C; de Wreede L; van Biezen A; Koenecke C; Gohring G; Volin L; Maertens J; Finke J; Passweg J; Beelen D; Cornelissen JJ; Itaelae-Remes M; Chevallier P; Russell N; Petersen E; Milpied N; Espiga CR; Peniket A; Sierra J; Mufti G; Crawley C; Veelken JH; Ljungman P; Cahn JY; Alessandrino EP; de Witte T; Robin M; Kroeger N
Article: INTERNATIONAL JOURNAL OF HEMATOLOGY. 2017;106(4):471-475
Toxicological effects of fludarabine and treosulfan conditioning before allogeneic stem-cell transplantation
Remberger M; Torlen J; El Serafi I; Garming-Legert K; Bjorklund A; Ljungman P; Sundin M; Hassan M; Mattsson J
Article: HAEMATOLOGICA. 2017;102(10):1683-1690
Incidence and outcome of acquired aplastic anemia: real-world data from patients diagnosed in Sweden from 2000-2011
Vaht K; Goransson M; Carlson K; Isaksson C; Lenhoff S; Sandstedt A; Uggla B; Winiarski J; Ljungman P; Brune M; Andersson P-O
Article: ACTA ONCOLOGICA. 2017;56(8):1103-1110
Oncologists and hematologists' perceptions of fertility-related communication - a nationwide survey
Obol CM; Armuand GM; Rodriguez-Wallberg KA; Ahlgren J; Ljungman P; Wettergren L; Lampic C
Article: AMERICAN JOURNAL OF HEMATOLOGY. 2017;92(8):789-796
ABO incompatibility in mismatched unrelated donor allogeneic hematopoietic cell transplantation for acute myeloid leukemia: A report from the acute leukemia working party of the EBMT
Canaani J; Savani BN; Labopin M; Michallet M; Craddock C; Socie G; Volin L; Maertens JA; Crawley C; Blaise D; Ljungman PT; Cornelissen J; Russell N; Baron F; Gorin N; Esteve J; Ciceri F; Schmid C; Giebel S; Mohty M; Nagler A
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2017;23(4):677-683
Impact of Pretransplantation Indices in Hematopoietic Stem Cell Transplantation: Knowledge of Center-Specific Outcome Data Is Pivotal before Making Index-Based Decisions
Torlen J; Remberger M; Le Blanc K; Ljungman P; Mattsson J
Article: BLOOD ADVANCES. 2017;1(7):477-485
Alternative donors for allogeneic hematopoietic stem cell transplantation in poor-risk AML in CR1
Versluis J; Labopin M; Ruggeri A; Socie G; Wu D; Volin L; Blaise D; Milpied N; Craddock C; Yakoub-Agha I; Maertens J; Ljungman P; Huynh A; Michallet M; Deconinck E; Chevallier P; Passweg J; Ciceri F; Mohty M; Cornelissen JJ; Nagler A
Article: CLINICAL INFECTIOUS DISEASES. 2017;64(1):87-91
Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials
Ljungman P; Boeckh M; Hirsch HH; Josephson F; Lundgren J; Nichols G; Pikis A; Razonable RR; Miller V; Griffiths PD
Article: HAEMATOLOGICA. 2016;101(11):1417-1425
A prospective randomized trial comparing cyclosporine/methotrexate and tacrolimus/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantation
Torlen J; Ringden O; Garming-Legert K; Ljungman P; Winiarski J; Remes K; Itala-Remes M; Remberger M; Mattsson J
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2016;22(9):1684-1689
Risk Factors for Invasive Mold Infections and Implications for Choice of Prophylaxis after Allogeneic Stem Cell Transplantation
Blennow O; Remberger M; Torlen J; Szakos A; Ljungman P; Mattsson J
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2016;22(9):1615-1620
Comparison of Intensive Chemotherapy and Hypomethylating Agents before Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndromes: A Study of the Myelodysplastic Syndrome Subcommittee of the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplant Research
Potter VT; Iacobelli S; van Biezen A; Maertens J; Bourhis J-H; Passweg JR; Yakhoub-Agha I; Tabrizi R; Bay J-O; Chevallier P; Chalandon Y; Huynh A; Cahn JY; Ljungman P; Craddock C; Lenhoff S; Russell NH; Fegueux N; Socie G; Benedetto B; Meijer E; Mufti GJ; de Witte T; Robin M; Kroeger N
Article: HAEMATOLOGICA. 2016;101(7):884-890
Unrelated alternative donor transplantation for severe acquired aplastic anemia: a study from the French Society of Bone Marrow Transplantation and Cell Therapies and the EBMT Severe Aplastic Anemia Working Party.
Devillier R; Dalle J-H; Kulasekararaj A; D'aveni M; Clément L; Chybicka A; Vigouroux S; Chevallier P; Koh M; Bertrand Y; Michallet M; Zecca M; Yakoub-Agha I; Cahn J-Y; Ljungman P; Bernard M; Loiseau P; Dubois V; Maury S; Socié G; Dufour C; Peffault de Latour R
Article: JOURNAL OF CLINICAL ONCOLOGY. 2016;34(19):2212-2220
Impact of Donor Epstein-Barr Virus Serostatus on the Incidence of Graft-Versus-Host Disease in Patients With Acute Leukemia After Hematopoietic Stem-Cell Transplantation: A Study From the Acute Leukemia and Infectious Diseases Working Parties of the European Society for Blood and Marrow Transplantation
Styczynski J; Tridello G; Gil L; Ljungman P; Hoek J; Iacobelli S; Ward KN; Cordonnier C; Einsele H; Socie G; Milpied N; Veelken H; Chevallier P; Yakoub-Agha I; Maertens J; Blaise D; Cornelissen J; Michallet M; Daguindau E; Petersen E; Passweg J; Greinix H; Duarte RF; Kroeger N; Dreger P; Mohty M; Nagler A; Cesaro S
Article: HAEMATOLOGICA. 2016;101(6):773-780
Expanding transplant options to patients over 50 years. Improved outcome after reduced intensity conditioning mismatched-unrelated donor transplantation for patients with acute myeloid leukemia: a report from the Acute Leukemia Working Party of the EBMT
Savani BN; Labopin M; Kroeger N; Finke J; Ehninger G; Niederwieser D; Schwerdtfeger R; Bunjes D; Glass B; Socie G; Ljungman P; Craddock C; Baron F; Ciceri F; Gorin NC; Esteve J; Schmid C; Giebel S; Mohty M; Nagler A
Article: BONE MARROW TRANSPLANTATION. 2016;51(4):573-580
The incidence, mortality and timing of Pneumocystis jiroveci pneumonia after hematopoietic cell transplantation: a CIBMTR analysis
Williams KM; Ahn KW; Chen M; Aljurf MD; Agwu AL; Chen AR; Walsh TJ; Szabolcs P; Boeckh MJ; Auletta JJ; Lindemans CA; Zanis-Neto J; Malvezzi M; Lister J; de Toledo Codina JS; Sackey K; Chakrabarty JLH; Ljungman P; Wingard JR; Seftel MD; Seo S; Hale GA; Wirk B; Smith MS; Savani BN; Lazarus HM; Marks DI; Ustun C; Abdel-Azim H; Dvorak CC; Szer J; Storek J; Yong A; Riches MR
Article: BONE MARROW TRANSPLANTATION. 2016;51(3):418-423
Influence of pre-existing invasive aspergillosis on allo-HSCT outcome: a retrospective EBMT analysis by the Infectious Diseases and Acute Leukemia Working Parties
Penack O; Tridello G; Hoek J; Socie G; Blaise D; Passweg J; Chevallier P; Craddock C; Milpied N; Veelken H; Maertens J; Ljungman P; Cornelissen J; Thiebaut-Bertrand A; Lioure B; Michallet M; Iacobelli S; Nagler A; Mohty M; Cesaro S
Article: HAEMATOLOGICA. 2016;101(2):115-208
The European Hematology Association Roadmap for European Hematology Research: a consensus document
Engert A; Balduini C; Brand A; Coiffier B; Cordonnier C; Doehner H; de Wit TD; Eichinger S; Fibbe W; Green T; de Haas F; Iolascon A; Jaffredo T; Rodeghiero F; Salles G; Schuringa JJ; Andre M; Andre-Schmutz I; Bacigalupo A; Bochud P-Y; den Boer M; Bonini C; Camaschella C; Cant A; Cappellini MD; Cazzola M; Lo Celso C; Dimopoulos M; Douay L; Dzierzak E; Einsele H; Ferreri A; De Franceschi L; Gaulard P; Gottgens B; Greinacher A; Gresele P; Gribben J; de Haan G; Hansen J-B; Hochhaus A; Kadir R; Kaveri S; Kouskoff V; Kuehne T; Kyrle P; Ljungman P; Maschmeyer G; Mendez-Ferrer S; Milsom M; Mummery C; Ossenkoppele G; Pecci A; Peyvandi F; Philipsen S; Reitsma P; Maria Ribera J; Risitano A; Rivella S; Ruf W; Schroeder T; Scully M; Socie G; Staal F; Stanworth S; Stauder R; Stilgenbauer S; Tamary H; Theilgaard-Monch K; Thein SL; Tilly H; Trneny M; Vainchenker W; Vannucchi AM; Viscoli C; Vrielink H; Zaaijer H; Zanella A; Zolla L; Zwaginga JJ; Martinez PA; van den Akker E; Allard S; Anagnou N; Andolfo I; Andrau J-C; Angelucci E; Anstee D; Aurer I; Avet-Loiseau H; Aydinok Y; Bakchoul T; Balduini A; Barcellini W; Baruch D; Baruchel A; Bayry J; Bento C; van den Berg A; Bernardi R; Bianchi P; Bigas A; Biondi A; Bohonek M; Bonnet D; Borchmann P; Borregaard N; Braekkan S; van den Brink M; Brodin E; Bullinger L; Buske C; Butzeck B; Cammenga J; Campo E; Carbone A; Cervantes F; Cesaro S; Charbord P; Claas F; Cohen H; Conard J; Coppo P; Vives Corrons J-L; da Costa L; Davi F; Delwel R; Dianzani I; Domanovic D; Donnelly P; Drnovsek TD; Dreyling M; Du M-Q; Dufour C; Durand C; Efremov D; Eleftheriou A; Elion J; Emonts M; Engelhardt M; Ezine S; Falkenburg F; Favier R; Federico M; Fenaux P; Fitzgibbon J; Flygare J; Foa R; Forrester L; Galacteros F; Garagiola I; Gardiner C; Garraud O; van Geet C; Geiger H; Geissler J; Germing U; Ghevaert C; Girelli D; Godeau B; Goekbuget N; Goldschmidt H; Goodeve A; Graf T; Graziadei G; Griesshammer M; Gruel Y; Guilhot F; von Gunten S; Gyssens I; Halter J; Harrison C; Harteveld C; Hellstrom-Lindberg E; Hermine O; Higgs D; Hillmen P; Hirsch H; Hoskin P; Huls G; Inati A; Johnson P; Kattamis A; Kiefel V; Kleanthous M; Klump H; Krause D; Hovinga JK; Lacaud G; Lacroix-Desmazes S; Landman-Parker J; LeGouill S; Lenz G; von Lilienfeld-Toal M; von Lindern M; Lopez-Guillermo A; Lopriore E; Lozano M; MacIntyre E; Makris M; Mannhalter C; Martens J; Mathas S; Matzdorff A; Medvinsky A; Menendez P; Migliaccio AR; Miharada K; Mikulska M; Minard V; Montalban C; de Montalembert M; Montserrat E; Morange P-E; Mountford J; Muckenthaler M; Mueller-Tidow C; Mumford A; Nadel B; Navarro J-T; el Nemer W; Noizat-Pirenne F; O'Mahony B; Oldenburg J; Olsson M; Oostendorp R; Palumbo A; Passamonti F; Patient R; de Latour RP; Pflumio F; Pierelli L; Piga A; Pollard D; Raaijmakers M; Radford J; Rambach R; Rao AK; Raslova H; Rebulla P; Rees D; Ribrag V; Rijneveld A; Rinalducci S; Robak T; Roberts I; Rodrigues C; Rosendaal F; Rosenwald A; Rule S; Russo R; Saglio G; Sanchez M; Scharf RE; Schlenke P; Semple J; Sierra J; So-Osman C; Manuel Soria J; Stamatopoulos K; Stegmayr B; Stunnenberg H; Swinkels D; Taborda Barata JP; Taghon T; Taher A; Terpos E; Thachil J; Tissot JD; Touw I; Toye A; Trappe R; Traverse-Glehen A; Unal S; Vaulont S; Viprakasit V; Vitolo U; van Wijk R; Wojtowicz A; Zeerleder S; Zieger B
Article: JOURNAL OF IMMUNOLOGY. 2016;196(3):1400-1411
Naive Donor NK Cell Repertoires Associated with Less Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation
Bjorklund AT; Clancy T; Goodridge JP; Beziat V; Schaffer M; Hovig E; Ljunggren H-G; Ljungman PT; Malmberg K-J
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2016;96(2):175-180
Decreased invasive fungal disease but no impact on overall survival by posaconazole compared to fluconazole prophylaxis: a retrospective cohort study in patients receiving induction therapy for acute myeloid leukaemia/myelodysplastic syndromes
Dahlen T; Kalin M; Cederlund K; Nordlander A; Bjorkholm M; Ljungman P; Blennow O
Article: HAEMATOLOGICA. 2016;101(2):248-255
Monosomal karyotype as an adverse prognostic factor in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem-cell transplantation in first complete remission: a retrospective survey on behalf of the ALWP of the EBMT
Brands-Nijenhuis AVM; Labopin M; Schouten HC; Volin L; Socie G; Cornelissen JJ; Huynh A; Ljungman P; Malard F; Esteve J; Nagler A; Mohty M
Article: EBIOMEDICINE. 2015;2(12):2101-2109
Economics and Outcome After Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study
Gratwohl A; Sureda A; Baldomero H; Gratwohl M; Dreger P; Kroeger N; Ljungman P; McGrath E; Mohty M; Nagler A; Rambaldi A; de Elvira CR; Snowden JA; Passweg J; Apperley J; Niederwieser D; Stijnen T; Brand R
Article: TRANSPLANT INFECTIOUS DISEASE. 2015;17(6):785-794
Prolonged outbreak of adenovirus A31 in allogeneic stem cell transplant recipients
Swartling L; Allard A; Torlen J; Ljungman P; Mattsson J; Sparrelid E
Article: BRITISH JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY. 2015;53(10):1007-1011
Role of intravenous dosage regimens of bisphosphonates in relation to other aetiological factors in the development of osteonecrosis of the jaws in patients with myeloma
Jarnbring F; Kashani A; Bjork A; Hoffman T; Krawiec K; Ljungman P; Lund B
Article: BLOOD. 2015;126(16):1885-1892
Stem cell transplantation in severe congenital neutropenia: an analysis from the European Society for Blood and Marrow Transplantation
Fioredda F; Iacobelli S; van Biezen A; Gaspar B; Ancliff P; Donadieu J; Aljurf M; Peters C; Calvillo M; Matthes-Martin S; Morreale G; van't Veer-Tazelaar N; de Wreede L; Al Seraihy A; Yesilipek A; Fischer A; Bierings M; Ozturk G; Smith O; Veys P; Ljungman P; de latour RP; Codina JSDT; Or R; Ganser A; Afanasyev B; Wynn R; Kalwak K; Marsh J; Dufour C
Article: TRANSFUSION. 2015;55(10):2339-2350
Quality of the hematopoietic stem cell graft affects the clinical outcome of allogeneic stem cell transplantation
Watz E; Remberger M; Ringden O; Ljungman P; Sundin M; Mattsson J; Uhlin M
Article: BONE MARROW TRANSPLANTATION. 2015;50(9):1217-1223
Increased incidence of chronic GvHD and CMV disease in patients with vitamin D deficiency before allogeneic stem cell transplantation
von Bahr L; Blennow O; Alm J; Bjorklund A; Malmberg K-J; Mougiakakos D; Le Blanc A; Oefner PJ; Labopin M; Ljungman P; Le Blanc K
Article: CLINICAL INFECTIOUS DISEASES. 2015;61(3):313-323
Immunogenicity, Safety, and Tolerability of 13-Valent Pneumococcal Conjugate Vaccine Followed by 23-Valent Pneumococcal Polysaccharide Vaccine in Recipients of Allogeneic Hematopoietic Stem Cell Transplant Aged ≥2 Years: An Open-Label Study
Cordonnier C; Ljungman P; Juergens C; Maertens J; Selleslag D; Sundaraiyer V; Giardina PC; Clarke K; Gruber WC; Scott DA; Schmoele-Thoma B
Article: MYCOSES. 2015;58(8):470-477
Epidemiology and outcomes of patients with invasive mould infections: a retrospective observational study from a single centre (2005-2009)
Klingspor L; Saaedi B; Ljungman P; Szakos A
Article: BONE MARROW TRANSPLANTATION. 2015;50(7):978-983
Long-term persistence of the immune response to antipneumococcal vaccines after Allo-SCT: 10-year follow-up of the EBMT-IDWP01 trial
Cordonnier C; Labopin M; Robin C; Ribaud P; Cabanne L; Chadelat C; Cesaro S; Ljungman P
Article: TRANSPLANT INFECTIOUS DISEASE. 2015;17(3):371-379
Immunogenicity of virosomal adjuvanted trivalent influenza vaccination in allogeneic stem cell transplant recipients
Ambati A; Einarsdottir S; Magalhaes I; Poiret T; Bodenstein R; LeBlanc K; Brune M; Maeurer M; Ljungman P
Article: BONE MARROW TRANSPLANTATION. 2015;50(6):858-864
Evaluation of pretransplant influenza vaccination in hematopoietic SCT: a randomized prospective study
Ambati A; Boas LSV; Ljungman P; Testa L; de Oliveira JF; Aoun M; Colturato V; Maeurer M; Machado CM
Article: BONE MARROW TRANSPLANTATION. 2015;50(6):802-807
Comparison of upfront tandem autologous-allogeneic transplantation versus reduced intensity allogeneic transplantation for multiple myeloma
Sahebi F; Iacobelli S; Biezen AV; Volin L; Dreger P; Michallet M; Ljungman PT; de Witte T; Henseler A; Schaap NPM; Lopez-Corral L; Poire X; Passweg J; Hamljadi R-M; Thomas SH; Schonland S; Gahrton G; Morris C; Kroeger N; Garderet L
Article: AMERICAN JOURNAL OF TRANSPLANTATION. 2015;15(3):705-714
Allogeneic Hematopoietic Stem Cell Transplantation in Solid Organ Transplant Recipients: A Retrospective, Multicenter Study of the EBMT
Basak GW; Wiktor-Jedrzejczak W; Labopin M; Schoemans H; Ljungman P; Kobbe G; Beguin Y; Lang P; Koenecke C; Sykora KW; te Boome L; van Biezen A; van der Werf S; Mohty M; de Witte T; Marsh J; Dreger P; Kroeger N; Duarte R; Ruutu T
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2014;20(10):1646-1649
Varicella-zoster reactivation after allogeneic stem cell transplantation without routine prophylaxis--the incidence remains high.
Blennow O; Fjaertoft G; Winiarski J; Ljungman P; Mattsson J; Remberger M
Article: CLINICAL INFECTIOUS DISEASES. 2014;59(4):473-481
Donor Cytomegalovirus Status Influences the Outcome of Allogeneic Stem Cell Transplant: A Study by the European Group for Blood and Marrow Transplantation
Ljungman P; Brand R; Hoek J; de la Camara R; Cordonnier C; Einsele H; Styczynski J; Ward KN; Cesaro S
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2014;93(2):137-142
Long-term follow-up of bone density, general and reproductive health in female survivors after treatment for haematological malignancies
Naessen S; Bergstrom I; Ljungman P; Landgren B-M
Article: BONE MARROW TRANSPLANTATION. 2014;49(6):836-842
Occupational status among adult survivors following allo-SCT
Winterling J; Johansson E; Wennman-Larsen A; Petersson L-M; Ljungman P; Alexanderson K
Article: HAEMATOLOGICA. 2014;99(5):908-915
Use of the quality management system "JACIE" and outcome after hematopoietic stem cell transplantation
Gratwohl A; Brand R; McGrath E; van Biezen A; Sureda A; Ljungman P; Baldomero H; Chabannon C; Apperley J
Article: HAEMATOLOGICA. 2014;99(2):346-352
Risk factors for Epstein-Barr virus-related post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation
Uhlin M; Wikell H; Sundin M; Blennow O; Maeurer M; Ringden O; Winiarski J; Ljungman P; Remberger M; Mattsson J
Article: CLINICAL INFECTIOUS DISEASES. 2014;58(3):309-318
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
Rubin LG; Levin MJ; Ljungman P; Davies EG; Avery R; Tomblyn M; Bousvaros A; Dhanireddy S; Sung L; Keyserling H; Kang I
Article: TRANSPLANT INFECTIOUS DISEASE. 2014;16(1):106-114
Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations
Blennow O; Ljungman P; Sparrelid E; Mattsson J; Remberger M
Article: CLINICAL INFECTIOUS DISEASES. 2014;58(3):E44-E100
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
Rubin LG; Levin MJ; Ljungman P; Davies EG; Avery R; Tomblyn M; Bousvaros A; Dhanireddy S; Sung L; Keyserling H; Kang I
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2014;20(2):264-271
Analysis of Donor and Recipient ABO Incompatibility and Antibody-Associated Complications after Allogeneic Stem Cell Transplantation with Reduced-Intensity Conditioning
Watz E; Remberger M; Ringden E; Lundahl J; Ljungman P; Mattsson J; Wikman A; Uhlin M
Article: PLOS ONE. 2014;9(4):e89648
Whole CMV Proteome Pattern Recognition Analysis after HSCT Identifies Unique Epitope Targets Associated with the CMV Status
Perez-Bercoff L; Valentini D; Gaseitsiwe S; Mahdavifar S; Schutkowski M; Poiret T; Perez-Bercoff A; Ljungman P; Maeurer MJ
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2014;20(1):128-132
Reduced IL-7 Responsiveness Defined by Signal Transducer and Activator of Transcription 5 Phosphorylation in T Cells May Be a Marker for Increased Risk of Developing Cytomegalovirus Disease in Patients after Hematopoietic Stem Cell Transplantation
Perez-Bercoff L; Vudattu NK; Byrareddy SN; Mattsson J; Maeurer M; Ljungman P
Article: CLINICAL INFECTIOUS DISEASES. 2013;57(6):794-802
Response to Rituximab-Based Therapy and Risk Factor Analysis in Epstein Barr Virus-Related Lymphoproliferative Disorder After Hematopoietic Stem Cell Transplant in Children and Adults: A Study From the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation
Styczynski J; Gil L; Tridello G; Ljungman P; Donnelly P; van der Velden W; Omar H; Martino R; Halkes C; Faraci M; Theunissen K; Kalwak K; Hubacek P; Sica S; Nozzoli C; Fagioli F; Matthes S; Diaz MA; Migliavacca M; Balduzzi A; Tomaszewska A; de la Camara R; van Biezen A; Hoek J; Iacobelli S; Einsele H; Cesaro S
Article: BLOOD. 2013;122(7):1284-1292
Tyrosine kinase inhibitor usage, treatment outcome, and prognostic scores in CML: report from the population-based Swedish CML registry
Hoglund M; Sandin F; Hellstrom K; Bjoreman M; Bjorkholm M; Brune M; Dreimane A; Ekblom M; Lehmann S; Ljungman P; Malm C; Markevarn B; Myhr-Eriksson K; Ohm L; Olsson-Stromberg U; Sjalander A; Wadenvik H; Simonsson B; Stenke L; Richter J
Article: JOURNAL OF INTERNAL MEDICINE. 2013;274(2):153-162
A prospective randomized toxicity study to compare reduced-intensity and myeloablative conditioning in patients with myeloid leukaemia undergoing allogeneic haematopoietic stem cell transplantation
Ringden O; Erkers T; Aschan J; Garming-Legert K; Le Blanc K; Hagglund H; Omazic B; Svenberg P; Dahllof G; Mattsson J; Ljungman P; Remberger M
Article: CLINICAL TRANSPLANTATION. 2013;27(4):E368-E374
A high antithymocyte globulin dose increases the risk of relapse after reduced intensity conditioning HSCT with unrelated donors
Remberger M; Ringden O; Hagglund H; Svahn B-M; Ljungman P; Uhlin M; Mattsson J
Article: TRANSPLANT INFECTIOUS DISEASE. 2013;15(3):251-258
Environmental prevention of infection in stem cell transplant recipients: a survey of the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation
Hicheri Y; Einsele H; Martino R; Cesaro S; Ljungman P; Cordonnier C
Article: BLOOD. 2013;121(14):2678-2688
NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs
Beziat V; Liu LL; Malmberg J-A; Ivarsson MA; Sohlberg E; Bjorklund AT; Retiere C; Sverremark-Ekstrom E; Traherne J; Ljungman P; Schaffer M; Price DA; Trowsdale J; Michaelsson J; Ljunggren H-G; Malmberg K-J
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2013;45(4):285-291
Bacteremia in Swedish hematological patients with febrile neutropenia: Bacterial spectrum and antimicrobial resistance patterns
Aust C; Tolfvenstam T; Broliden K; Ljungman P; Kalin M; Giske CG; Ohrmalm L
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2013;19(4):E218-E221
Candidaemia in Sweden: a nationwide prospective observational survey
Ericsson J; Chryssanthou E; Klingspor L; Johansson AG; Ljungman P; Svensson E; Sjolin J
Article: LUPUS. 2013;22(3):245-253
Autologous haematopoietic stem cell transplantation for systemic lupus erythematosus: data from the European Group for Blood and Marrow Transplantation registry
Alchi B; Jayne D; Labopin M; Kotova O; Sergeevicheva V; Alexander T; Gualandi F; Gruhn B; Ouyang J; Rzepecki P; Held G; Sampol A; Voswinkel J; Ljungman P; Fassas A; Badoglio M; Saccardi R; Farge D
Article: LEUKEMIA. 2013;27(2):377-388
Immunosuppressive CD14⁺HLA-DR^low/neg IDO⁺ myeloid cells in patients following allogeneic hematopoietic stem cell transplantation
Mougiakakos D; Jitschin R; von Bahr L; Poschke I; Gary R; Sundberg B; Gerbitz A; Ljungman P; Le Blanc K
Article: MEDICAL ONCOLOGY. 2012;29(4):2348-2358
Different impact of intermediate and unfavourable cytogenetics at the time of diagnosis on outcome of de novo AML after allo-SCT: a long-term retrospective analysis from a single institution
Nahi H; Remberger M; Machaczka M; Ungerstedt J; Mattson J; Ringden O; Le-Blanc K; Ljungman P; Hagglund H
Article: TRANSPLANTATION. 2012;94(10):1066-1074
Factors With an Impact on Chimerism Development and Long-Term Survival After Umbilical Cord Blood Transplantation
Berglund S; Le Blanc K; Remberger M; Gertow J; Uzunel M; Svenberg P; Winiarski J; Ljungman P; Ringden O; Uhlin M; Mattsson J
Article: CLINICAL INFECTIOUS DISEASES. 2012;55(8):1064-1073
Rapid Salvage Treatment With Virus-Specific T Cells for Therapy-Resistant Disease
Uhlin M; Gertow J; Uzunel M; Okas M; Berglund S; Watz E; Brune M; Ljungman P; Maeurer M; Mattsson J
Article: TRANSPLANT INFECTIOUS DISEASE. 2012;14(5):468-478
No increased mortality from donor or recipient hepatitis B- and/or hepatitis C-positive serostatus after related-donor allogeneic hematopoietic cell transplantation
Tomblyn M; Chen M; Kukreja M; Aljurf MD; Al Mohareb F; Bolwell BJ; Cahn J-Y; Carabasi MH; Gale RP; Gress RE; Gupta V; Hale GA; Ljungman P; Maziarz RT; Storek J; Wingard JR; Young J-AH; Horowitz MM; Ballen KK
Article: MEDICAL ONCOLOGY. 2012;29(3):2191-2199
Autologous hematopoietic stem cell transplantation in multiple myeloma and lymphoma: an analysis of factors influencing stem cell collection and hematological recovery
Ungerstedt JS; Watz E; Uttervall K; Johansson B-M; Wahlin BE; Nasman P; Ljungman P; Gruber A; Nygell UA; Nahi H
Article: BONE MARROW TRANSPLANTATION. 2012;47(9):1217-1221
Long-term follow-up of HCV-infected hematopoietic SCT patients and effects of antiviral therapy
Ljungman P; Locasciulli A; de Soria VG; Bekassy AN; Brinch L; Espigado I; Ferrant A; Franklin IM; O'Riordan J; Rovira M; Shaw P; Einsele H
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2012;18(4):557-564
Long-Term Complications, Immunologic Effects, and Role of Passage for Outcome in Mesenchymal Stromal Cell Therapy
von Bahr L; Sundberg B; Lonnies L; Sander B; Karbach H; Hagglund H; Ljungman P; Gustafsson B; Karlsson H; Le Blanc K; Ringden O
Article: BLOOD. 2012;119(6):1599-1606
Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation.
Schmid C; Labopin M; Nagler A; Niederwieser D; Castagna L; Tabrizi R; Stadler M; Kuball J; Cornelissen J; Vorlicek J; Socié G; Falda M; Vindeløv L; Ljungman P; Jackson G; Kröger N; Rank A; Polge E; Rocha V; Mohty M; Acute Leukaemia Working Party of the European Grou
Article: PLOS ONE. 2012;7(5):e36543
Viral Findings in Adult Hematological Patients with Neutropenia
Ohrmalm L; Wong M; Aust C; Ljungman P; Norbeck O; Broliden K; Tolfvenstam T
Article: PEDIATRIC TRANSPLANTATION. 2011;15(7):691-698
The socioeconomic and psychosocial circumstances of adult long-term survivors of hematopoietic stem cell transplantation in childhood
Lof CM; Winiarski J; Ljungman P; Forinder U
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2011;17(11):1688-1697
Improved Survival after Allogeneic Hematopoietic Stem Cell Transplantation in Recent Years. A Single-Center Study
Remberger M; Ackefors M; Berglund S; Blennow O; Dahllof G; Dlugosz A; Garming-Legert K; Gertow J; Gustafsson B; Hassan M; Hassan Z; Hauzenberger D; Hagglund H; Karlsson H; Klingspor L; Kumlien G; Le Blanc K; Ljungman P; Machaczka M; Malmberg K-J; Marschall H-U; Mattsson J; Olsson R; Omazic B; Sairafi D; Schaffer M; Svahn B-M; Svenberg P; Swartling L; Szakos A; Uhlin M; Uzunel M; Watz E; Wernerson A; Wikman A; Wikstrom A-C; Winiarski J; Ringden O
Article: HAEMATOLOGICA. 2011;96(8):1231-1235
Outcome of pandemic H1N1 infections in hematopoietic stem cell transplant recipients
Ljungman P; de la Camara R; Perez-Bercoff L; Abecasis M; Nieto Campuzano JB; Jimena Cannata-Ortiz M; Cordonnier C; Einsele H; Gonzalez-Vicent M; Espigado I; Halter J; Martino R; Mohty B; Sucak G; Ullmann AJ; Vazquez L; Ward KN; Engelhard D
Article: JOURNAL OF CLINICAL ONCOLOGY. 2011;29(15):1980-1986
Introduction of a Quality Management System and Outcome After Hematopoietic Stem-Cell Transplantation
Gratwohl A; Brand R; Niederwieser D; Baldomero H; Chabannon C; Cornelissen J; de Witte T; Ljungman P; McDonald F; McGrath E; Passweg J; Peters C; Rocha V; Slaper-Cortenbach I; Sureda A; Tichelli A; Apperley J
Article: JOURNAL OF IMMUNOTHERAPY. 2011;34(4):390-396
Decreased IL-7 Signaling in T Cells From Patients With PTLD After Allogeneic HSCT
Omar H; Ahmed R; Rane L; Bjorklund A; Gustafsson-Jernberg A; Ljungman P; Maeurer MJ
Article: THE LANCET INFECTIOUS DISEASES. 2011;11(4):284-292
Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial
Marty FM; Ljungman P; Papanicolaou GA; Winston DJ; Chemaly RF; Strasfeld L; Young J-AH; Rodriguez T; Maertens J; Schmitt M; Einsele H; Ferrant A; Lipton JH; Villano SA; Chen H; Boeckh M
Article: BONE MARROW TRANSPLANTATION. 2011;46(3):408-415
Prospective comparison of PCR-based vs late mRNA-based preemptive antiviral therapy for HCMV infection in patients after allo-SCT
Hebart H; Lengerke C; Ljungman P; Paya CV; Klingebiel T; Loeffler J; Pfaffenrath S; Lewensohn-Fuchs I; Barkholt L; Tomiuk J; Meisner C; Lunenberg J; Top B; Razonable RR; Patel R; Litzow MR; Jahn G; Einsele H
Article: PEDIATRIC BLOOD AND CANCER. 2011;56(3):444-451
Hematopoietic Stem Cell Transplantation in Severe Congenital Neutropenia
Carlsson G; Winiarski J; Ljungman P; Ringden O; Mattsson J; Nordenskjold M; Touw I; Henter J-I; Palmblad J; Fadeel B; Hagglund H
Article: BONE MARROW TRANSPLANTATION. 2011;46(2):267-272
Evaluation of a surveillance strategy for early detection of adenovirus by PCR of peripheral blood in hematopoietic SCT recipients: incidence and outcome
Ohrmalm L; Lindblom A; Omar H; Norbeck O; Gustafson I; Lewensohn-Fuchs I; Johansson J-E; Brune M; Ljungman P; Broliden K
Article: HEMATOLOGY/ONCOLOGY CLINICS OF NORTH AMERICA. 2011;25(1):151-169
Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients
Ljungman P; Hakki M; Boeckh M
Article: HAEMATOLOGICA. 2011;96(1):156-162
The European LeukemiaNet: achievements and perspectives
Hehlmann R; Grimwade D; Simonsson B; Apperley J; Baccarani M; Barbui T; Barosi G; Bassan R; Bene MC; Berger U; Buechner T; Burnett A; Cross NCP; de Witte TJM; Doehner H; Dombret H; Einsele H; Engelich G; Foa R; Fonatsch C; Goekbuget N; Gluckman E; Gratwohl A; Guilhot F; Haferlach C; Haferlach T; Hallek M; Hasford J; Hochhaus A; Hoelzer D; Kiladjian J-J; Labar B; Ljungman P; Mansmann U; Niederwieser D; Ossenkoppele G; Ribera JM; Rieder H; Serve H; Schrotz-King P; Sanz MA; Saussele S
Article: BONE MARROW TRANSPLANTATION. 2010;45(12):1710-1718
Randomized PCR-based therapy and risk factors for invasive fungal infection following reduced-intensity conditioning and hematopoietic SCT
Blennow O; Remberger M; Klingspor L; Omazic B; Fransson K; Ljungman P; Mattsson J; Ringden O
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2010;16(12):1728-1737
Leukemia Lineage-Specific Chimerism Analysis and Molecular Monitoring Improve Outcome of Donor Lymphocyte Infusions
Sairafi D; Remberger M; Uhlin M; Ljungman P; Ringden O; Mattsson J
Article: HAEMATOLOGICA. 2010;95(10):1762-1768
Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study
Cordonnier C; Rovira M; Maertens J; Olavarria E; Faucher C; Bilger K; Pigneux A; Cornely OA; Ullmann AJ; Bofarull RM; de la Camara R; Weisser M; Liakopoulou E; Abecasis M; Heussel CP; Pineau M; Ljungman P; Einsele H
Article: TRANSPLANT INFECTIOUS DISEASE. 2010;12(5):465-469
Poor outcome of adenovirus infections in adult hematopoietic stem cell transplant patients with sustained adenovirus viremia
Omar H; Yun Z; Lewensohn-Fuchs I; Perez-Bercoff L; Orvell C; Engstrom L; Vuong G-K; Ljungman P
Article: BONE MARROW TRANSPLANTATION. 2010;45(9):1423-1426
Relationship between IgG titers and opsonocytophagocytic activity of anti-pneumococcal antibodies after immunization with the 7-valent conjugate vaccine in allogeneic stem cell transplant
Cordonnier C; Labopin M; Jansen KU; Pride M; Chesnel V; Bonnet E; Einsele H; Ljungman P
Article: INFECTIOUS DISEASE CLINICS OF NORTH AMERICA. 2010;24(2):319-337
Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients
Ljungman P; Hakki M; Boeckh M
Article: INTERNATIONAL JOURNAL OF HEMATOLOGY. 2010;91(4):596-601
Molecular monitoring of viral infections after hematopoietic stem cell transplantation
Ljungman P
Article: BLOOD. 2010;115(13):2686-2694
NK cells expressing inhibitory KIR for non-self-ligands remain tolerant in HLA-matched sibling stem cell transplantation
Bjorklund AT; Schaffer M; Fauriat C; Ringden O; Remberger M; Hammarstedt C; Barrett AJ; Ljungman P; Ljunggren H-G; Malmberg K-J
Article: VACCINE. 2010;28(15):2730-2734
Immune response to the 23-valent polysaccharide pneumococcal vaccine after the 7-valent conjugate vaccine in allogeneic stem cell transplant recipients: Results from the EBMT IDWP01 trial
Cordonnier C; Labopin M; Chesnel V; Ribaud P; De La Camara R; Martino R; Ullmann AJ; Parkkali T; Locasciulli A; Yakouben K; Pauksens K; Bonnet E; Einsele H; Niederwieser D; Apperley J; Ljungman P
Article: BONE MARROW TRANSPLANTATION. 2010;45(3):558-564
Outcome of patients developing GVHD after DLI given to treat CML relapse: a study by the chronic leukemia working party of the EBMT
Chalandon Y; Passweg JR; Schmid C; Olavarria E; Dazzi F; Simula MP; Ljungman P; Schattenberg A; de Witte T; Lenhoff S; Jacobs P; Volin L; Iacobelli S; Finke J; Niederwieser D; Guglielmi C
Article: BONE MARROW TRANSPLANTATION. 2010;45(2):219-234
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009
Ljungman P; Bregni M; Brune M; Cornelissen J; de Witte T; Dini G; Einsele H; Gaspar HB; Gratwohl A; Passweg J; Peters C; Rocha V; Saccardi R; Schouten H; Sureda A; Tichelli A; Velardi A; Niederwieser D
Article: BONE MARROW TRANSPLANTATION. 2010;45(1):53-61
Comparison of general vs regional anaesthesia for BM harvesting: a retrospective study of anaesthesia-related complications
Machaczka M; Kalaitzakis E; Eleborg L; Ljungman P; Hagglund H
Article: TRANSPLANTATION. 2009;88(10):1222-1226
Respiratory Syncytial Virus Infection in Recipients of Allogeneic Stem-Cell Transplantation: A Retrospective Study of the Incidence, Clinical Features, and Outcome
Avetisyan G; Mattsson J; Sparrelid E; Ljungman P
Article: BONE MARROW TRANSPLANTATION. 2009;44(9):589-594
Outcome after allogeneic transplantation for adult acute myeloid leukemia patients exhibiting isolated or associated trisomy 8 chromosomal abnormality: a survey on behalf of the ALWP of the EBMT
Chevallier P; Labopin M; Nagler A; Ljungman P; Verdonck LF; Volin L; Zander AR; Finke J; Socie G; Cordonnier C; Harousseau J-L; Mohty M; Rocha V
Article: BONE MARROW TRANSPLANTATION. 2009;44(8):521-526
Vaccination of hematopoietic cell transplant recipients
Ljungman P; Cordonnier C; Einsele H; Englund J; Machado CM; Storek J; Small T
Article: BONE MARROW TRANSPLANTATION. 2009;44(8):471-482
Viral disease prevention after hematopoietic cell transplantation
Zaia J; Baden L; Boeckh MJ; Chakrabarti S; Einsele H; Ljungman P; McDonald GB; Hirsch H
Article: TRANSPLANT INFECTIOUS DISEASE. 2009;11(5):393-399
Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction
Omar H; Hagglund H; Gustafsson-Jernberg A; LeBlanc K; Mattsson J; Remberger M; Ringden O; Sparrelid E; Sundin M; Winiarski J; Yun Z; Ljungman P
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2009;15(9):1108-1115
Lymphocyte Recovery Is a Major Determinant of Outcome after Matched Unrelated Myeloablative Transplantation for Myelogenous Malignancies
Le Blanc K; Barrett AJ; Schaffer M; Hagglund H; Ljungman P; Ringden O; Remberger M
Article: HAEMATOLOGICA. 2009;94(4):542-549
Risk factors for therapy-related myelodysplastic syndrome and acute myeloid leukemia treated with allogeneic stem cell transplantation.
Kröger N; Brand R; van Biezen A; Zander A; Dierlamm J; Niederwieser D; Devergie A; Ruutu T; Cornish J; Ljungman P; Gratwohl A; Cordonnier C; Beelen D; Deconinck E; Symeonidis A; de Witte T; Myelodysplastic Syndromes Subcommittee of The Chro
Article: BONE MARROW TRANSPLANTATION. 2009;43(7):553-561
A prospective randomized controlled trial comparing PCR-based and empirical treatment with liposomal amphotericin Bin patients after allo-SCT
Hebart H; Klingspor L; Klingebiel T; Loeffler J; Tollemar J; Ljungman P; Wandt H; Schaefer-Eckart K; Dornbusch HJ; Meisner C; Engel C; Stenger N; Mayer T; Ringden O; Einsele H
Article: BONE MARROW TRANSPLANTATION. 2009;43(6):461-468
Health-related quality of life in adult survivors after paediatric allo-SCT
Lof CM; Winiarski J; Giesecke A; Ljungman P; Forinder U
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2009;144(6):933-945
Serial chimerism analyses indicate that mixed haemopoietic chimerism influences the probability of graft rejection and disease recurrence following allogeneic stem cell transplantation (SCT) for severe aplastic anaemia (SAA): indication for routine assessment of chimerism post SCT for SAA
Lawler M; McCann SR; Marsh JCW; Ljungman P; Hows J; Vandenberghe E; O'Riordan J; Locasciulli A; Socie G; Kelly A; Schrezenmeier H; Marin P; Tichelli A; Passweg JR; Dickenson A; Ryan J; Bacigalupo A
Article: JOURNAL OF CLINICAL VIROLOGY. 2008;43(1):79-85
Quantification of adenovirus DNA in unrelated donor hematopoietic stem cell transplant recipients
Gustafson I; Lindblom A; Yun Z; Omar H; Engstrom L; Lewensohn-Fuchs I; Ljungman P; Broliden K
Article: TRANSPLANTATION. 2008;86(2):257-263
Evaluation of immune responses to seasonal influenza vaccination in healthy volunteers and in patients after stem cell transplantation
Avetisyan G; Aschan J; Hassan M; Ljungman P
Article: APMIS. 2008;116(5):345-351
A prospective study of diagnosis of Toxoplasma gondii infection after bone marrow transplantation
Edvinsson B; Lundquist J; Ljungman P; Ringden O; Evengard B
Article: BONE MARROW TRANSPLANTATION. 2008;41(8):737-742
BK-viruria and haemorrhagic cystitis are more frequent in allogeneic haematopoietic stem cell transplant patients receiving full conditioning and unrelated-HLA-mismatched grafts
Giraud G; Priftakis P; Bogdanovic G; Remberger M; Dubrulle M; Hau A; Gutmark R; Mattson J; Svahn B-M; Ringden O; Winiarski J; Ljungman P; Dalianis T
Article: JOURNAL OF INFECTION. 2008;56(3):204-210
Identification of species of viridans group streptococci in clinical blood culture isolates by sequence analysis of the RNase P RNA gene, rnpB
Westling K; Julander I; Ljungman P; Vondracek M; Wretlind B; Jalal S
Article: BONE MARROW TRANSPLANTATION. 2008;41(3):267-273
Allogeneic stem cell transplantation:: low immunoglobulin levels associated with decreased survival
Norlin A-C; Sairafi D; Mattsson J; Ljungman P; Ringden O; Remberger M
Article: BONE MARROW TRANSPLANTATION. 2008;41(1):45-50
Recent improvement in outcome of unrelated donor transplantation for aplastic anemia
Viollier R; Socie G; Tichelli A; Bacigalupo A; Korthof ET; Marsh J; Cornish J; Ljungman P; Oneto R; Bekassy AN; Fuehrer M; Maury S; Schrezenmeier H; van Lint MT; Wojcik D; Locasciulli A; Passweg JR
Article: BONE MARROW TRANSPLANTATION. 2007;40(11):1055-1062
Risk factors for fatal infectious complications developing late after allogeneic stem cell transplantation
Bjorklund A; Aschan J; Labopin M; Remberger M; Ringden O; Winiarski J; Ljungman P
Article: BONE MARROW TRANSPLANTATION. 2007;40(9):865-869
Evaluation of intervention strategy based on CMV-specific immune responses after allogeneic SCT
Avetisyan G; Aschan J; Haegglund H; Ringden O; Ljungman P
Article: HAEMATOLOGICA. 2007;92(8):1139-1142
Factors influencing CMV seropositivity in stem cell transplant patients and donors
Ljungman P; Brandan R
Article: LEUKEMIA. 2007;21(8):1733-1738
Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells
Le Blanc K; Samuelsson H; Gustafsson B; Remberger M; Sundberg B; Arvidson J; Ljungman P; Lonnies H; Nava S; Ringden O
Article: SUPPORTIVE CARE IN CANCER. 2007;15(7):849-857
Factors associated with poor general health after stem-cell transplantation
Larsen J; Nordstrom G; Ljungman P; Gardulf A
Article: BEST PRACTICE AND RESEARCH: CLINICAL HAEMATOLOGY. 2007;20(2):209-217
Risk assessment in haematopoietic stem cell transplantation: Viral status
Ljungman P
Article: BONE MARROW TRANSPLANTATION. 2007;39(8):497-499
Effectiveness of ganciclovir against human herpesvirus-6 excreted in saliva in stem cell transplant recipients
Ljungman P; Dahl H; Xu Y-H; Larsson K; Brytting M; Linde A
Article: BONE MARROW TRANSPLANTATION. 2007;39(7):383-388
Fludarabine-based disease-specific conditioning or conventional myeloablative conditioning in hematopoietic stem cell transplantation for treatment of non-malignant diseases
Ringden O; Remberger M; Svenberg P; Svahn B-M; Dahllof G; Gustafsson B; Hassan Z; Omazic B; Uzunel M; Aschan J; Barkholt L; Winiarski J; Ljungman P; Mattsson J
Article: ANNALS OF ONCOLOGY. 2007;18(4):694-700
Long-term follow-up of the SBG 9401 study comparing tailored FEC-based therapy versus marrow-supported high-dose therapy
Wilking N; Lidbrink E; Wiklund T; Erikstein B; Lindman H; Malmstroem P; Kellokumpu-Lehtinen P; Bengtsson N-O; Soederlund G; Anker G; Wist E; Ottosson S; Salminen E; Ljungman P; Holte H; Nilsson J; Blomqvist C; Bergh J
Article: BONE MARROW TRANSPLANTATION. 2006;38(12):799-805
Comparison of long-term outcomes after allogeneic hematopoietic stem cell transplantation from matched sibling and unrelated donors
Hows JM; Passweg JR; Tichelli A; Locasciulli A; Szydlo R; Bacigalupo A; Jacobson N; Ljungman P; Cornish J; Nunn A; Bradley B; Socie G
Article: BONE MARROW TRANSPLANTATION. 2006;38(10):687-692
Impact on the cytomegalovirus (CMV) viral load by CMV-specific T-cell immunity in recipients of allogeneic stem cell transplantation
Avetisyan G; Larsson K; Aschan J; Nilsson C; Hassan M; Ljungman P
Article: BLOOD. 2006;108(9):2928-2936
Impact of the intensity of the pretransplantation conditioning regimen in patients with prior invasive aspergillosis undergoing allogeneic hematopoietic stem cell transplantation:: a retrospective survey of the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation
Martino R; Parody R; Fukuda T; Maertens J; Theunissen K; Ho A; Mufti GJ; Kroger N; Zander AR; Heim D; Paluszewska M; Selleslag D; Steinerova K; Ljungman P; Cesaro S; Nihtinen A; Cordonnier C; Vazquez L; Lopez-Duarte M; Lopez J; Cabrera R; Rovira M; Neuburger S; Cornely O; Hunter AE; Marr KA; Dombusch HJ; Einsele H
Article: LEUKEMIA AND LYMPHOMA. 2006;47(9):1768-1773
Successful mobilization of Ph-negative blood stem cells with intensive chemotherapy plus G-CSF in patients with chronic myelogenous leukemia in first chronic phase
Olsson-Stromberg U; Hoglund M; Bjorkholm M; Braide I; Carlson K; Gahrton G; Grimfors G; Hast R; Lerner R; Linder O; Ljungman P; Lofvenberg E; Malm C; Nilsson P-G; Paul C; Rodjer S; Stenke L; Tidefeldt U; Turesson I; Uden A-M; Wahlin A; Vilen L; Winqvist I; Zettervall O; Oberg G; Simonsson B
Article: LAKARTIDNINGEN. 2006;103(21-22):1741-1743
[Diphosphonates can cause necrosis of the jaw. Patients with malignant skeletal diseases are at risk].
Jarnbring F; Ulmner M; Blomlöf J; Ljungman P
Article: JOURNAL OF CLINICAL MICROBIOLOGY. 2006;44(5):1847-1850
Polymorphisms in the genes encoding chemokine receptor 5, interleukin-10, and monocyte chemoattractant protein 1 contribute to cytomegalovirus reactivation and disease after allogeneic stem cell transplantation
Loeffler J; Michael S; Arlt EM; Toliat MR; Mezger M; Suk A; Wienker TF; Hebart H; Nürnberg P; Boeckh M; Ljungman P; Trenschel R; Einsele H
Article: JOURNAL OF CLINICAL VIROLOGY. 2006;35(4):493-495
Would monitoring CMV immune responses allow improved control of CMV in stem cell transplant patients
Ljungman P
Article: TRANSPLANTATION. 2006;81(5):718-725
Allogeneic hematopoietic stem cell transplantation for inherited disorders:: Experience in a single center
Ringdén O; Remberger M; Svahn BM; Barkholt L; Mattsson J; Aschan J; Le Blanc K; Gustafsson B; Hassan Z; Omazic B; Svenberg P; Solders G; von Döbeln U; Winiarski J; Ljungman P; Malm G
Article: HAEMATOLOGICA. 2006;91(3):401-404
The incidence of hemorrhagic cystitis and BK-viruria in allogeneic hematopoietic stem cell recipients according to intensity of the conditioning regimen
Giraud G; Bogdanovic G; Priftakis P; Remberger M; Svahn B-M; Barkholt L; Ringden O; Winiarski J; Ljungman P; Dalianis T
Article: BONE MARROW TRANSPLANTATION. 2006;37(5):439-449
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe
Ljungman P; Urbano-Ispizua A; Cavazzana-Calvo M; Demirer T; Dini G; Einsele H; Gratwohl A; Madrigal A; Niederwieser D; Passweg J; Rocha V; Saccardi R; Schouten H; Schmitz N; Socie G; Sureda A; Apperley J
Article: HAEMATOLOGICA. 2006;91(1):78-83
Risk factors for the development of cytomegalovirus disease after allogeneic stem cell transplantation
Ljungman P; Perez-Bercoff L; Jonsson J; Avetisyan G; Sparrelid E; Aschan J; Barkholt L; Larsson K; Winiarski J; Yun Z; Ringden O
Article: BONE MARROW TRANSPLANTATION. 2005;36(5):411-415
Cell-mediated immune responses to influenza vaccination in healthy volunteers and allogeneic stem cell transplant recipients
Avetisyan G; Ragnavölgyi E; Toth GT; Hassan M; Ljungman P
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2005;130(1):96-98
Vaccination of patients with haematological malignancies with one or two doses of influenza vaccine: a randomised study
Ljungman P; Nahi H; Linde A
Article: BONE MARROW TRANSPLANTATION. 2005;35(8):737-746
Vaccination of stem cell transplant recipients:: recommendations of the Infectious Diseases Working Party of the EBMT
Ljungman P; Engelhard D; de la Cámara R; Einsele H; Locasciulli A; Martino R; Ribaud P; Ward K; Cordonnier C
Article: BONE MARROW TRANSPLANTATION. 2005;35(6):609-617
The impact of donor gender on outcome of allogeneic hematopoietic stem cell transplantation for multiple myeloma:: reduced relapse risk in female to male transplants
Gahrton G; Iacobelli S; Apperley J; Bandini G; Björkstrand B; Bladé J; Boiron JM; Cavo M; Cornelissen J; Corradini P; Kröger N; Ljungman P; Michallet M; Russell NH; Samson D; Schattenberg A; Sirohi B; Verdonck LF; Volin L; Zander A; Niederwieser D
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2005;37(2):121-126
The value of CMV and fungal PCR for monitoring of acute leukaemia and autologous stem cell transplant patients
Ljungman P; Von Döbeln L; Ringholm L; Lewensohn-Fuchs I; Klingspor L; Sparrelid E
Article: ACTA HAEMATOLOGICA. 2005;113(3):155-162
Intensive treatment and stem cell transplantation in chronic myelogenous leukemia:: Long-term follow-up
Simonsson B; Öberg G; Björeman M; Björkholm M; Carneskog J; Karlsson K; Gahrton G; Grimfors G; Hast R; Karle H; Linder O; Ljungman P; Nielsen JL; Nilsson J; Löfvenberg E; Malm C; Olsson K; Olsson-Strömberg U; Paul C; Stenke L; Stentoft J; Turesson I; Udén AM; Wahlin A; Vilén L; Weis-Bjerrum O
Article: BONE MARROW TRANSPLANTATION. 2004;34(11):955-962
Lenograstim after autologous peripheral blood progenitor cell transplantation: results of a double-blind, randomized trial.
Schmitz N; Ljungman P; Cordonnier C; Kempf C; Linkesch W; Alegre A; Solano C; Simonsson B; Sonnen R; Diehl V; Fischer T; Caballero D; Littlewood T; Noppeney R; Schafhausen P; Jost L; Delabarre F; Marcus R
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2004;10(12):877-882
Allogenic stem cell transplantation for nonmalignant disorders using matched unrelated donors
Svenberg P; Remberger M; Svennilson J; Mattsson J; Leblanc K; Gustafsson B; Aschan J; Barkholt L; Winiarski J; Ljungman P; Ringdén O
Article: BONE MARROW TRANSPLANTATION. 2004;34(12):1067-1069
Long-term immunity to poliovirus after vaccination of allogeneic stem cell transplant recipients
Ljungman P; Aschan J; Gustafsson B; Lewensohn-Fuchs I; Winiarski J; Ringdén O
Article: JOURNAL OF CLINICAL MICROBIOLOGY. 2004;42(11):5394-5396
Association between a high BK virus load in urine samples of patients with graft-versus-host disease and development of hemorrhagic cystitis after hematopoietic stem cell transplantation
Bogdanovic G; Priftakis P; Giraud G; Kuzniar M; Ferraldeschi R; Kokhaei P; Mellstedt H; Remberger M; Ljungman P; Winiarski J; Dalianis T
Article: BONE MARROW TRANSPLANTATION. 2004;34(7):589-593
Measles immunity after allogeneic stem cell transplantation;: influence of donor type, graft type, intensity of conditioning, and graft-versus host disease
Ljungman P; Aschan J; Barkholt L; Broliden PA; Gustafsson B; Lewensohn-Fuchs I; Löfgren C; Winiarski J; Ringdén O
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2004;10(10):899-903
Reduced susceptibility to penicillin of viridans group streptococci in the oral cavity of patients with haematological disease
Westling K; Julander I; Ljungman P; Heimdahl A; Thalme A; Nord CE
Article: BONE MARROW TRANSPLANTATION. 2004;33(11):1075-1081
Management of CMV infections: recommendations from the infectious diseases working party of the EBMT.
Ljungman P; Reusser P; de la Camara R; Einsele H; Engelhard D; Ribaud P; Ward K; European Group for Blood and Marrow Transplantatio
Article: CLINICAL INFECTIOUS DISEASES. 2004;38(9):1229-1236
Mycobacterial infection: a difficult and late diagnosis in stem cell transplant recipients.
Cordonnier C; Martino R; Trabasso P; Held TK; Akan H; Ward MS; Fabian K; Ullmann AJ; Wulffraat N; Ljungman P; Alessandrino EP; Pretnar J; Gmür J; Varela R; Vitek A; Sica S; Rovira M; European Blood and Marrow Transplant Group Infecti
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2004;10(3):195-203
Graft-versus-Host disease is associated with a lower relapse incidence after hematopoietic stem cell transplantation in patients with acute lymphoblastic leukemia
Nordlander A; Mattsson J; Ringdén O; Leblanc K; Gustafsson B; Ljungman P; Svenberg P; Svennilson J; Remberger M
Article: TRANSPLANTATION. 2004;77(4):526-531
Reduced risk for extensive chronic graft-versus-host disease in patients receiving transplants with human leukocyte antigen-identical sibling donors given polymerase chain reaction-based preemptive therapy against cytomegalovirus
Larsson K; Aschan J; Remberger M; Ringdén O; Winiarski J; Ljungman P
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2004;10(2):128-134
Which donor should be chosen for hematopoietic stem cell transplantation among unrelated HLA-A, -B, and-DRB1 genomically identical volunteers?
Ringdén O; Schaffer M; Le Blanc AA; Persson U; Hauzenberger D; Abedi MR; Olerup O; Ljungman P; Remberger M
Article: BONE MARROW TRANSPLANTATION. 2004;33(1):79-85
Viridans streptococcal septicaemia in neutropenic patients:: role of proinflammatory cytokines
Ihendyane N; Sparrelid E; Wretlind B; Remberger M; Andersson J; Ljungman P; Ringdén O; Normark BH; Allen U; Low DE; Norrby-Teglund A
Article: HEMATOLOGY JOURNAL. 2004;5(6):462-466
Comparison of busulphan, hydroxyurea and allogeneic bone marrow transplantation (BMT) in chronic myeloid leukaemia:: BMT prolongs survival
Olsson-Strömberg U; Simonsson B; Ahlgren T; Björkholm M; Carlsson K; Gahrton G; Hast R; Löfvenberg E; Linder O; Ljungman P; Malm C; Paul C; Rödjer S; Turesson I; Udén AM; Wahlin A; Killander A; Wadman B; Westin J; Vikrot O; Zettervall O; Öberg G
Article: CANCER NURSING. 2004;27(1):55-64
Symptom occurrence, symptom intensity, and symptom distress in patients undergoing high-dose chemotherapy with stem-cell transplantation
Larsen J; Nordström G; Ljungman P; Gardulf A
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2004;36(8):593-600
A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies
Cherif H; Björkholm M; Engervall P; Johansson P; Ljungman P; Hast R; Kalin M
Article: BLOOD. 2003;102(13):4255-4260
Donor CMV serologic status and outcome of CMV-seropositive recipients after unrelated donor stem cell transplantation: an EBMT megafile analysis.
Ljungman P; Brand R; Einsele H; Frassoni F; Niederwieser D; Cordonnier C
Article: SUPPORTIVE CARE IN CANCER. 2003;11(11):739-741
Vaccination of autologous stem cell transplant recipients with live varicella vaccine: a pilot study.
Ljungman P; Wang FZ; Nilsson C; Solheim V; Linde A
Article: JOURNAL OF VIROLOGICAL METHODS. 2003;110(1):73-79
A real-time TaqMan PCR for routine quantitation of cytomegalovirus DNA in crude leukocyte lysates from stem cell transplant patients
Yun ZB; Lewensohn-Fuchs I; Ljungman P; Ringholm L; Jonsson J; Alberta J
Article: BLOOD. 2003;101(6):2426-2433
Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial.
van Rhenen D; Gulliksson H; Cazenave J-P; Pamphilon D; Ljungman P; Klüter H; Vermeij H; Kappers-Klunne M; de Greef G; Laforet M; Lioure B; Davis K; Marblie S; Mayaudon V; Flament J; Conlan M; Lin L; Metzel P; Buchholz D; Corash L; euroSPRITE trial
Article: BONE MARROW TRANSPLANTATION. 2003;31(6):481-486
Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation
Ljungman P; Ribaud P; Eyrich M; Matthes-Martin S; Einsele H; Bleakley M; Machaczka M; Bierings M; Bosi A; Gratecos N; Cordonnier C
Article: BONE MARROW TRANSPLANTATION. 2003;31(6):429-435
The effect of metronidazole on busulfan pharmacokinetics in patients undergoing hematopoietic stem cell transplantation
Nilsson C; Aschan J; Hentschke P; Ringdén O; Ljungman P; Hassan M
Article: EUROPEAN JOURNAL OF CANCER CARE. 2003;12(1):71-80
Symptom distress, functional status and health-related quality of life before high-dose chemotherapy with stem-cell transplantation
Larsen J; Nordström G; Björkstrand B; Ljungman P; Gardulf A
Article: BONE MARROW TRANSPLANTATION. 2002;30(12):833-841
A phase II trial of liposomal busulphan as an intravenous myeloablative agent prior to stem cell transplantation:: 500 mg/m² as a optimal total dose for conditioning
Hassan M; Nilsson C; Hassan Z; Gungor T; Aschan J; Winiarski J; Hentschke P; Ringdén O; Eber S; Seger R; Ljungman P
Article: BONE MARROW TRANSPLANTATION. 2002;30(11):761-768
The graft-versus-leukaemia effect in haematopoietic stem cell transplantation using unrelated donors
Remberger M; Mattsson J; Hentschke P; Aschan J; Barkholt L; Svennilson J; Ljungman P; Ringdén O
Article: BONE MARROW TRANSPLANTATION. 2002;30(8):521-526
Human herpesvirus 6 infection and cytomegalovirus-specific lymphoproliferative responses in allogeneic stem cell transplant recipients
Wang FZ; Larsson K; Linde A; Ljungman P
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2002;118(4):1112-1119
Thrombotic thrombocytopenic purpura after allogeneic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation (EBMT).
Ruutu T; Hermans J; Niederwieser D; Gratwohl A; Kiehl M; Volin L; Bertz H; Ljungman P; Spence D; Verdonck LF; Prentice HG; Bosi A; Du Toit CE; Brinch L; Apperley JF; EBMT Chronic Leukaemia Working Party
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2002;118(4):1048-1054
Intensive chemotherapy in patients with chronic myelogenous leukaemia (CML) in accelerated or blastic phase -: a report from the Swedish CML Group
Axdorph U; Stenke L; Grimfors G; Carneskog J; Hansen J; Linder O; Ljungman P; Löfvenberg E; Malm C; Simonsson B; Turesson I; Vilén L; Udén AM; Björkholm M
Article: BLOOD. 2002;100(2):397-405
Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: prognostic relevance of the initial cell dose.
Guglielmi C; Arcese W; Dazzi F; Brand R; Bunjes D; Verdonck LF; Schattenberg A; Kolb H-J; Ljungman P; Devergie A; Bacigalupo A; Gomez M; Michallet M; Elmaagacli A; Gratwohl A; Apperley J; Niederwieser D
Article: TRANSPLANT INFECTIOUS DISEASE. 2002;4(2):75-79
CMV retinitis after allogeneic bone marrow transplantation: a report of five cases.
Larsson K; Lönnqvist B; Ringdén O; Hedquist B; Ljungman P
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2002;117(2):444-450
Early and late invasive pneumococcal infection following stem cell transplantation: a European Bone Marrow Transplantation survey.
Engelhard D; Cordonnier C; Shaw PJ; Parkalli T; Guenther C; Martino R; Dekker AW; Prentice HG; Gustavsson A; Nurnberger W; Ljungman P; Infectious Disease Working Party of the European B
Article: BLOOD. 2002;99(8):3050-3056
Randomized study of valacyclovir as prophylaxis against cytomegalovirus reactivation in recipients of allogeneic bone marrow transplants.
Ljungman P; de La Camara R; Milpied N; Volin L; Russell CA; Crisp A; Webster A; Valacyclovir International Bone Marrow Transplant
Article: CLINICAL INFECTIOUS DISEASES. 2002;34(8):1094-1097
Definitions of cytomegalovirus infection and disease in transplant recipients
Ljungman P; Griffiths P; Paya C
Article: BONE MARROW TRANSPLANTATION. 2002;29(8):639-646
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe.
Urbano-Ispizua A; Schmitz N; de Witte T; Frassoni F; Rosti G; Schrezenmeier H; Gluckman E; Friedrich W; Cordonnier C; Socie G; Tyndall A; Niethammer D; Ljungman P; Gratwohl A; Apperley J; Niederwieser D; Bacigalupo A; European Group for Blood and Marrow Transplantatio
Article: TRANSPLANTATION. 2002;73(6):930-936
Clinical tolerance after allogeneic hematopoietic stem cell transplantation -: A study of influencing factors
Hentschke P; Remberger M; Mattsson J; Barkholt L; Aschan J; Ljungman P; Ringdén O
Article: BLOOD. 2002;99(4):1159-1164
Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation.
Reusser P; Einsele H; Lee J; Volin L; Rovira M; Engelhard D; Finke J; Cordonnier C; Link H; Ljungman P; Infectious Diseases Working Party of the European
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2002;8(12):674-682
Risk factors for moderate-to-severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
Remberger M; Kumlien G; Aschan J; Barkholt L; Hentschke P; Ljungman P; Mattsson J; Svennilson J; Ringdén O
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2002;34(5):347-350
Leukocyte depleted, unscreened blood products give a low risk for CMV infection and disease in CMV seronegative allogeneic stem cell transplant recipients with seronegative stem cell donors
Ljungman P; Larsson K; Kumlien G; Aschan J; Barkholt L; Gustaffson-Jernberg Å; Lewensohn-Fuchs I; Ringdén O
Article: STEM CELLS AND DEVELOPMENT. 2001;10(6):895-903
Practices of infectious disease prevention and management during hematopoietic stem cell transplantation: a survey from the European group for blood and marrow transplantation.
Krüger WH; Hornung RJ; Hertenstein B; Kern WV; Kröger N; Ljungman P; Zander AR; European group for blood and marrow transplantatio
Article: BONE MARROW TRANSPLANTATION. 2001;28(7):657-664
Population pharmacokinetic analysis resulting in a tool for dose individualization of busulphan in bone marrow transplantation recipients
Sandström M; Karlsson MO; Ljungman P; Hassan Z; Jonsson EN; Nilsson C; Ringden O; Öberg G; Bekassy A; Hassan M
Article: BONE MARROW TRANSPLANTATION. 2001;28(5):479-484
Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation
Ljungman P; Ward KN; Crooks BNA; Parker A; Martino R; Shaw PJ; Brinch L; Brune M; De La Camara R; Dekker A; Pauksen K; Russell N; Schwarer AP; Cordonnier C
Article: THE LANCET. 2001;358(9278):271-276
Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey.
Salooja N; Szydlo RM; Socie G; Rio B; Chatterjee R; Ljungman P; Van Lint MT; Powles R; Jackson G; Hinterberger-Fischer M; Kolb HJ; Apperley JF; Late Effects Working Party of the European Group f
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2001;47(6):855-861
Comparable aciclovir exposures produced by oral valaciclovir and intravenous aciclovir in immunocompromised cancer patients
Höglund M; Ljungman P; Weller S
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2001;113(1):209-216
Progress in allogenic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983--93 and 1994--8 at European Group for Blood and Marrow Transplantation centres.
Gahrton G; Svensson H; Cavo M; Apperly J; Bacigalupo A; Björkstrand B; Bladé J; Cornelissen J; de Laurenzi A; Facon T; Ljungman P; Michallet M; Niederwieser D; Powles R; Reiffers J; Russell NH; Samson D; Schaefer UW; Schattenberg A; Tura S; Verdonck LF; Vernant JP; Willemze R; Volin L; European Group for Blood and Marrow Transplantatio
Article: BONE MARROW TRANSPLANTATION. 2001;27(5):511-515
Alpha-interferon maintenance treatment is associated with improved survival after high-dose treatment and autologous stem cell transplantation in patients with multiple myeloma:: a retrospective registry study from the European Group for Blood and Marrow Transplantation (EBMT)
Björkstrand B; Svensson H; Goldschmidt H; Ljungman P; Apperley J; Mandelli F; Marcus R; Boogaerts M; Alegre A; Remes K; Cornelissen JJ; Bladé J; Lenhoff S; Iriondo A; Carlson K; Volin L; Littlewood T; Goldstone AH; San Miguel J; Schattenberg A; Gahrton G
Article: BONE MARROW TRANSPLANTATION. 2001;27(5):479-485
Pharmacokinetics of liposomal busulphan in man
Hassan Z; Ljungman P; Ringdén O; Winiarski J; Nilsson C; Aschan J; Whitley HR; Hassan M
Article: BLOOD. 2001;97(2):388-392
Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipients. The Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.
Ljungman P; Deliliers GL; Platzbecker U; Matthes-Martin S; Bacigalupo A; Einsele H; Ullmann J; Musso M; Trenschel R; Ribaud P; Bornhäuser M; Cesaro S; Crooks B; Dekker A; Gratecos N; Klingebiel T; Tagliaferri E; Ullmann AJ; Wacker P; Cordonnier C
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2001;33(5):323-328
Management of infections caused by respiratory syncytial virus
Rastad AA; Andersson J; Beermann B; Bohlin AB; Brandt C; Eriksson M; Ewald U; Göthberg S; Lind A; Lindroth M; Ljungman P; Navér L; Norrby SR; Pauksen K; Ransjö U; Rebbel H; Östlund MR; Sigurs N; Ståhle L; Säwe J; Sönnerborg A; Uhnoo I; Stopner B
Article: CANCER INVESTIGATION. 2001;19(1):13-22
A randomized, double-blind trial of famciclovir versus acyclovir for the treatment of localized dermatomal herpes zoster in immunocompromised patients
Tyring S; Belanger R; Bezwoda W; Ljungman P; Boon R; Saltzman RL
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2001;66(1):50-56
An ethnic role for chronic, but not acute, graft-versus-host disease after HLA-identical sibling stem cell transplantation
Remberger M; Aschan J; Lönnqvist B; Carlens S; Gustafsson B; Hentschke P; Klaesson S; Mattsson J; Ljungman P; Ringdén O
Article: JOURNAL OF MEDICAL VIROLOGY. 2000;62(4):498-504
Antibodies to human herpesvirus 8 latent and lytic antigens in blood donors and potential high-risk groups in Sweden:: Variable frequencies found in a multicenter serological study
Enbom M; Sheldon J; Lennette E; Schulz T; Ablashi DV; Neipel F; Biberfeld P; Carlberg H; Ljungman P; Nilsson A; Söderström T; Wadström J; Linde A
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2000;111(3):774-781
High levels of human herpesvirus 6 DNA in peripheral blood leucocytes are correlated to platelet engraftment and disease in allogeneic stem cell transplant patients
Ljungman P; Wang FZ; Clark DA; Emery VC; Remberger M; Ringdén O; Linde A
Article: LAKARTIDNINGEN. 2000;97(45):5086-5087
[Defend vaccination against measles! A life-threatening disease for immunocompromised patients].
Ljungman P
Article: THE LANCET. 2000;356(9239):1384-1391
Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer:: a randomised trial
Bergh J; Wiklund T; Erikstein B; Lidbrink E; Lindman H; Malmström P; Kellokumpu-Lehtinen P; Bengtsson NO; Söderlund G; Anker G; Wist E; Ottosson S; Salminen E; Ljungman P; Holte H; Nilsson J; Blomqvist C; Wilking N
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2000;110(3):620-630
Haematopoietic stem cell transplantation for patients with myelodysplastic syndromes and secondary acute myeloid leukaemias: a report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)
de Witte T; Hermans J; Vossen J; Bacigalupo A; Meloni G; Jacobsen N; Ruutu T; Ljungman P; Gratwohl A; Runde V; Niederwieser D; van Biezen A; Devergie A; Cornelissen J; Jouet JP; Arnold R; Apperley J
Article: THERAPEUTIC DRUG MONITORING. 2000;22(4):383-385
Ketobemidone may alter busulfan pharmacokinetics during high-dose therapy
Hassan M; Svensson JO; Nilsson C; Hentschke P; AL-Shurbaji A; Aschan J; Ljungman P; Ringdén O
Article: BONE MARROW TRANSPLANTATION. 2000;26(2):187-192
Cardiac systolic function before and after hematopoietic stem cell transplantation
Lehmann S; Isberg B; Ljungman P; Paul C
Article: BONE MARROW TRANSPLANTATION. 2000;25(9):915-924
The effect of busulphan on the pharmacokinetics of cyclophosphamide and its 4-hydroxy metabolite:: time interval influence on therapeutic efficacy and therapy-related toxicity
Hassan M; Ljungman P; Ringdén O; Hassan Z; Öberg G; Nilsson C; Békassy A; Bielenstein M; Abdel-Rehim M; Georén S; Astner L
Article: TRANSPLANTATION. 2000;69(8):1733-1736
Real-time monitoring of cytomegalovirus infections after stem cell transplantation using the TaqMan polymerase chain reaction assays
Yun ZB; Lewensohn-Fuchs I; Ljungman P; Vahlne A
Article: TRANSPLANTATION. 2000;69(8):1582-1586
Serum immunoglobulin levels in relation to levels of specific antibodies in allogeneic and autologous bone marrow transplant recipients
Hammarström V; Pauksen K; Svensson H; Lönnqvist B; Simonsson B; Ringdén O; Ljungman P
Article: LEUKEMIA. 2000;14(2):247-254
Minimal residual disease is common after allogeneic stem cell transplantation in patients with B cell chronic lymphocytic leukemia and may be controlled by graft-versus-host disease
Mattsson J; Uzunel M; Remberger M; Ljungman P; Kimby E; Ringdén O; Zetterquist H
Article: CLINICAL INFECTIOUS DISEASES. 2000;30(2):342-348
Granulocyte-macrophage colony-stimulating factor as immunomodulating factor together with influenza vaccination in stem cell transplant patients
Pauksen K; Linde A; Hammarström V; Sjölin J; Carneskog J; Jonsson G; Öberga G; Engelmann H; Ljungman P
Article: BLOOD. 2000;95(3):807-814
Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease:: prophylactic infusion of EBV-specific cytotoxic T cells
Gustafsson Å; Levitsky V; Zou JZ; Frisan T; Dalianis T; Ljungman P; Ringden O; Winiarski J; Ernberg I; Masucci MG
Article: BLOOD. 2000;95(2):422-429
Outcome of 69 allogeneic stem cell transplantations for Fanconi anemia using HLA-matched unrelated donors: a study on behalf of the European Group for Blood and Marrow Transplantation.
Guardiola P; Pasquini R; Dokal I; Ortega JJ; van Weel-Sipman M; Marsh JC; Ball SE; Locatelli F; Vermylen C; Skinner R; Ljungman P; Miniero R; Shaw PJ; Souillet G; Michallet M; Bekassy AN; Krivan G; Di Bartolomeo P; Heilmann C; Zanesco L; Cahn JY; Arcese W; Bacigalupo A; Gluckman E
Article: BONE MARROW TRANSPLANTATION. 1999;24(11):1201-1206
Human herpesvirus 6 infection inhibits specific lymphocyte proliferation responses and is related to lymphocytopenia after allogeneic stem cell transplantation
Wang FZ; Linde A; Dahl H; Ljungman P
Article: TRANSPLANTATION. 1999;68(10):1486-1491
The role of hepatitis C and B virus infections as risk factors for severe liver complications following allogeneic BMT: A prospective study by the Infectious Disease Working Party of the European Blood and Marrow Transplantation Group
Locasciulli A; Testa M; Valsecchi MG; Bacigalupo A; Solinas S; Tomas JF; Ljungman P; Alberti A
Article: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 1999;48(5):669-677
A mechanism-based pharmacokinetic-enzyme model for cyclophosphamide autoinduction in breast cancer patients
Hassan M; Svensson USH; Ljungman P; Björkstrand B; Olsson H; Bielenstein M; Abdel-Rehim M; Nilsson C; Johansson M; Karlsson MO
Article: BONE MARROW TRANSPLANTATION. 1999;24(9):1033-1035
Bilateral subdural haematomas following lumbar puncture in three haematopoietic stem cell transplant recipients
Hentschke P; Hägglund H; Mattsson J; Carlens S; Lönnqvist B; Ljungman P; Aschan J; Fredrikson S; Ringdén O
Article: BONE MARROW TRANSPLANTATION. 1999;24(7):741-745
Syngeneic transplantation in multiple myeloma - a case-matched comparison with autologous and allogeneic transplantation. European Group for Blood and Marrow Transplantation.
Gahrton G; Svensson H; Björkstrand B; Apperley J; Carlson K; Cavo M; Ferrant A; Fouillard L; Gratecos N; Gratwohl A; Guilhot F; Lambertenghi Deliliers G; Ljungman P; Masszi T; Milligan DW; Powles RL; Reiffers J; Samson JD; Stoppa AM; Vernant JP; Volin L; Wallvik J
Article: BONE MARROW TRANSPLANTATION. 1999;23(10):1043-1047
Nutritional status and growth after bone marrow transplantation (BMT) during childhood:: EBMT Late-Effects Working Party retrospective data
Cohen A; Duell T; Socié G; van Lint MT; Weiss M; Tichelli A; Rovelli A; Apperley JF; Ljungman P; Kolb HJ
Article: BONE MARROW TRANSPLANTATION. 1999;23(8):835-837
Acute quadriplegic myopathy following autologous peripheral blood stem cell transplantation for breast cancer
Samuelsson J; Zackrisson H; Tokics L; Ljungman P; Lidbrink E; Pircher P; Larsson L
Article: BLOOD. 1999;93(7):2196-2201
Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation:: Long-term results of a randomized trial in allogeneic marrow recipients with leukemia
Ringdén O; Remberger M; Ruutu T; Nikoskelainen J; Volin L; Vindelov L; Parkkali T; Lenhoff S; Sallerfors B; Mellander L; Ljungman P; Jacobsen N
Article: CLINICAL INFECTIOUS DISEASES. 1999;28(3):562-568
Human herpesvirus 6 DNA in cerebrospinal fluid specimens from allogeneic bone marrow transplant patients:: Does it wave clinical significance?
Wang FZ; Linde A; Hägglund A; Testa M; Locasciulli A; Ljungman P
Article: ANNALS OF INTERNAL MEDICINE. 1999;130(3):193-201
Effectiveness of immunosuppressive therapy in older patients with aplastic anemia. European Group for Blood and Marrow Transplantation Severe Aplastic Anaemia Working Party.
Tichelli A; Socié G; Henry-Amar M; Marsh J; Passweg J; Schrezenmeier H; McCann S; Hows J; Ljungman P; Marin P; Raghavachar A; Locasciulli A; Gratwohl A; Bacigalupo A
Article: JOURNAL OF MEDICAL VIROLOGY. 1999;57(2):134-139
Lymphoproliferative responses to human herpesvirus-6 variant A and variant B in healthy adults
Wang FZ; Dahl H; Ljungman P; Linde A
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 1999;31(1):43-49
Subsets of T-cells and in vitro cytokine production after measles and varicellae-zoster virus antigen stimulation in allogeneic BMT patients
Pauksen K; Sjölin J; Linde A; Andersson B; Lenkei R; Öberg G; Ljungman P
Article: ACTA ONCOLOGICA. 1999;38(2):239-245
FEC mobilized stem cells for high-dose therapy in breast cancer patients
Lindman H; Wiklund T; Holte H; Ljungman P; Blomqvist C; Kvalheim G; Bengtsson M; Höglund M; Wilking N; Bergh J
Article: BLOOD. 1998;92(12):4568-4572
Norethisterone treatment, a major risk-factor for veno-occlusive disease in the liver after allogeneic bone marrow transplantation
Hägglund H; Remberger M; Klaesson S; Lönnqvist B; Ljungman P; Ringdén O
Article: BONE MARROW TRANSPLANTATION. 1998;22(11):1119-1122
Improved peripheral nerve conduction, EEG and verbal IQ after bone marrow transplantation for adult metachromatic leukodystrophy
Solders G; Celsing G; Hagenfeldt L; Ljungman P; Isberg B; Ringdén O
Article: TRANSPLANTATION. 1998;66(10):1330-1334
Results of different strategies for reducing:: Cytomegalovirus-associated mortality in allogeneic stem cell transplant recipients
Ljungman P; Aschan J; Lewensohn-Fuchs I; Carlens S; Larsson K; Lönnqvist B; Mattsson J; Sparrelid E; Winiarski J; Ringdén O
Article: BONE MARROW TRANSPLANTATION. 1998;22(8):795-800
Bacteraemia during the aplastic phase after allogeneic bone marrow transplantation is associated with early death from invasive fungal infection
Sparrelid E; Hägglund H; Remberger M; Ringdén O; Lönnqvist B; Ljungman P; Andersson J
Article: BONE MARROW TRANSPLANTATION. 1998;22(8):755-761
Risk factors for chronic graft-versus-host disease after bone marrow transplantation:: a retrospective single centre analysis
Carlens S; Ringdén O; Remberger M; Lönnqvist B; Hägglund H; Klaesson S; Mattsson J; Svahn BM; Winiarski J; Ljungman P; Aschan J
Article: TRANSPLANTATION. 1998;66(5):620-625
Low incidence of acute graft-versus-host disease, using unrelated HLA-A-, HLA-B-, and HLA-DR-compatible donors and conditioning, including, anti-T-cell antibodies
Ringdén O; Remberger M; Carlens S; Hagglund H; Mattsson J; Aschan J; Lönnqvist B; Klaesson S; Winiarski J; Dalianis T; Olerup O; Sparrelid E; Elmhorn-Rosenborg A; Svahn BM; Ljungman P
Article: BONE MARROW TRANSPLANTATION. 1998;22(5):499-501
Detection of hepatitis G virus GB virus C after allogeneic bone marrow transplantation
Ljungman P; Halasz R; Hägglund H; Sönnerborg A; Ringdén O
Article: BONE MARROW TRANSPLANTATION. 1998;22(5):445-448
High-dose chemotherapy with autologous stem cell support in patients with responding stage IV breast cancer
Ljungman P; Björkstrand B; Fornander T; Höglund M; Juliusson G; Lindman H; Malmström A; Rotstein S; Söderberg M; Wilking N; Villman K; Bergh J
Article: SUPPORTIVE CARE IN CANCER. 1998;6(5):469-472
Tetanus immunity in patients with hematological malignancies
Hamarstrom V; Pauksen K; Svensson H; Oberg G; Paul C; Ljungman P
Article: BONE MARROW TRANSPLANTATION. 1998;22(1):67-71
Tetanus immunity in autologous bone marrow and blood stem cell transplant recipients.
Hammarström V; Pauksen K; Björkstrand B; Simonsson B; Oberg G; Ljungman P
Article: SUPPORTIVE CARE IN CANCER. 1998;6(4):378-383
Faster engraftment but no reduction in infectious complications after peripheral blood stem cell transplantation compared to autologous bone marrow transplantation
Larsson K; Bjorkstrand B; Ljungman P
Article: BONE MARROW TRANSPLANTATION. 1998;22(1):73-78
Booster marrow or blood cells for graft failure after allogeneic bone marrow transplantation
Remberger M; Ringdén O; Ljungman P; Hägglund H; Winiarski J; Lönnqvist B; Aschan J
Article: BONE MARROW TRANSPLANTATION. 1998;21(12):1231-1238
Influence of protective isolation on outcome of allogeneic bone marrow transplantation for leukemia.
Passweg JR; Rowlings PA; Atkinson KA; Barrett AJ; Gale RP; Gratwohl A; Jacobsen N; Klein JP; Ljungman P; Russell JA; Schaefer UW; Sobocinski KA; Vossen JM; Zhang MJ; Horowitz MM
Article: PEDIATRIC TRANSPLANTATION. 1998;2(2):150-156
Engraftment and chimerism, particularly of T- and B-cells, in children undergoing allogeneic bone marrow transplantation.
Winiarski J; Mattsson J; Gustafsson A; Wester D; Borgström B; Ringdén O; Ljungman P; Dalianis T
Article: CLINICAL INFECTIOUS DISEASES. 1998;26(5):1098-1103
Impact of previous aspergillosis on the outcome of bone marrow transplantation
Offner F; Cordonnier C; Ljungman P; Prentice HG; Engelhard D; De Bacquer D; Meunier F; De Pauw B
Article: CLINICAL TRANSPLANTATION. 1998;12(2):84-92
Risk factors in bone marrow transplant recipients with leukaemia. Increased relapse risk in patients treated with ciprofloxacin for gut decontamination
Carlens S; Ringden O; Aschan J; Hagglund H; Ljungman P; Mattsson J; Remberger M
Article: BONE MARROW TRANSPLANTATION. 1998;21(5):473-476
Use of intravenous immune globulin in addition to antiviral therapy in the treatment of CMV gastrointestinal disease in allogeneic bone marrow transplant patients:: a report from the European Group for Blood and Marrow Transplantation (EBMT)
Ljungman P; Cordonnier C; Einsele H; Bender-Götze C; Bosi A; Dekker A; De la Camara R; Gmür J; Newland AC; Prentice HG; Robinson AJ; Rovira M; Rösler W; Veil D
Article: BONE MARROW TRANSPLANTATION. 1998;21(3):255-261
Bone marrow transplantation from HLA identical siblings as first-line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved outcome
Runde V; de Witte T; Arnold R; Gratwohl A; Hermans J; Van Biezen A; Niederwieser D; Labopin M; Walter-Noel MP; Bacigalupo A; Jacobsen N; Ljungman P; Carreras E; Kolb HJ; Aul C; Apperley J
Article: BONE MARROW TRANSPLANTATION. 1998;21(1):43-49
Transplantation with unrelated bone marrow in leukaemic patients above 40 years of age
Ringdén O; Remberger M; Mattsson J; Aschan J; Carlens S; Hägglund H; Lönnqvist B; Sparrelid E; Ljungman P
Article: BONE MARROW TRANSPLANTATION. 1997;20(11):909-913
High busulfan concentrations are associated with increased transplant-related mortality in allogeneic bone marrow transplant patients
Ljungman P; Hassan M; Bekassy AN; Ringden O; Oberg G
Article: SUPPORTIVE CARE IN CANCER. 1997;5(6):485-488
Peroperative teicoplanin for prevention of gram-positive infections in neutropenic patients with indwelling central venous catheters: a randomized, controlled study
Ljungman P; Hagglund H; Bjorkstrand B; Lonnqvist B; Ringden O
Article: BONE MARROW TRANSPLANTATION. 1997;20(4):317-323
Th1 and Th2 cytokine responses after measles antigen stimulation in vitro in bone marrow transplant patients: response to measles vaccination
Pauksen K; Sjolin J; Linde A; Alm G; Andersson B; Lonnerholm G; Ljungman P
Article: BONE MARROW TRANSPLANTATION. 1997;20(1):11-19
European results of matched unrelated donor bone marrow transplantation for chronic myeloid leukemia. Impact of HLA class II matching. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Devergie A; Apperley JF; Labopin M; Madrigal A; Jacobsen N; Carreras E; Prentice HG; Jouet JP; Kolb HJ; Herstenstein B; Bacigalupo A; Evensen SA; Ljungman P; de Witte T; Reiffers J; Nagler A; Clark RE; Goldman JM; Gratwohl A
Article: BONE MARROW TRANSPLANTATION. 1997;19(9):905-908
Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections
Sparrelid E; Ljungman P; EkelofAndstrom E; Aschan J; Ringden O; Winiarski J; Wahlin B; Andersson J
Article: AMERICAN JOURNAL OF MEDICINE. 1997;102(3A):44-47
Respiratory virus infections in bone marrow transplant recipients: the European perspective.
Ljungman P
Article: BONE MARROW TRANSPLANTATION. 1997;19(3):237-240
Hepatitis C virus genotypes and liver disease in patients undergoing allogeneic bone marrow transplantation
Locasciulli A; Testa M; Pontisso P; Bacigalupo A; Ljungman P; Frickhofen N; Alberti A
Article: BONE MARROW TRANSPLANTATION. 1997;19(3):233-236
No prevention of cytomegalovirus infection by anti-cytomegalovirus hyperimmune globulin in seronegative bone marrow transplant recipients
Ruutu T; Ljungman P; Brinch L; Lenhoff S; Lonnqvist B; Ringden O; Ruutu P; Volin L; Albrechtsen D; Sallerfors B; Ebeling F; Myllyla G
Article: ANNALS OF INTERNAL MEDICINE. 1997;126(3):184-192
Health and functional status of long-term survivors of bone marrow transplantation. EBMT Working Party on Late Effects and EULEP Study Group on Late Effects. European Group for Blood and Marrow Transplantation.
Duell T; van Lint MT; Ljungman P; Tichelli A; Socié G; Apperley JF; Weiss M; Cohen A; Nekolla E; Kolb HJ
Article: BONE MARROW TRANSPLANTATION. 1997;19(2):129-133
Long-term survival in allogeneic bone marrow transplant recipients following acyclovir prophylaxis for CMV infection. The European Acyclovir for CMV Prophylaxis Study Group.
Prentice HG; Gluckman E; Powles RL; Ljungman P; Milpied NJ; Camara R; Mandelli F; Kho P; Kennedy L; Bell AR
Article: BLOOD. 1996;88(12):4711-4718
Allogeneic bone marrow transplantation versus autologous stem cell transplantation in multiple myeloma: A retrospective case-matched study from the European group for blood and marrow transplantation
Bjorkstrand B; Ljungman P; Svensson H; Hermans J; Alegre A; Apperley J; Blade J; Carlson K; Cavo M; Ferrant A; Goldstone AH; deLaurenzi A; Majolino I; Marcus R; Prentice HG; Remes K; Samson D; Sureda A; Verdonck LF; Volin L; Gahrton G
Article: BONE MARROW TRANSPLANTATION. 1996;18(6):1179-1181
Rejection of the second allogeneic graft in a patient with severe aplastic anemia reversed by antilymphocyte globulin and donor lymphocyte infusions
Ljungman P; Lawler M; Lonnqvist B; Ringden O; Shanwell A
Article: BONE MARROW TRANSPLANTATION. 1996;18(5):969-973
Influence of the specific T cell response on seroconversion after measles vaccination in autologous bone marrow transplant patients
Pauksen K; Linde A; Lonnerholm G; Ljungman P; Sjolin J
Article: BLOOD. 1996;88(9):3615-3620
Lymphotropic herpesviruses in allogeneic bone marrow transplantation
Wang FZ; Dahl H; Linde A; Brytting M; Ehrnst A; Ljungman P
Article: TRANSPLANTATION. 1996;62(8):1076-1080
Treatment of hepatic venoocclusive disease with recombinant human tissue plasminogen activator or orthotopic liver transplantation after allogeneic bone marrow transplantation
Hagglund H; Ringden O; Ericzon BG; Duraj F; Ljungman P; Lonnqvist B; Winiarski J; Tyden G
Article: BONE MARROW TRANSPLANTATION. 1996;18(4):677-691
The European Group for Blood and Marrow Transplantation (EBMT): a report from the president and the chairmen of the working parties.
Gratwohl A; Gorin C; Apperley J; Goldstone A; Rosti G; Bacigalupo A; Gluckman E; Fischer A; Ljungman P; Kolb HJ; Niethammer D
Article: CANCER NURSING. 1996;19(5):368-375
Health-related quality of life in women with breast cancer undergoing autologous stem cell transplantation
Larsen J; Gardulf A; Nordstrom G; Bjorkstrand B; Ljungman P
Article: JOURNAL OF CHEMOTHERAPY. 1996;8(5):382-386
Imipenem/cilastatin monotherapy as salvage treatment in febrile neutropenic patients
Engervall P; Gunther G; Ljungman P; Lonnqvist B; Hast R; Stiernstedt G; Kalin M; Ringertz S; Bjorkholm M
Article: BONE MARROW TRANSPLANTATION. 1996;18(3):565-568
Foscarnet for pre-emptive therapy of CMV infection detected by a leukocyte-based nested PCR in allogeneic bone marrow transplant patients
Ljungman P; Oberg G; Aschan J; Ehrnst A; Lonnqvist B; Pauksen K; Sulila P
Article: BONE MARROW TRANSPLANTATION. 1996;18(2):333-337
Loss of seroreactivity against human papillomavirus (HPV) in bone marrow transplant recipients
LewensohnFuchs I; Ljungman P; Kjerrstrom A; Ringden O; Dalianis T
Article: BONE MARROW TRANSPLANTATION. 1996;18(1):241-242
Lymphoblastoid human interferon and low dose IL-2 combined with donor lymphocyte infusion as therapy of a third relapse of CML--a case report.
Lönnqvist B; Brune M; Ljungman P
Article: CLINICAL INFECTIOUS DISEASES. 1996;23(1):167-169
Oral ribavirin for prevention of severe liver disease caused by hepatitis C virus during allogeneic bone marrow transplantation
Ljungman P; Andersson J; Aschan J; Bjorkstrand B; Hagglund H; Lonnqvist B; Ringden O; Winiarski J
Article: BONE MARROW TRANSPLANTATION. 1996;17(6):1105-1111
Late-onset keratoconjunctivitis sicca syndrome after bone marrow transplantation: Incidence and risk factors
Tichelli A; Duell T; Weiss M; Socie G; Ljungman P; Cohen A; vanLint M; Gratwohl A; Kolb HJ
Article: BONE MARROW TRANSPLANTATION. 1996;17(5):813-817
European survey of herpesvirus resistance to antiviral drugs in bone marrow transplant recipients. Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Reusser P; Cordonnier C; Einsele H; Engelhard D; Link D; Locasciulli A; Ljungman P
Article: JOURNAL OF CLINICAL MICROBIOLOGY. 1996;34(5):1166-1170
A three-center European external quality control study of PCR for detection of cytomegalovirus DNA in blood.
Grundy JE; Ehrnst A; Einsele H; Emery VC; Hebart H; Prentice HG; Ljungman P
Article: BONE MARROW TRANSPLANTATION. 1996;17(4):583-587
Use of a semi-quantitative PCR for cytomegalovirus DNA as a basis for pre-emptive antiviral therapy in allogeneic bone marrow transplant patients
Ljungman P; Lore K; Aschan J; Klaesson S; LewensohnFuchs I; Lonnqvist B; Ringden O; Winiarski J; Ehrnst A
Article: BONE MARROW TRANSPLANTATION. 1996;17(4):573-576
Presence of human polyomavirus DNA in the peripheral circulation of bone marrow transplant patients with and without hemorrhagic cystitis
Bogdanovic G; Ljungman P; Wang F; Dalianis T
Article: ACTA PAEDIATRICA, INTERNATIONAL JOURNAL OF PAEDIATRICS. 1996;85(3):327-335
Bone marrow transplantation in children using unrelated donors at Huddinge Hospital
Winiarski J; Ringden O; Remberger M; Dalianis T; Ljungman P; Borgstrom B
Article: TRANSPLANTATION. 1996;61(4):600-609
Cytomegalovirus-induced CD13-specific autoimmunity - A possible cause of chronic graft-versus-host disease
Soderberg C; Larsson S; Rozell BL; SumitranKaruppan S; Ljungman P; Moller E
Article: TRANSPLANTATION. 1996;61(4):594-600
CD13-specific autoimmunity in cytomegalovirus infected immunocompromised patients
Soderberg C; SumitranKaruppan S; Ljungman P; Moller E
Article: ACTA PAEDIATRICA, INTERNATIONAL JOURNAL OF PAEDIATRICS. 1996;85(2):168-172
Fungal pneumonia: The predominant lung infection causing death in children undergoing bone marrow transplantation
Heurlin N; Bergstrom SE; Winiarski J; Ringden O; Ljungman P; Lonnqvist B; Andersson J
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 1996;28(3):297-303
Trimethoprim-sulfamethoxazole plus amikacin versus ceftazidime monotherapy as empirical treatment in patients with neutropenia and fever
Engervall P; Gunther G; Ljungman P; Lonnqvist B; Hast R; Stiernstedt G; Kalin M; Ringertz S; Bjokholm M
Article: TRANSPLANTATION. 1995;60(11):1225-1230
Does high-dose intravenous immune globulin treatment after bone marrow transplantation increase mortality in veno-occlusive disease of the liver?
Klaesson S; Ringden O; Ljungman P; Aschan J; Hagglund H; Winiarski J
Article: BONE MARROW TRANSPLANTATION. 1995;16(6):807-813
Specific T and B cell immunity to measles after allogeneic and autologous bone marrow transplantation
Pauksen K; Linde A; Ljungman P; Bolme P; Lonnerholm G; Oberg G; Sjolin J
Article: BONE MARROW TRANSPLANTATION. 1995;16(6):747-753
Risk factors for acute graft-versus-host disease in 291 consecutive HLA-identical bone marrow transplant recipients
Hagglund H; Bostrom L; Remberger M; Ljungman P; Nilsson B; Ringden O
Article: TRANSPLANTATION. 1995;60(9):961-965
CYTOMEGALOVIRUS DNA IN PERIPHERAL-BLOOD LEUKOCYTES AND PLASMA FROM BONE-MARROW TRANSPLANT RECIPIENTS
BRYTTING M; MOUSAVIJAZI M; BOSTROM L; LARSSON M; LUNDEBERG J; LJUNGMAN P; RINGDEN O; SUNDQVIST VA
Article: BLOOD. 1995;86(5):2041-2050
GRAFT-VERSUS-LEUKEMIA EFFECT OF DONOR LYMPHOCYTE TRANSFUSIONS IN MARROW GRAFTED PATIENTS
KOLB HJ; SCHATTENBERG A; GOLDMAN JM; HERTENSTEIN B; JACOBSEN N; ARCESE W; LJUNGMAN P; FERRANT A; VERDONCK L; NIEDERWIESER D; VANRHEE F; MITTERMUELLER J; DEWITTE T; HOLLER E; ANSARI H
Article: BLOOD. 1995;86(4):1614-1618
LONG-TERM EFFECTS OF HEPATITIS-C VIRUS-INFECTION IN ALLOGENEIC BONE-MARROW TRANSPLANT RECIPIENTS
LJUNGMAN P; JOHANSSON N; ASCHAN J; GLAUMANN H; LONNQVIST B; RINGDEN O; SPARRELID E; SONNERBORG A; WINIARSKI J; GAHRTON G
Article: STEM CELLS. 1995;13 Suppl 2:122-125
An update of prognostic factors for allogeneic bone marrow transplantation in multiple myeloma using matched sibling donors. European Group for Blood and Marrow Transplantation.
Gahrton G; Tura S; Ljungman P; Bladé J; Cavo M; De Laurenzi A; Façon T; Gratwohl A; Michallet M; Nikoskelainen J
Article: CURRENT OPINION IN INFECTIOUS DISEASES. 1995;8(4):254-257
IMMUNIZATION IN THE IMMUNOCOMPROMISED HOST
LJUNGMAN P
Article: STEM CELLS. 1995;13:140-146
AUTOLOGOUS STEM-CELL TRANSPLANTATION IN MULTIPLE-MYELOMA - RESULTS OF THE EUROPEAN GROUP FOR BONE-MARROW TRANSPLANTATION
BJORKSTRAND B; LJUNGMAN P; BIRD JM; SAMSON D; BRANDT L; ALEGRE A; AUZANNEAU G; BLADE J; BRUNET S; CARLSON K; CAVO M; FERRANT A; GRAVETT P; DELAURENZI A; PRENTICE HG; PROCTOR S; REMES K; TROUSSARD X; VERDONCK LF; WILLIAMS C; GAHRTON G
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 1995;55(1):19-23
MITOXANTRONE, ETOPOSIDE AND ARA-C VS DOXORUBICIN-DNA, ARA-C, THIOGUANINE, VINCRISTINE AND PREDNISOLONE IN THE TREATMENT OF PATIENTS WITH ACUTE MYELOCYTIC-LEUKEMIA - A RANDOMIZED COMPARISON
BJORKHOLM M; LILIEMARK J; GAHRTON G; GRIMFORS G; GRUBER A; HAST R; JULIUSSON G; JARNMARK M; KILLANDER A; KIMBY E; LERNER R; LJUNGMAN P; LONNQVIST B; PALMBLAD J; PAUL C; PETTERSON C; SIMONSSON B; STALFELT AM; STENKE L; SUNDSTROM C; TIDEFELT U; UDEN AM; OBERG G; OST A
Article: JOURNAL OF CLINICAL ONCOLOGY. 1995;13(6):1312-1322
Prognostic factors in allogeneic bone marrow transplantation for multiple myeloma.
Gahrton G; Tura S; Ljungman P; Bladé J; Brandt L; Cavo M; Façon T; Gratwohl A; Hagenbeek A; Jacobs P
Article: BONE MARROW TRANSPLANTATION. 1995;15(6):869-871
BUSULFAN CONCENTRATION IN RELATION TO PERMANENT ALOPECIA IN RECIPIENTS OF BONE-MARROW TRANSPLANTS
LJUNGMAN P; HASSAN M; BEKASSY AN; RINGDEN O; OBERG G
Article: BIODRUGS. 1995;3(5):330-337
IMMUNIZATION OF TRANSPLANT RECIPIENTS
LJUNGMAN P; HAMMARSTROM V
Article: CLINICAL AND DIAGNOSTIC VIROLOGY. 1995;3(4):371-375
CONTINUOUS DETECTION OF CMV DNA IN PLASMA OF PATIENTS WITH ADVANCED HIV-INFECTION IMPLIES THE POOREST PROGNOSIS
WANG FH; BRYTTING M; BRATT G; LJUNGMAN P; WAHREN B
Article: BONE MARROW TRANSPLANTATION. 1995;15(4):619-625
SIMILAR INCIDENCE OF GRAFT-VERSUS-HOST DISEASE USING HLA-A, HLA-B AND HLA-DR IDENTICAL UNRELATED BONE-MARROW DONORS AS WITH HLA-IDENTICAL SIBLINGS
RINGDEN O; REMBERGER M; PERSSON U; LJUNGMAN P; ALDENER A; ANDSTROM E; ASCHAN J; BOLME P; DAHLLOF G; DALIANIS T; GAHRTON G; HAGGLUND H; LONNQVIST B; OLERUP O; SHANWELL A; SPARRELID E; WINIARSKI J; MOLLER E; OBERG M
Article: BONE MARROW TRANSPLANTATION. 1995;15(3):455-460
Immunisations after bone marrow transplantation: results of a European survey and recommendations from the infectious diseases working party of the European Group for Blood and Marrow Transplantation.
Ljungman P; Cordonnier C; de Bock R; Einsele H; Engelhard D; Grundy J; Link H; Locasciulli A; Prentice G; Reusser P
Article: LAKARTIDNINGEN. 1995;92(9):849-853
[High-dose chemotherapy in breast cancer. Promising results in combination with stem cell support].
Ljungman P; Björkstrand B; Gahrton G; Nordenström J; Shanwell A; Glas U; Rotstein S; Rutqvist LE; Wilking N
Article: BONE MARROW TRANSPLANTATION. 1995;15(3):367-371
DOUBLE HIGH-DOSE CHEMORADIOTHERAPY WITH AUTOLOGOUS STEM-CELL TRANSPLANTATION CAN INDUCE MOLECULAR REMISSIONS IN MULTIPLE-MYELOMA
BJORKSTRAND B; LJUNGMAN P; BIRD JM; SAMSON D; GAHRTON G
Article: BONE MARROW TRANSPLANTATION. 1995;15(3):331-335
ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN SWEDEN
BOLME P; HENTER JI; WINIARSKI J; ELINDER G; LJUNGMAN P; LONNERHOLM G; RINGDEN O
Article: CLINICAL AND DIAGNOSTIC VIROLOGY. 1995;3(2):139-153
CMV PCR MONITORING IN LEUKOCYTES OF TRANSPLANT PATIENTS
EHRNST A; BARKHOLT L; LEWENSOHNFUCHS I; LJUNGMAN P; TEODOSIU O; STALAND A; RINGDEN O; TYDEN G; JOHANSSON B
Article: NORDISK MEDICIN. 1995;110(12):320-321
[Infections following bone marrow transplantation].
Ljungman P; Andersson J; Sparrelid E
Visa fler

Alla övriga publikationer

Letter: LEUKEMIA. 2023;37(9):1933-1938
Update of recommendations for the management of COVID-19 in patients with haematological malignancies, haematopoietic cell transplantation and CAR T therapy, from the 2022 European Conference on Infections in Leukaemia (ECIL 9)
Cesaro S; Mikulska M; Hirsch HH; Styczynski J; Meylan S; Cordonnier C; Navarro D; von Lilienfeld-Toal M; Mehra V; Marchesi F; Besson C; Masculano RC; Beutel G; Einsele H; Maertens J; de la Camara R; Ljungman P; Pagano L
Review: THE LANCET HAEMATOLOGY. 2023;10(4):e295-e305
Endemic or regionally limited parasitic and fungal infections in haematopoietic stem-cell transplantation recipients: a Worldwide Network for Blood and Marrow Transplantation (WBMT) Review
Muhsen IN; Galeano S; Niederwieser D; Koh MBC; Ljungman P; Machado CM; Kharfan-Dabaja MA; de la Camara R; Kodera Y; Szer J; Rasheed W; Cesaro S; Hashmi SK; Seber A; Atsuta Y; Saleh MFM; Srivastava A; Styczynski J; Alrajhi A; Almaghrabi R; Abid MB; Chemaly RF; Gergis U; Brissot E; El Fakih R; Riches M; Mikulska M; Worel N; Weisdorf D; Greinix H; Cordonnier C; Aljurf M
Review: THE LANCET HAEMATOLOGY. 2023;10(4):e284-e294
Endemic or regionally limited bacterial and viral infections in haematopoietic stem-cell transplantation recipients: a Worldwide Network for Blood and Marrow Transplantation (WBMT) Review
Muhsen IN; Galeano S; Niederwieser D; Koh MBC; Ljungman P; Machado CM; Kharfan-Dabaja MA; de la Camara R; Kodera Y; Szer J; Rasheed W; Cesaro S; Hashmi SK; Seber A; Atsuta Y; Saleh MFM; Srivastava A; Styczynski J; Alrajhi A; Almaghrabi R; Abid MB; Chemaly RF; Gergis U; Brissot E; El Fakih R; Riches M; Mikulska M; Worel N; Weisdorf D; Greinix H; Cordonnier C; Aljurf M
Corrigendum: FRONTIERS IN IMMUNOLOGY. 2023;14:1195142
Different recovery patterns of CMV-specific and WT1-specific T cells in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: impact of CMV infection and leukemia relapse (vol 13, 1027593, 2023)
Luo X-H; Poiret T; Liu Z; Meng Q; Nagchowdhury A; Ljungman P
Review: TRANSPLANT INFECTIOUS DISEASE. 2022;24(6):e13977
Cytomegalovirus in the transplant setting: Where are we now and what happens next? A report from the International CMV Symposium 2021.
Kotton CN; Torre-Cisneros J; International CMV Symposium Faculty; Aguado JM; Alain S; Baldanti F; Baumann G; Boeken U; de la Calle M; Carbone J; Ciceri F; Comoli P; Couzi L; Danziger-Isakov L; Fernández-Ruiz M; Girmenia C; Grossi PA; Hirsch HH; Humar A; Kamar N; Kotton C; Ljungman P; Malagola M; Mira E; Mueller N; Sester M; Teng C-LJ; Torre-Cisneros J; Ussetti P; Westall G; Wolf D; Zamora M
Letter: HAEMATOLOGICA. 2022;107(6):1479-1482
Reduced immunogenicity of a third COVID-19 vaccination among recipients of allogeneic hematopoietic stem cell transplantation
Einarsdottir S; Martner A; Nicklasson M; Wiktorin HG; Arabpour M; Tornell A; Vaht K; Waldenstrom J; Ringlander J; Bergstrom T; Brune M; Hellstrand K; Ljungman P; Lagging M
Review: LEUKEMIA. 2022;36(6):1467-1480
Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European Conference on Infections in Leukaemia (ECIL 9)
Cesaro S; Ljungman P; Mikulska M; Hirsch HH; Von Lilienfeld-Toal M; Cordonnier C; Meylan S; Mehra V; Styczynski J; Marchesi F; Besson C; Baldanti F; Cordoba Masculano R; Beutel G; Einsele H; Azoulay E; Maertens J; de la Camara R; Pagano L
Corrigendum: BONE MARROW TRANSPLANTATION. 2022;57(2):331
Correction to: Special issues related to the diagnosis and management of acquired aplastic anemia in countries with restricted resources, a report on behalf of the Eastern Mediterranean Blood and Marrow Transplantation (EMBMT) Group and Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation (SAAWP of EBMT).
Iftikhar R; Ahmad P; de Latour R; Dufour C; Risitano A; Chaudhri N; Bazarbachi A; De La Fuente J; Höchsmann B; Osman Ahmed S; Gergis U; Elhaddad A; Halkes C; Albeirouti B; Alotaibi S; Kulasekararaj A; Alzahrani H; Ben Othman T; Cesaro S; Alahmari A; Rihani R; Alshemmari S; Hamidieh AA; Bekadja M-A; Passweg J; Al-Khabori M; Rasheed W; Bacigalupo A; Chaudhry Q-U; Ljungman P; Marsh J; El Fakih R; Aljurf M; Eastern Mediterranean Blood and Marrow Transplanta; Severe Aplastic Anemia Working Party of the Europe
Letter: BONE MARROW TRANSPLANTATION. 2022;57(2):299-301
Defining the impact of SARS-COV-2 on delivery of CAR T-cell therapy in Europe: a retrospective survey from the CTIWP of the EBMT
Ghorashian S; Malard F; Yuksel MK; Mauff K; Hoogenboom JD; Urbano-Ispizua A; Kuball J; de la Camara R; Ljungman P; Ruggeri A; Chabannon C
Editorial comment: HEMASPHERE. 2021;5(12):e662
The EHA Research Roadmap: Infections in Hematology
Cordonnier C; Ljungman P; Cesaro S; Hirsch HH; Maschmeyer G; von Lilienfeld-Toal M; Vehreschild M; Mikulska M; Emonts M; Gennery AR; Neofytos D; Bochud P-Y; Einsele H; Maertens J
Letter: LEUKEMIA. 2021;35(12):3585-3588
Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group
Spanjaart AM; Ljungman P; de La Camara R; Tridello G; Ortiz-Maldonado V; Urbano-Ispizua A; Barba P; Kwon M; Caballero D; Sesques P; Bachy E; Di Blasi R; Thieblemont C; Calkoen F; Mutsaers P; Maertens J; Giannoni L; Nicholson E; Collin M; Vaz CP; Metafuni E; Martinez-Lopez J; Dignan FL; Ribera J-M; Nagler A; Folber F; Sanderson R; Bloor A; Ciceri F; Knelange N; Ayuk F; Kroger N; Kersten MJ; Mielke S
Editorial comment: BLOOD. 2021;138(14):1208-1209
One step at a time
Schoemans H; Ljungman P
Editorial comment: HAEMATOLOGICA. 2021;106(10):2783-2787
Successful pregnancies after transplantation of ovarian tissue retrieved and cryopreserved at time of childhood acute lymphoblastic leukemia - a case report
Rodriguez-Wallberg KA; Milenkovic M; Papaikonomou K; Keros V; Gustafsson B; Sergouniotis F; Wikander I; Perot R; Borgstrom B; Ljungman P; Barbany G
Review: JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2021;9(6):e002630
COVID-19 in immunocompromised populations: implications for prognosis and repurposing of immunotherapies
Goldman JD; Robinson PC; Uldrick TS; Ljungman P
Corrigendum: BONE MARROW TRANSPLANTATION. 2021;56(3):755
Correction: The challenge of COVID-19 and hematopoietic cell transplantation: EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy.
Ljungman P; Mikulska M; de la Camara R; Basak GW; Chabannon C; Corbacioglu S; Duarte R; Dolstra H; Lankester AC; Mohty M; Montoto S; Murray J; de Latour RP; Snowden JA; Yakoub-Agha I; Verhoeven B; Kröger N; Styczynski J; European Society for Blood and Marrow Transplantat
Corrigendum: FRONTIERS IN IMMUNOLOGY. 2021;12:813838
Haplotype Motif-Based Models for KIR-Genotype Informed Selection of Hematopoietic Cell Donors Fail to Predict Outcome of Patients With Myelodysplastic Syndromes or Secondary Acute Myeloid Leukemia (vol 11, 584520, 2021)
Schetelig J; Baldauf H; Koster L; Kuxhausen M; Heidenreich F; de Wreede LC; Spellman S; van Gelder M; Bruno B; Onida F; Lange V; Massalski C; Potter V; Ljungman P; Schaap N; Hayden P; Lee SJ; Kroeger N; Hsu K; Schmidt AH; Yakoub-Agha I; Robin M
Corrigendum: BONE MARROW TRANSPLANTATION. 2020;55(9):1884
Correction: Long-term outcome after allogeneic hematopoietic stem cell transplantation for Shwachman-Diamond syndrome: a retrospective analysis and a review of the literature by the Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation (SAAWP-EBMT).
Cesaro S; Pillon M; Sauer M; Smiers F; Faraci M; de Heredia CD; Wynn R; Greil J; Locatelli F; Veys P; Uyttebroeck A; Ljungman P; Chevalier P; Ansari M; Badell I; Güngör T; Salim R; Tischer J; Tecchio C; Russell N; Chybicka A; Styczynski J; Krivan G; Smith O; Stein J; Afanasyev B; Pochon C; Menconi MC; Bosman P; Mauro M; Tridello G; de Latour RP; Dufour C
Letter: BRITISH JOURNAL OF HAEMATOLOGY. 2020;189(5):e213-e217
Treosulfan conditioning for allogeneic transplantation in multiple myeloma - improved overall survival in first line haematopoietic stem cell transplantation - a large retrospective study by the Chronic Malignancies Working Party of the EBMT
Gran C; Wang J; Nahi H; Koster L; Gahrton G; Einsele H; Niittyvoupio R; Edinger M; Beelen D; Ciceri F; Bornhaeuser M; Finke J; de Wreede LC; Ljungman P; Mielke S; Tischer J; Garderet L; Schoenland S; Yakoub-Agha I; Kroeger N
Review: BLOOD. 2020;135(19):1619-1629
How I treat CMV reactivation after allogeneic hematopoietic stem cell transplantation
Einsele H; Ljungman P; Boeckh M
Editorial comment: BLOOD. 2020;135(17):1413-1414
Is antiviral therapy against HHV-6B beneficial?
Ljungman P
Corrigendum: BONE MARROW TRANSPLANTATION. 2020;55(4):838-839
Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) (vol 55, pg 681, 2019)
Snowden JA; Saccardi R; Orchard K; Ljungman P; Duarte RF; Labopin M; McGrath E; Brook N; de Elvira CR; Gordon D; Poirel HA; Ayuk F; Beguin Y; Bonifazi F; Gratwohl A; Milpied N; Moore J; Passweg J; Rizzo JD; Spellman SR; Sierra J; Solano C; Sanchez-Guijo F; Worel N; Gusi A; Adams G; Balan T; Baldomero H; Macq G; Marry E; Mesnil F; Oldani E; Pearce R; Perry J; Raus N; Schanz U; Tran S; Wilcox L; Basak GW; Chabannon C; Corbacioglu S; Dolstra H; Kuball J; Mohty M; Lankester A; Montoto S; Nagler A; Styczynski J; Yakoub-Agha I; de Latour RP; Kroeger N; Brand R; de Wreede LC; van Zwet E; Putter H
Review: BONE MARROW TRANSPLANTATION. 2020;55(4):681-694
Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)
Snowden JA; Saccardi R; Orchard K; Ljungman P; Duarte RF; Labopin M; McGrath E; Brook N; de Elvira CR; Gordon D; Poirel HA; Ayuk F; Beguin Y; Bonifazi F; Gratwohl A; Milpied N; Moore J; Passweg J; Rizzo JD; Spellman SR; Sierra J; Solano C; Sanchez-Guijo F; Worel N; Gusi A; Adams G; Balan T; Baldomero H; Macq G; Marry E; Mesnil F; Oldani E; Pearce R; Perry J; Raus N; Schanz U; Tran S; Wilcox L; Basak GW; Chabannon C; Corbacioglu S; Dolstra H; Kuball J; Mohty M; Lankester A; Montoto S; Nagler A; Styczynski J; Yakoub-Agha I; de Latour RP; Kroeger N; Brand R; de Wreede LC; van Zwet E; Putter H
Review: BONE MARROW TRANSPLANTATION. 2020;55(1):110-116
Incidence and outcome of Kaposi sarcoma after hematopoietic stem cell transplantation: a retrospective analysis and a review of the literature, on behalf of infectious diseases working party of EBMT
Cesaro S; Tridello G; van der Werf S; Bader P; Socie G; Ljungman P; McQuaker G; Giardino S; Uckan-Cetinkaya D; Anagnostopoulos A; Ozdogu H; Schots R; Jindra P; Ladetto M; Schroyens W; Mikulska M; Styczynski J
Editorial comment: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2019;25(12):1451-1453
Reporting infectious complications in haematology clinical trials should be improved
Cordonnier C; Maschmeyer G; Cesaro S; Ljungman P
Editorial comment: THE LANCET INFECTIOUS DISEASES. 2019;19(9):921-922
Varicella zoster virus vaccine in patients with haematological malignancies
Ljungman P
Review: THE LANCET INFECTIOUS DISEASES. 2019;19(8):e260-e272
Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European Conference on Infections in Leukaemia (ECIL 7)
Ljungman P; de la Camara R; Robin C; Crocchiolo R; Einsele H; Hill JA; Hubacek P; Navarro D; Cordonnier C; Ward KN; Greinix H; Slavin M; De Greef J; Maertens J; Hubacek P; Racil Z; Lundgren J; Bergeron A; Cordonnier C; Di Blasi R; Herbrecht R; Lortholary O; Robin C; Thiebaut A; Einsele H; Lehrnbecher T; Maschmeyer G; Mellinghoff S; Penack O; Roilides E; Kassa C; Averbuch D; Busca A; Cesaro S; Crocchiolo R; Gallo G; Mikulska M; Nosari AM; Pagano L; Viscoli C; Blijlevens N; Donnelly P; Koltan PS; Styczynski J; de Sousa AB; Klyasova G; Aljurf M; Drgona L; de la Camara R; Duarte R; Martino R; Navarro D; Rovira M; Einarsdottir S; Ljungman P; Paukssen K; Wenneras C; Calandra T; Akova M; de lavallade H; Ward KN; Hill JA; Dubel L; Mills L; Rupp M; Sanchez S; Zeitler S
Review: INFECTIOUS DISEASES. 2019;51(7):479-484
Management of BK-virus infection - Swedish recommendations
Dalianis T; Eriksson B-M; Felldin M; Friman V; Hammarin A-L; Herthelius M; Ljungmang P; Molne J; Wennberg L; Swartling L
Letter: THE LANCET INFECTIOUS DISEASES. 2019;19(7):694-695
2017 ECIL 7 vaccine guidelines
Cordonnier C; Mikulska M; Einarsdottir S; Cesaro S; Ljungman P
Published conference paper: THE LANCET INFECTIOUS DISEASES. 2019;19(6):e188-e199
Vaccination of patients with haematological malignancies who did not have transplantations: guidelines from the 2017 European Conference on Infections in Leukaemia (ECIL 7)
Mikulska M; Cesaro S; de Lavallade H; Di Blasi R; Einarsdottir S; Gallo G; Rieger C; Engelhard D; Lehrnbecher T; Ljungman P; Cordonnier C; Akova M; Aljurf M; Averbuch D; Bergeron A; Blijlevens N; de Sousa AB; Busca A; Calandra T; Crocchiolo R; De Greef J; de la Camara R; Donnelly P; Drgona L; Duarte R; Einsele H; Greinix H; Herbrecht R; Hill J; Hubacek P; Kassa C; Klyasova G; Koltan S; Lortholary O; Lundgren J; Maertens J; Martino R; Maschmeyer G; Mellinghoff S; Navarro D; Nosari AM; Pagano L; Paukssen K; Penack O; Racil Z; Robin C; Roilides E; Rovira M; Slavin M; Styczynski J; Thiebaut A; Viscoli C; Ward K; Wenneras C
Published conference paper: THE LANCET INFECTIOUS DISEASES. 2019;19(6):e200-e212
Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7)
Cordonnier C; Einarsdottir S; Cesaro S; Di Blasi R; Mikulska M; Rieger C; de Lavallade H; Gallo G; Lehrnbecher T; Engelhard D; Ljungman P; Akova M; Aljurf M; Averbuch D; Bergeron A; Blijlevens N; de Sousa AB; Busca A; Calandra T; Cesaro S; Crocchiolo R; De Greef J; de la Camara R; Donnelly P; Drgona L; Duarte R; Einarsdottir S; Einsele H; Greinix H; Herbrecht R; Hill J; Hubacek P; Kassa C; Klyasova G; Koltan S; Lortholary O; Lundgren J; Maertens J; Martino R; Maschmeyer G; Mellinghoff S; Navarro D; Nosari AM; Pagano L; Paukssen K; Penack O; Racil Z; Robin C; Roilides E; Rovira M; Slavin M; Styczynski J; Thiebaut A; Viscoli C; Ward K; Wenneras C
Review: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2018;73(12):3221-3230
European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia
Maertens JA; Girmenia C; Bruggemann RJ; Duarte RF; Kibbler CC; Ljungman P; Racil Z; Ribaud P; Slavin MA; Cornely OA; Donnelly JP; Cordonnier C
Review: TRANSPLANTATION AND CELLULAR THERAPY. 2018;24(11):2324-2336
Human Herpesvirus-6B Reactivation Is a Risk Factor for Grades II to IV Acute Graft-versus-Host Disease after Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis
Phan TL; Carlin K; Ljungman P; Politikos I; Boussiotis V; Boeckh M; Shaffer ML; Zerr DM
Review: TRANSPLANTATION AND CELLULAR THERAPY. 2018;24(10):2101-2109
Comparative Efficacy and Safety of Different Antiviral Agents for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation: A Systematic Review and Meta-Analysis
Gagelmann N; Ljungman P; Styczynski J; Kroeger N
Editorial comment: ANNALS OF ONCOLOGY. 2018;29(6):1348-1349
Stringent vaccination of cancer patients: is it that important
Weber T; Ljungman P
Review: CLINICAL INFECTIOUS DISEASES. 2018;66(4):617-631
Use of Viral Load as a Surrogate Marker in Clinical Studies of Cytomegalovirus in Solid Organ Transplantation: A Systematic Review and Meta-analysis
Natori Y; Alghamdi A; Tazari M; Miller V; Husain S; Komatsu T; Griffiths P; Ljungman P; Orchanian-Cheff A; Kumar D; Humar A
Review: TRANSPLANTATION AND CELLULAR THERAPY. 2017;23(10):1614-1621
Measuring Immune Response to Commonly Used Vaccinations in Adult Recipients of Allogeneic Hematopoietic Cell Transplantation
Kennedy LB; Li Z; Savani BN; Ljungman P
Editorial comment: BLOOD. 2017;130(8):961-962
Chromosomally integrated HHV-6: a new piece of the puzzle
Ljungman P
Letter: ANNALS OF ONCOLOGY. 2017;28(7):1672-1673
Lethal aplastic anemia caused by dual immune checkpoint blockade in metastatic melanoma
Helgadottir H; Kis L; Ljungman P; Larkin J; Kefford R; Ascierto PA; Hansson J; Masucci G
Review: BLOOD. 2017;129(13):1753-1762
Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel
de Witte T; Bowen D; Robin M; Malcovati L; Niederwieser D; Yakoub-Agha I; Mufti GJ; Fenaux P; Sanz G; Martino R; Alessandrino EP; Onida F; Symeonidis A; Passweg J; Kobbe G; Ganser A; Platzbecker U; Finke J; van Gelder M; van de Loosdrecht AA; Ljungman P; Stauder R; Volin L; Deeg HJ; Cutler C; Saber W; Champlin R; Giralt S; Anasetti C; Kroeger N
Letter: BONE MARROW TRANSPLANTATION. 2016;51(11):1518-1521
High incidence of severe chronic GvHD after HSCT with sibling donors. A single center analysis
Remberger M; Afram G; Sundin M; Uhlin M; LeBlanc K; Bjorklund A; Mattsson J; Ljungman P
Review: HAEMATOLOGICA. 2016;101(7):803-811
Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines
Styczynski J; van der Velden W; Fox CP; Engelhard D; de la Camara R; Cordonnier C; Ljungman P
Review: THE LANCET INFECTIOUS DISEASES. 2016;16(5):606-617
Management of viral hepatitis in patients with haematological malignancy and in patients undergoing haemopoietic stem cell transplantation: recommendations of the 5th European Conference on Infections in Leukaemia (ECIL-5)
Mallet V; van Boemmel F; Doerig C; Pischke S; Hermine O; Locasciulli A; Cordonnier C; Berg T; Moradpour D; Wedemeyer H; Ljungman P
Review: BLOOD REVIEWS. 2016;30(2):139-147
Vaccinations in patients with hematological malignancies
Tsigrelis C; Ljungman P
Editorial comment: THE LANCET HAEMATOLOGY. 2016;3(3):e102
Does cytomegalovirus viral load in stem-cell transplant recipients matter?
Ljungman P
Review: BRITISH JOURNAL OF HAEMATOLOGY. 2016;172(4):497-511
The challenge of antibiotic resistance in haematology patients
Blennow O; Ljungman P
Review: BONE MARROW TRANSPLANTATION. 2015;50(7):899-903
Pretransplant vaccinations in allogeneic stem cell transplantation donors and recipients: an often-missed opportunity for immunoprotection?
Harris AE; Styczynski J; Bodge M; Mohty M; Savani BN; Ljungman P
Editorial comment: BLOOD. 2015;125(11):1683-1684
Enterovirus D68: a new threat to hematology patients?
Ljungman P
Letter: TRANSPLANTATION. 2014;98(12):e95-e96
Allogeneic Hematopoietic Cell Transplantation for GATA2 Deficiency in a Patient With Disseminated Human Papillomavirus Disease
Maeurer M; Magalhaes I; Andersson J; Ljungman P; Sandholm E; Uhlin M; Mattsson J; Ringden O
Review: CURRENT OPINION IN HEMATOLOGY. 2014;21(6):466-469
The role of cytomegalovirus serostatus on outcome of hematopoietic stem cell transplantation
Ljungman P
Editorial comment: JOURNAL OF INFECTIOUS DISEASES. 2014;209(8):1151-1152
Respiratory Syncytial Virus in Hematopoietic Cell Transplant Recipients: Factors Determining Progression to Lower Respiratory Tract Disease
Ljungman P
Review: VACCINE. 2013;32(1):4-10
Priorities for CMV vaccine development
Krause PR; Bialek SR; Boppana SB; Griffiths PD; Laughlin CA; Ljungman P; Mocarski ES; Pass RF; Read JS; Schleiss MR; Plotkin SA
Letter: BONE MARROW TRANSPLANTATION. 2013;48(10):1366-1367
Human parvovirus B19 in pediatric and adult recipients of allogeneic hematopoietic stem cell transplantation
Ohrmalm L; Gustafson I; Lindblom A; Norbeck O; Johansson J-E; Brune M; Ljungman P; Broliden K
Editorial comment: BLOOD. 2013;122(7):1101-1102
CMV: a warrior against leukemia?
Ljungman P
Review: TRANSPLANT INFECTIOUS DISEASE. 2013;15(3):219-232
European guidelines for prevention and management of influenza in hematopoietic stem cell transplantation and leukemia patients: summary of ECIL-4 (2011), on behalf of ECIL, a joint venture of EBMT, EORTC, ICHS, and ELN
Engelhard D; Mohty B; de la Camara R; Cordonnier C; Ljungman P
Corrigendum: LUPUS. 2013;22(6):653
Autologous haematopoietic stem cell transplantation for systemic lupus erythematosus: data from the European Group for Blood and Marrow Transplantation registry (vol 22, pg 245, 2013)
Alchi B; Jayne D; Labopin M; Demin A; Sergeevicheva V; Alexander T; Gualandi F; Gruhn B; Ouyang J; Rzepecki P; Held G; Sampol A; Voswinkel J; Ljungman P; Fassas A; Badoglio M; Saccardi R; Farge D
Review: BONE MARROW TRANSPLANTATION. 2013;48(4):574-580
HHV-6 encephalitis in umbilical cord blood transplantation: a systematic review and meta-analysis
Scheurer ME; Pritchett JC; Amirian ES; Zemke NR; Lusso P; Ljungman P
Review: BONE MARROW TRANSPLANTATION. 2013;48(2):168-173
Supportive care in severe and very severe aplastic anemia
Hoechsmann B; Moicean A; Risitano A; Ljungman P; Schrezenmeier H
Review: CLINICAL INFECTIOUS DISEASES. 2013;56(2):258-266
Fourth European Conference on Infections in Leukaemia (ECIL-4): Guidelines for Diagnosis and Treatment of Human Respiratory Syncytial Virus, Parainfluenza Virus, Metapneumovirus, Rhinovirus, and Coronavirus
Hirsch HH; Martino R; Ward KN; Boeckh M; Einsele H; Ljungman P
Review: TRANSPLANT INFECTIOUS DISEASE. 2012;14(6):555-563
European guidelines for diagnosis and treatment of adenovirus infection in leukemia and stem cell transplantation: summary of ECIL-4 (2011)
Matthes-Martin S; Feuchtinger T; Shaw PJ; Engelhard D; Hirsch HH; Cordonnier C; Ljungman P
Review: EUROPEAN RESPIRATORY JOURNAL. 2012;40(4):990-1013
The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement
Bumbacea D; Arend SM; Eyuboglu F; Fishman JA; Goletti D; Ison MG; Jones CE; Kampmann B; Kotton CN; Lange C; Ljungman P; Milburn H; Morris MI; Muller E; Munoz P; Nellore A; Rieder HL; Sester U; Theodoropoulos N; Wagner D; Sester M
Review: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2012;18:93-99
Vaccination of immunocompromised patients
Ljungman P
Letter: BONE MARROW TRANSPLANTATION. 2011;46(4):621
Vaccination of SCT recipients
Ljungman P; Small TN
Review: ANTICANCER RESEARCH. 2011;31(3):939-944
Full Myeloablative Conditioning and an Unrelated HLA Mismatched Donor Increase the Risk for BK Virus-positive Hemorrhagic Cystitis in Allogeneic Hematopoetic Stem Cell Transplanted Patients
Dalianis T; Ljungman P
Editorial comment: TRANSPLANTATION AND CELLULAR THERAPY. 2011;17(1):S2-S5
Viral Infections in Immunocompromised Patients
Englund J; Feuchtinger T; Ljungman P
Letter: BRITISH JOURNAL OF HAEMATOLOGY. 2010;150(3):377-379
Should irradiated blood products be given routinely to all patients with aplastic anaemia undergoing immunosuppressive therapy with antithymocyte globulin (ATG)? A survey from the European Group for Blood and Marrow Transplantation Severe Aplastic Anaemia Working Party
Marsh J; Socie G; Tichelli A; Schrezenmeier H; Hochsmann B; Risitano AM; Fuehrer M; Bekassy AN; Korthof ET; Locasciulli A; Ljungman P; Bacigalupo A; Camitta B; Young NS; Passweg J
Letter: THE LANCET INFECTIOUS DISEASES. 2010;10(8):506-507
Solid-organ transplants and the risks of pandemic influenza
Ljungman P
Meeting abstract: HUMAN IMMUNOLOGY. 2009;70:S100
MAINTAINED TOLERANCE OF NK CELLS EXPRESSING INHIBITORY KIR FOR NON-SELF LIGANDS IN HLA-MATCHED SIBLING STEM CELL TRANSPLANTATION
Schaffer M; Bjorklund A; Fauriat C; Ringden O; Remberger M; Ljungman P; Ljunggren H-G; Malmberg K-J
Review: TRANSPLANT INFECTIOUS DISEASE. 2009;11(5):383-392
Outcome of treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases
Styczynski J; Einsele H; Gil L; Ljungman P
Review: BLOOD. 2009;113(23):5711-5719
How I treat cytomegalovirus in hematopoietic cell transplant recipients
Boeckh M; Ljungman P
Published conference paper: CLINICAL INFECTIOUS DISEASES. 2009;48(10):1392-1401
Randomized Study of Early versus Late Immunization with Pneumococcal Conjugate Vaccine after Allogeneic Stem Cell Transplantation
Cordonnier C; Labopin M; Chesnel V; Ribaud P; De la Camara R; Martino R; Ullmann AJ; Parkkali T; Locasciulli A; Yakouben K; Pauksens K; Einsele H; Niederwieser D; Apperley J; Ljungman P
Review: BONE MARROW TRANSPLANTATION. 2009;43(10):757-770
Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia
Styczynski J; Reusser P; Einsele H; de la Camara R; Cordonnier C; Ward KN; Ljungman P; Engelhard D
Letter: BRITISH JOURNAL OF HAEMATOLOGY. 2008;143(5):751-753
Transmission of chronic lymphocytic leukaemia from a blood stem cell sibling donor to the recipient
Nahi H; Jansson M; Sander B; Ljungman P; Hagglund H
Review: BONE MARROW TRANSPLANTATION. 2008;42(10):637-641
Influenza vaccination in hematopoietic SCT recipients
Ljungman P; Avetisyan G
Review: BONE MARROW TRANSPLANTATION. 2008;42:S70-S72
CMV infections after hematopoietic stem cell transplantation
Ljungman P
Review: BONE MARROW TRANSPLANTATION. 2008;42(4):227-240
Management of CMV, HHV-6, HHV-7 and Kaposi-sarcoma herpesvirus (HHV-8) infections in patients with hematological malignancies and after SCT
Ljungman P; de la Camara R; Cordonnier C; Einsele H; Engelhard D; Reusser P; Styczynski J; Ward K
Review: TRANSPLANTATION. 2008;86(2):183-191
Antifungal therapy strategies in hematopoietic stem-cell transplant recipients: Early treatment options for improving outcomes
Chandrasekar P; Ljungman PT
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2008;14(2):118-119
ROLE OF RITUXIMAB FOR PROPHYLACTIC OR PREEMPTIVE THERAPY OF EBV-DNA-emia AND THERAPY OF EBV-PTLD IN HSCT RECIPIENTS: A SYSTEMATIC REVIEW
Styczynski J; Einsele H; de la Camara R; Engelhard D; Reusser P; Ward KN; Ljungman P
Review: BLOOD. 2008;111(2):534-536
Polymorphisms, in the chemokine (C-X-C motif) ligand 10 are associated with invasive aspergillosis after allogeneic stem-cell transplantation and influence CXCL10 epression in monocyte-derived dendritic cells
Mezger M; Steffens M; Beyer M; Manger C; Eberle J; Toliat M-R; Wienker TF; Ljungman P; Hebart H; Dornbusch HJ; Einsele H; Loeffler J
Editorial comment: MEDICAL ONCOLOGY. 2007;24(3):354-356
Relapse of preB-ALL after rituximab treatment for chronic graft versus host disease.: Implications for its use?
Deneberg S; Lerner R; Ljungman P; Ringden O; Hagglund H
Published conference paper: JOURNAL OF CLINICAL VIROLOGY. 2006;37:S87-S91
Human herpesvirus-6 infection in solid organ and stem cell transplant recipients
Ljungman P; Singh N
Editorial comment: CLINICAL INFECTIOUS DISEASES. 2006;43(8):1031-1039
Clinical research in the lay press: Irresponsible journalism raises a huge dose of doubt
Anaissie EJ; Segal BH; Graybill JR; Arndt C; Perfect JR; Kleinberg M; Pappas P; Benjamin D; Rubin R; Aberg JA; Adderson EE; Adler-Shohet FC; Akan H; Akova M; Almyroudis NG; Alexander BD; Andes D; Arrieta A; Baddley JW; Barron MA; Belzberg H; Boucher HW; Boyce TG; Casadevall A; Chandrasekar PH; Cleary JD; Cordonnier C; Cornely OA; Cuenca-Estrella M; Daly JS; Daoura N; Denning DW; dePauw B; de Repentigny L; Dignani MC; Dismukes WE; Donnelly JP; Donowitz GR; Dupont B; Drusano G; Ellis M; Espinel-Ingroff A; Fishman JA; Fleming R; Forrest G; Ghannoum M; Goldman M; Grazziutti M; Greene JN; Greenberg RN; Gubbins PO; Hadley S; Herbrecht R; Hiemenz JW; Hope W; Hospenthal DR; Husain S; Ito JI; Jacobson RM; Johnson M; Keating MR; Kett DH; Knapp K; Kontoyiannis DP; Krcmery VC; Larsen R; Laverdiere M; Ljungman P; Lortholary O; Maertens J; Marriott D; Mattiuzzi G; McGinnis MR; Morris M; Nucci M; Odds FC; Pankey GA; Patterson T; Pfaller M; Razonable RR; Reboli AC; Rinaldi MG; Roberts GD; Rodriguez Tudela JL; Rotstein C; Ruhnke M; Schuster M; Shoham S; Sia IG; Siebel N; Silviera F; Singh N; Sobel J; Solomkin JS; Sorrell TC; Steinbach WJ; Temesgen Z; Tortorano A; Vartivarian S; VerWeij P; Viscoli C; Viviani MA; Walker RC; Wheat JL; Wiley J; Williamson P; Wingard JR; Yu VL; Zaoutis T
Published conference paper: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2006;28(4):292-296
Viridans group streptococci in blood culture isolates in a Swedish university hospital: antibiotic susceptibility and identification of erythromycin resistance genes
Westling K; Julander I; Ljungman P; Jalal S; Nord CE; Wretlind B
Review: TRANSFUSION MEDICINE REVIEWS. 2006;20(1):45-56
The role of photochemical treatment with amotosalen and UV-A light in the prevention of transfusion-transmitted cytomegalovirus infections
Roback JD; Conlan M; Drew WL; Ljungman P; Nichols WG; Preiksaitis JK
Review: BONE MARROW TRANSPLANTATION. 2004;34(8):657-665
Transmission of donor illness by stem cell transplantation:: should screening be different in older donors?
Niederwieser D; Gentilini C; Hegenbart U; Lange T; Moosmann P; Pönisch W; Al-Ali H; Raida M; Ljungman P; Tyndall A; Urbano-Ispizua A; Lazarus HM; Gratwohl A
Review: EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES. 2004;23(8):583-588
Treatment of adenovirus infections in the immunocompromised host
Ljungman P
Review: BRITISH JOURNAL OF HAEMATOLOGY. 2004;125(2):107-116
Risk of cytomegalovirus transmission by blood products to immunocompromised patients and means for reduction
Ljungman P
Published conference paper: HEMATOLOGY JOURNAL. 2004;5 Suppl 3:s63-s68
Viral infections: current diagnosis and treatment.
Ljungman P
Published conference paper: JOURNAL OF INFECTIOUS DISEASES. 2002;186:S99-S109
β-herpesvirus challenges in the transplant recipient
Ljungman P
Review: BRITISH JOURNAL OF HAEMATOLOGY. 2002;118(1):44-57
Prevention and treatment of viral infections in stem cell transplant recipients
Ljungman P
Published conference paper: INTERNATIONAL JOURNAL OF HEMATOLOGY. 2002;76:300
New strategies in the management of herpesvirus infections
Ljungman P
Editorial comment: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2002;34(4):316-319
Streptococcus viridans septicaemia: A comparison study in patients admitted to the departments of infectious diseases and haematology in a university hospital
Westling K; Ljungman P; Thalme A; Julander I
Published conference paper: CLINICAL INFECTIOUS DISEASES. 2001;33 Suppl 1:s15-s21
Prophylactic measures in the solid-organ recipient before transplantation.
Avery RK; Ljungman P
Published conference paper: TRANSPLANTATION PROCEEDINGS. 2001;33(1-2):1769-1770
An ethnic role for chronic, but not acute, graft-versus-host disease after HLA-identical sibling stem cell transplantation
Remberger M; Aschan J; Lönnqvist B; Carlens S; Gustafsson B; Hentschke P; Klaesson S; Mattsson J; Ljungman P; Ringdén O
Letter: BLOOD. 2001;98(5):1628
Response: Cidofovir against cytomegalovirus after allogeneic stem cell transplantation
Ljungman P; Cordonnier C
Published conference paper: TRANSPLANTATION AND CELLULAR THERAPY. 2001;7:5S-7S
Respiratory virus infections in stem cell transplant patients: The European experience
Ljungman P
Review: DRUGS. 2001;61(2):187-196
Prophylaxis against herpesvirus infections in transplant recipients
Ljungman P
Meeting abstract: EUROPEAN JOURNAL OF CANCER. 1999;35:S298
Lenograstim (glycosylated rHuG-CSF) post high-dose chemotherapy and PBPC transplant in breast cancer and NHL patients
Björkstrand B; Ljungman P; Juliusson G; Villman K; Cohen-Scali S
Meeting abstract: EUROPEAN JOURNAL OF CANCER. 1999;35:S297
Lenograstim (glycosylated rHuG-CSF) enables mobilization of enough PBPC in breast cancer and NHL patients from dose of 2.5 μg/kg/day
Björkstrand B; Ljungman P; Villman K; Juliusson G; Cohen-Scali S
Editorial comment: BONE MARROW TRANSPLANTATION. 1999;23(7):635-636
Immunization of transplant recipients
Ljungman P
Published conference paper: BONE MARROW TRANSPLANTATION. 1998;21 Suppl 2:S72-S74
Immune reconstitution and viral infections after stem cell transplantation.
Ljungman P
Published conference paper: BONE MARROW TRANSPLANTATION. 1998;21:S24-S27
Allogeneic stem cell transplantation for Fanconi anaemia
Guardiola P; Socié G; Pasquini R; Dokal I; Ortega JJ; van Weel-Sipman M; Marsh J; Locatelli F; Souillet G; Cahn JY; Ljungman P; Miniero R; Shaw J; Vermylen C; Archimbaud E; Bekassy AN; Krivan G; Di Bartolomeo P; Bacigalupo A; Gluckman E
Published conference paper: ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY. 1998;451:493-497
Gene marking and gene therapy in multiple myeloma
Gahrton G; Björkstrand B; Dilber MS; Sundman-Engberg B; Ljungman P; Smith CIE
Published conference paper: TRANSPLANTATION PROCEEDINGS. 1997;29(7):3147-3149
Factors affecting risk of relapse and leukemia-free survival in HLA-identical sibling marrow transplant recipients with leukemia
Carlens S; Ringden O; Remberger M; Mattsson J; Aschan J; Hagglund H; Ljungman P
Published conference paper: TRANSPLANTATION PROCEEDINGS. 1997;29(7):3145-3146
Transplantation with unrelated bone marrow in leukemic patients above 40 years of age
Ringden O; Remberger M; Mattsson J; Aschan J; Hagglund H; Carlens S; Lonnqvist B; Sparrelid E; Ljungman P
Published conference paper: TRANSPLANTATION PROCEEDINGS. 1997;29(1-2):735-736
A low incidence of grade II to IV acute GVHD, but high mortality from, infection using HLA-A, -B, and -DR-identical unrelated donors and immunosuppression with ATG, cyclosporine, and methotrexate
Mattsson J; Ringden O; Aschan J; Barkholt L; Dalianis T; Hagglund H; Ljungman P; Lonnqvist B; Tollemar J; Winiarski J; Remberger M
Published conference paper: BONE MARROW TRANSPLANTATION. 1996;18 Suppl 2:80-85
Unrelated-donor bone marrow transplantation for Philadelphia chromosome-positive chronic myelogenous leukemia in children: experience of eight European Countries. The EBMT Paediatric Diseases Working Party.
Dini G; Rondelli R; Miano M; Vossen J; Gluckman E; Peters C; Bordigoni P; Locatelli F; Miniero R; Ljungman P; Saarinen U; Klingebiel T; Ortega J; Lanino E
Review: LEUKEMIA AND LYMPHOMA. 1996;22(5-6):395-407
Aspects concerning busulfan pharmacokinetics and bioavailability
Hassan M; Ehrsson H; Ljungman P
Published conference paper: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, SUPPLEMENT. 1996;100:59-63
Cytomegalovirus infections in transplant patients
Ljungman P
Review: SEMINARS IN RESPIRATORY INFECTIONS. 1995;10(4):209-215
Cytomegalovirus pneumonia: presentation, diagnosis, and treatment.
Ljungman P
Letter: BONE MARROW TRANSPLANTATION. 1995;16(6):856-857
Transplantation with peripheral blood stem cells from unrelated donors without serious graft-versus-host disease
Ringden O; Lonnqvist B; Hagglund H; Ljungman P; Shanwell A; Lawlor E; Schmitz N
Published conference paper: TRANSPLANTATION PROCEEDINGS. 1995;27(6):3535
No beneficial effects, but severe side effects caused by recombinant human tissue plasminogen activator for treatment of hepatic veno-occlusive disease after allogeneic bone marrow transplantation
Hagglund H; Ringden O; Ljungman P; Winiarski J; Ericzon B; Tyden G
Published conference paper: TRANSPLANTATION PROCEEDINGS. 1995;27(6):3531-3532
Bone marrow transplantation for chronic myelogenous leukemia using unrelated donors: The experience at Huddinge Hospital
Aschan J; Ringden O; Ljungman P; Hagglund H; Klaesson S; Dalianis T; Remberger M
Published conference paper: TRANSPLANTATION PROCEEDINGS. 1995;27(6):3530
Risk factors for septicemia during aplastic period after allogeneic bone marrow transplantation
Sparrelid E; Hagglund H; Remberger M; Ljungman P; Malmborg AS; Winiarski J; Andersson J; Ringden O
Published conference paper: TRANSPLANTATION PROCEEDINGS. 1995;27(6):3528-3529
Less acute GVHD in patients receiving totally matched transplants from unrelated donors
Lonnqvist B; Ljungman P; Norrby M; Olerup O; Ringden O; Winiarski J
Letter: BLOOD. 1995;85(9):2640
THE GENOTYPE OF HEPATITIS-C VIRUS DOES NOT AFFECT SEVERITY OF LIVER-DISEASE AFTER BONE-MARROW TRANSPLANTATION
LOCASCIULLI A; PONTISSO P; ALBERTI A; BACIGALUPO A; LJUNGMAN P; FRICKHOFEN N
Other: BONE MARROW TRANSPLANTATION. 1995;15(5):799-801
BONE-MARROW TRANSPLANTATION IN 2 CHILDREN WITH CONGENITAL AMEGAKARYOCYTIC THROMBOCYTOPENIA
HENTER JJ; WINIARSKI J; LJUNGMAN P; RINGDEN O; OST A
Letter: BRITISH JOURNAL OF HAEMATOLOGY. 1995;89(3):691
Transmission of human T-lymphotrophic virus type 1 by bone marrow transplantation.
Miyoshi I; Murata N; Machida H; Taguchi H
Editorial comment: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 1995;:87-89
Workshop on CMV disease; Definitions, clinical severity scores, and new syndromes
Ljungman P; Plotkin SA
Visa fler

Om mig

Forskningsbeskrivning

Artiklar

Alla övriga publikationer

Nyheter från KI

Kalenderhändelser från KI